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ABSTRACT OF THE DISSERTATION
Neuropsychological Correlates of Anosognosia in MCI and Dementia
by
Kyrstle Dina Barrera
Doctor of Philosophy, Graduate Program in Psychology
Loma Linda University, September 2013
Drs. Travis G. Fogel and Susan A. Ropacki, Co-Chairpersons

Anosognosia is a general term used to describe a lack of awareness of a disability
and is well documented in various disorders associated with neurological compromise.
While anosognosia is well documented as part and parcel to Alzheimer’s dementia, less
research has focused on determining the presence of anosognosia in what has come to be
viewed as the subclinical precursor to dementia, mild cognitive impairment. In addition, a
number of different methodologies and instruments are employed in quantifying and
assessing anosognosia in various populations, which make comparison across studies and
diagnoses difficult. Research commonly employs a paradigm that uses the discrepancy
between informant and patient reports as measures of anosognosia, using informant
reports as the benchmark against which patient ratings are compared. Little research has
been done, however, to investigate the accuracy of informant reports as they relate to
actual patient performance.
The current study sought to investigate the accuracy of patient and informant
reports as they relate to actual neuropsychological function, identify the presence or
absence of anosognosia within the MCI population, and explore the diagnostic utility of
anosognosia assessment in MCI and dementia populations. A total of 49 patients were
included in the sample (n=24 MCI patients and n=25 dementia patients). Patients

xix

underwent routine neuropsychological evaluation across 6 domains of function. They
were asked to predict their performance on each neuropsychological measure prior to
administration, and then evaluate their actual performance subsequent to administration.
Parallel prediction ratings were solicited from an informant.
Results indicated that informant predictions were often less accurate with respect
to actual neuropsychological performance than patient predictions. In addition, MCI
patients often demonstrated greater levels of anosognosia than their dementia
counterparts, with their ratings being less favorable than their actual performance. Lastly,
results indicate that anosognosia measures are reliable in predicting group membership,
with anosognosia for general cognitive ability and delayed contextual memory being the
most predictive of all the measures administered. Thus, the current study provides
evidence for the utility of routine assessment of anosognosia in MCI and dementia
neuropsychological evaluation.
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CHAPTER ONE
INTRODUCTION

Anosognosia Defined
Anosognosia is a general term used to describe a lack of awareness of a disability
and was initially coined by Joseph Babinski in 1914 to describe patients who denied leftsided hemiplegia. The clinical syndrome that Babinski described was one in which
patients professed that they were able to engage in activities that required full use of their
left side, when in fact the left side of their body lay flaccid in their hospital bed.
Although an unawareness of this magnitude could lead one to question the psychiatric
underpinning of these beliefs, it was noted long before Babinski’s involvement that this
behavioral anomaly was typically a result of acute focal cerebral lesions (Prigatano &
Schacter, 1991).
Unawareness of injury and its relation to denial of an injury are presumed to be
two different phenomena, and careful steps are taken in the literature to distinguish
between the two (Kortte & Wegener, 2004). Denial of injury is often used to describe a
characterological dynamic in which a patient is unwilling to accept the presence of a
medical condition and the impact that is may have on his/her health. For example, a
patient diagnosed with diabetes may deny the presence of the disorder and refuse to
account for the impact it may have on his/her overall well-being, continuing to eat foods
repeatedly shown to exacerbate the medical condition. Denial may also be viewed as a
psychological defense employed by an individual to guard against the emotional pain
associated with a significant loss (Heilman & Harciarek, 2010). The clinical presentation
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of denial lies in theoretical contrast to that of anosognosia, which is typically observed in
conjunction with neurological dysfunction.

Facets and Clinical Relevance of Anosognosia
Flashman and McAllister (2002) discuss unawareness as a multifaceted construct,
and identify three dimensions of unawareness that are important in conceptualizing the
anosognostic picture across different neurologic populations. The first dimension is
whether an individual is aware of a specific deficit, and this dimension is commonly a
dichotomous (yes or no) distinction that can vary across different areas of deficit. For
example, an individual may be aware of a deficit in memory but unaware of a deficit in
social pragmatics. The second dimension is a corresponding emotional response to each
area of functioning, regardless of whether or not an individual is aware of a deficit. This
second dimension is best understood on a continuum related to emotional arousal, with
complete indifference (anosodiasphoria) on one end of the spectrum and anger on the
other. Given these two dimensions, it is possible that an individual may be aware of a
deficit but display indifference to it. The third dimension relates to an individual’s ability
to appreciate the functional impact that a deficit may have on day-to-day life and speaks
to the real-world implications of anosognosia and the obstacle it creates in meaningful
rehabilitation. An individual may be aware of a deficit, have an emotional response to
experiencing the deficit, but have little or no grasp of how such a deficit would impede
his/her daily function, and may fail to appreciate the importance of procuring help from
friends and family members. Thus, this dimension is also best understood on a
continuum, with a lack of appreciation for the functional impact of a deficit on one end
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and complete appreciation for the functional impact on the other (Flashman & McAllister,
2002).
Unawareness puts patients in immediate physical danger, and the impact of
anosognosia on rehabilitation efforts after an acute injury is immense (Hartman-Maeir,
Soroker, & Katz, 2001). For example, a patient without an awareness of his/her own
hemiplegia may be inclined to get out of bed to use the restroom, which would ultimately
result in a fall. Patients with anosognosia have been found to have a higher incidence of
safety issues as well as a higher incidence of being deemed unsafe at discharge from
acute rehabilitation (Hartman-Maeir et al., 2001). Patients lacking insight into their
impairments will be unable to utilize compensatory strategies in real world situations and
have the propensity to get into situations that they will subsequently have difficulty
managing. They are likely to be unable to assimilate and utilize feedback about their
limitations to set realistic goals, and have poorer outcome after rehabilitation (see
Prigatano (2005) for a review). Due to the fact that they are unaware of their deficits, it is
likely that patients exhibiting anosognosia will resist help and/or treatment offered by
family and medical professionals who demonstrate concern for their overall well-being
(Flashman & McAllister, 2002; McGlynn & Kaszniak, 1991). In addition, a lack of
insight into their areas of difficulty will make it more difficult to engage them in
consistent rehabilitation efforts that are imperative to their overall improvement. While
these risks can be managed on an acute inpatient setting, once the patient is no longer in
daily contact with treating medical providers or family members who may or may not be
aware of their deficits, the responsibility for rehabilitation falls in the hands of the patient.
Although the literature on functional outcome after acute rehabilitation for patients with
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anosognosia is mixed, anosognosia has been implicated as having a negative impact on
recovery in acute rehabilitation settings as well as in long term recovery (Gialanella,
Monguzzi, Santoro, & Rocchi, 2005; Hartman-Maeir et al., 2001)
While it can be difficult to discuss the presence and impact of anosognosia with
patients who have just endured a life changing incident, having a specific event with
which to tie functional and/or cognitive changes can make these issues more tangible for
patients and their families. For patients who exhibit anosognostic traits in relation to
general, typically longstanding neurological dysfunction, in the absence of acute focal
neurological damage, clinical concerns become increasingly difficult to broach. Often
times cognitive degeneration associated with dementia, for example, is insidious and
even family members who are actively involved in caregiving for the patient have
difficulty pinpointing the onset of symptoms (for a review, see Levy (1994)). In the
elderly population, it is often difficult for family members to discern the nature of
cognitive decline associated with normal aging and abnormal cognitive decline indicative
of neurological dysfunction warranting medical attention (Levy, 1994). Thus, methods of
compensating for cognitive deficits and promoting healthy cognition are likely to be
ignored.

Anosognosia in Various Disorders
As previously discussed, the initial body of literature describing anosognosia
focused primarily on unawareness of, or lack of appreciation for, the functional impact of
encapsulated deficits of gross motor or perceptual ability that resulted from acute
neurological injury (Prigatano & Schacter, 1991). The nature of these deficits was such
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that they were readily apparent by observers, primarily complete hemiplegia or
hemianopia. Over time, the term has broadened in its application and has come to be
used to describe a lack of insight into any deficit resulting from atypical neurological
functioning, including focal neurologic damage such as stroke (Kortte & Hillis, 2009;
Pedersen, Jørgensen, Nakayama, Raaschou, & Olsen, 1996; Starkstein, Jorge, &
Robinson, 2010), cortical blindness (Prigatano & Wolf, 2010), Wernicke’s aphasia
(Kertesz, 2010), as well as more diffuse neurologic dysfunction, such as traumatic brain
injury (Prigatano, 1991, 2005, 2010a), schizophrenia (Gilleen & David, 2010), and a
variety of dementia (McGlynn & Kaszniak, 1991; O.C. Okonkwo, Spitznagel, Alosco, &
Tremont, 2010).

Anosognosia and Stroke
Anosognosia for motor deficits as a consequence of right hemisphere stroke is
well documented and thoroughly researched (Kortte & Hillis, 2009; Pedersen et al., 1996;
Starkstein et al., 2010), although the cause of anosognosia and the neuroanatomical
mechanism of action remains highly disputed. In a recent literature review on
anosognosia and stroke, the incidence of anosognosia was cited to range between 20% to
40%, with the variability across studies ascribed to time since stroke, age, and operational
definitions of anosognosia (Starkstein, Jorge & Robinson, 2010). According to Starkstein
et al.’s (2010) review of the literature, anosognosia often resolves relatively early on in
the rehabilitation trajectory and is rarely seen three months post-stroke. The occurrence
of anosognosia increases with age, and its incidence varies depending on the
methodology used to define anosognosia in the literature. Clinically, it is relatively
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simple to diagnose using discrepancies between interviews with patients reporting their
functional ability and observation of patients’ actual functional ability, especially for
impairments as blatant as hemiplegia. The operational definition that is necessitated by
systematic research, however, requires that true anosognosia be clearly distinguished
from other syndromes that are commonly observed with in clinical settings (Starkstein et
al., 2010).
Anosognosia in stroke patients is typically seen as one piece of a multifaceted
clinical presentation, and is often associated with a host of other peculiar symptoms, the
two most common being a lack of recognition of ownership of a limb (asomatognosia) as
well as attributing one’s limb to another person (somatoperephrenia). Anosognosia is
also observed with concomitant indifference to the affected limb (anosodiaphoria), as
well as feeling automatic movement in the affected limb (kinaesthetic hallucinations) and
negative feelings toward the affected limb (misoplegia) (see Starkstein et al., (2010) for
review). Interestingly, sensation in the affected limb in these patients is often intact, and
thus cannot be accounted for by a lack of incoming sensory stimuli. Although these
symptoms are typically documented in right hemisphere damage, anosognosia for motor
impairment has also been documented in left hemisphere damage, which complicates the
explanation of the anosognostic syndrome as being “housed” in right hemisphere
function (Cocchini, Beschin, Cameron, Fotopoulou, & Della Sala, 2009).

Anosognosia and Focal Lesions: Cortical Blindness
Anton’s syndrome, or cortical blindness, is a loss of vision characterized by
dysfunction of the occipital lobe where visual sensory information is processed. This is
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in contrast to the more common forms of blindness associated with a dysfunction of
sensory perception (Vighetto & Krolak-Salmon, 2007). Anosognosia for cortical
blindness is also highly documented in the literature, actually predating the time of
Babinski. In 1898, Anton reported cases of patients who demonstrated unawareness of
visual loss incurred as a result of focal cerebral lesions (as cited in Prigatano, 2010b).
Due to the fact that cortical blindness is not a focus of current anosognostic research,
there has been little advancement in its understanding. According to theoretical
discussion by Prigatano and Wolf (2010), the clinical presentation of anosognosia for
cortical blindness deserves special attention and the authors proposed a specific set of
terminology to differentiate between its subtypes. The authors argue that Anton’s
syndrome is a term that should be reserved for patients who experience true cortical
blindness, or experience complete loss of vision secondary to bilateral primary visual
cortex damage in the occipital lobe, and demonstrate an unawareness of this blindness.
The term Anton-like syndrome should be ascribed to patients who are completely blind
secondary to damage to the orbit or to the optic nerve, and thus not cortical in nature.
Lastly, Prigatano and Wolf (2010) posit that those patients unaware of a hemianopia
(UHEM) secondary to damage to visual projection areas should be differentiated as well.
These patients’ blindness is, by definition, limited to discernable portions of their visual
field(s) as a direct result of brain lesions. A majority of the literature on Anton’s and
related syndromes consists of case studies, and little is known about the neuroanatomical
underpinnings of how these conditions relate to unawareness and why the two often go
hand in hand.
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Anosognosia and Focal Lesions: Wernicke’s Aphasia
An arguably more frequent clinical syndrome that results from acute neurological
insult, and a prime example of anosognostic behavior, is that of jargon aphasia, also
referred to as “anosognosic aphasia” (Rubens & Garrett, 1991).

Jargon aphasia is

traditionally associated with Wernicke’s aphasia, but is also seen in transcortical sensory
and global aphasia. It is colloquially referred to as “word salad”, such that meaningless
combinations of words wrought with phonemic, semantic, and neologistic paraphasias
characterize a patient’s speech (for a review of aphasia, see Abutalebi & Cappa, 2008).
Of note, and the reason this behavioral pattern is associated with anosognosia, is that
patients exhibiting this type of speech have no awareness that their speech is nonsensical
and no insight into the fact that the listener is unable to comprehend what they are saying.
The fact that these patients are so fluent in their speech, speaking without correction,
pause, or hesitation, suggests that they are simply unaware that anything is in need of
being corrected (Kertesz, 2010; Rubens & M. F. Garrett, 1991).

Anosognosia and Traumatic Brain Injury
While many early accounts of anosognosia are related to focal cerebral injury,
more recent inquiry into anosognosia focuses on more diffuse neurological involvement.
Although detailed accounts date back to the time of Phineas Gage, anosognosia
subsequent to traumatic brain injury has been the topic of scientific investigation in more
recent anosognosia literature. While significant strides have been made in quantifying
and systematically studying the disorder, the wide range of abilities and disabilities for
which a patient could be lacking awareness as well as the variation in the degree of
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severity of unawareness makes generalizable conclusions difficult to achieve (Dirette &
Plaisier, 2007; Hart, Sherer, Whyte, Polansky, & Novack, 2004; Hoofien, Gilboa, Vakil,
& Barak, 2004; Newman, Garmoe, Beatty, & Ziccardi, 2000; G.P. Prigatano, 2010a;
Trahan, Pepin, & Hopps, 2006). While previously discussed anosognostic phenomena
were related to specific deficits in awareness, traumatic brain injury can lead to impaired
awareness across many areas of life. Thus, the lack of awareness in traumatic brain
injury is often multifaceted, including, but not limited to, overall cognitive ability,
sensorimotor functioning, general mood state and emotional lability, behavioral
impulsivity, and social pragmatics.
Flashman and McAllister (2002) reported that up to 45% of individuals who have
sustained a moderate to severe traumatic brain injury exhibit deficits in awareness of
disabilities that are readily observable by others, and that these deficits in awareness,
unlike that of anosognosia of hemiplegia post-stroke, are often permanent. Numerous
questionnaires and interviews have been constructed to measure anosognosia in traumatic
brain injury populations, but many of these studies are confounded by the presence of
denial that is not quantifiably differentiated. In the previously discussed neurological
disorders, anosognosia is often seen in the absence of any severe cognitive impairment,
thus the patients presumably have the capacity for awareness. This is in contrast to
traumatic brain injury, where impaired self-awareness is often seen as part of a
constellation of cognitive difficulties that may, in and of themselves, render the patient
cognitively incapable of grasping such an intangible construct.
Not surprisingly, the severity of the traumatic brain injury, as assessed by length
of post-traumatic amnesia and admitting Glasgow Come Scale score, has been shown to
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be related to severity and duration of anosognosia, such that mild traumatic brain injury
patients often become aware of deficits in balance, memory, concentration, and sensory
sensitivity (to light and noise) rather quickly (Prigatano, 2010a). This patient population
typically experiences distress secondary to their improved awareness, which typically
abates within the first 30 to 90 days post-injury with improved neuropsychological
functioning (Prigatano, 2010a). Their self-assessments of functioning are typically
comparable to the assessments provided by informants, which facilitates post-injury
rehabilitation efforts. For patients with severe traumatic brain injury, the clinical picture
is often more concerning. These patients typically have no recollection of their injury
and often fail to appreciate their need for medical care (Prigatano, 2010a). Many of these
individuals, even after undergoing acute inpatient neuropsychological rehabilitation,
continue to exhibit anosognosia for multiple impairments even one to two years post
injury. It is estimated that approximately 30-40% of patients suffering from severe
traumatic brain injury demonstrate anosognosia, but it is unknown what proportion of
these patients display longstanding anosognostic behavior (Prigatano, 2010a). For
patients with moderate traumatic brain injury, awareness typically emerges once
posttraumatic amnesia clears, but this rule of thumb is mitigated by frontal lobe
involvement, such that increased frontal lobe damage is associated with more severe
levels of anosognosia. Unfortunately, this group of patients has yet to be well-studied in
isolation and are typically combined with patients with severe traumatic brain injury in
research studies (Prigatano, 1991, 2005, 2010a).
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Anosognosia and Schizophrenia
Given the complicated nature of assessing anosognosia subsequent to an acute
neurological insult and the equivocal nature of conclusions from these studies, the study
of anosognosia in neurological conditions characterized by generalized cognitive
impairment can be expected to be increasingly complex. Schizophrenia is traditionally
viewed as a psychiatric disorder characterized by a general detachment from reality,
which can be conceptually linked to the unawareness inherent in anosognostic
phenomena. Patients with schizophrenia are typically unaware of the presence of a
mental disorder, which makes treatment and community integration notoriously difficult.
Given the evidence correlating schizophrenia to frontal lobe dysfunction, and frontal lobe
dysfunction to impaired self-awareness, viewing schizophrenic symptomology through
the lens of anosognosia provides an opportunity to combine theoretically related clinical
syndromes (Gilleen et al., 2010; McGlynn & Kaszniak, 1991; Stuss, 1991).
According to Gilleen and collegues (2010), the nature of unawareness seen in
schizophrenia is best conceptualized as a deficit in judgment and reasoning, such that
they interpret and attribute abnormal perceptions related to hallucinations and delusions
as true. Anosognosia secondary to neurological insult, however, is argued to be a product
of an inaccessibility of the information to monitoring systems responsible for modality
specific perception. In current literature, three main theories seek to conceptualize
unawareness in schizophrenia in the following ways: as a symptom of psychiatric
symptomology in general, as a result of neuropsychological impairment inherent in
schizophrenia, or as a psychologically motivated defense against negative emotions.
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Although the unawareness seen in schizophrenia can theoretically be
differentiated from the unawareness seen in neurologic populations, there are also
commonalities between the unawareness observed in the two populations. Interestingly,
patients with schizophrenia have been shown to lack awareness regarding their abnormal,
involuntary motor movements (McGlynn & Kaszniak, 1991). While it is parsimonious to
attribute both the presence of the motor movement and the lack of awareness of their
presence to the side effects of neuroleptic medications, the presence of these motoric
abnormalities has been documented long before the invention of neuroleptic medication
and are seen in patients who are unmedicated (McGlynn & Kaszniak, 1991). Thus, there
appears to be a connection between the neuroanatomical systems that mediate motor
movement and that which mediate awareness of motor movement that would account for
this dynamic, similar to that seen in right hemisphere stroke patients that demonstrate
anosognosia for hemiplegia. Analogous to patients with anosognosia secondary to
diffuse traumatic brain injury, and thus general neurological dysfunction, patients with
schizophrenia also often experience unawareness of deficit in various spheres of
functioning, including overall cognitive functioning, mood and irritability, as well as
social pragmatics. This implies that awareness may be linked to intact gross systemic
brain function as opposed to being localized in a specific brain area (Gilleen et al., 2010).

Anosognosia and Dementia
Similar to schizophrenia, dementia is also characterized by gross neurological
involvement that is often accompanied by an impaired awareness of both cognitive and
behavioral deficit. While the prevalence of anosognosia is debatable in stroke and
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traumatic brain injury literature, anosognosia is consistently part and parcel to the clinical
picture of dementia. It is most frequently reported in dementia of the Alzheimer’s type,
which is definitively diagnosed post-mortem and is colloquially distinguished by poor
memory ability (Wagner, Spangenberg, Bachman, & O’Connell, 1997). Alzheimer’s
dementia is a degenerative disorder that is characterized by amyloid plaque build up in
cortical tissue, which impedes proper functioning of neural networks and results in
dramatic functional decline. The initial cause for concern in patients who are eventually
diagnosed with Alzheimer’s dementia is marked forgetfulness, which progresses into
confusion, and ultimately into disorientation as the disease unfolds (McGlynn &
Kaszniak, 1991).
Anosognosia is a common feature of dementia of the Alzheimer’s type, and of
particular concern to family members and caregivers who cannot understand why their
loved one is unaware of their decline in functioning or is unconcerned and offers benign
explanations. Barrett, Eslinger, Ballentine, and Heilman (2005) conducted a study asking
patients diagnosed with probably Alzheimer’s dementia (pAD) to conduct pretest and
posttest estimations of their performance within various cognitive domains. The pretest
ratings asked the patient to estimate how well they thought they would do on tasks
assessing their ability within a certain cognitive domain, such as measures of memory or
visuospatial skills. The posttest ratings were conducted after the entire battery of
measures had been completed, presumably with the patient having a better understanding
of how they performed on the tasks and better insight into their own capabilities. The
authors created an anosognosia ratio, which allowed them to account for both
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overestimations as well as underestimations, and their performance was compared to a
control group.
Barrett and colleagues (2005) found that, compared to their healthy control
counterparts, patients with pAD overestimated their visuospatial skills on pretesting and
overestimated their memory skills on post testing. Thus, visuospatial skill estimations
were amended by actual performance on tasks, whereas estimations of memory continued
to be poorly estimated after testing took place. Thus, patients demonstrated anosognosia
for memory even after performing poorly on memory tasks. While the authors noted that
pAD patients performed significantly worse on memory measures, actual performance on
neuropsychological testing was not analyzed in relation to their pretest or posttest
estimations. Interestingly, these results elucidate domain specific anosognosia and
differential impact of poor performance on estimations of ability (Barrett et al., 2005).
Of note, it is unclear if the discrepancy in scores can more readily be accounted for by the
nature of the patient population’s poor memory, which would preclude participants from
providing accurate estimates of their performance on measures simply due to a lack of
memory for having completed them.
In a review by Agnew and Morris (1998), a number of correlates have been
proposed to coincide with anosognosia and Alzheimer’s dementia, and it is difficult to
determine which of these facets are directly related to and/or responsible for the
anosognostic phenomena seen in this population. Moreover, failure to adequately
measure these facets in controlled studies puts them in the position of being potential
confounds, and could account for the discrepancy in results across studies. According to
the authors, anosognosia has been associated with the severity of dementia, with higher
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levels of anosognosia related to more severe states of dementia, and relatively preserved
awareness associated with early stages of dementia.
Current literature on the topic, however, remains inconsistent, with argument that
even early stages of dementia exhibit marked anosognosia, and that the presence of early
anosognosia can be used as a predictor of dementia characterized by a more rapid
deterioration of overall ability (Carr, Gray, Baty, & J. C. Morris, 2000; Derouesné et al.,
1999). Agnew and Morris (1998) also discuss language impairment as a correlate of
anosognosia in dementia, which may be related to the anosognosia seen in aphasia
patients discussed earlier. Not surprisingly, memory impairment is also correlated with
anosognosia, as well as executive dysfunction and frontal lobe deficits (Agnew & Morris,
1998).
While initial anosognostic literature in Alzheimer’s dementia patients focused on
the lack of awareness for memory dysfunction, relatively recent literature also highlights
a lack of awareness for visuospatial skills as well (Agnew & Morris, 1998; Barrett,
Eslinger, Ballentine, & Heilman, 2005). Less is known about frontotemporal dementia
and primary progressive aphasia in relation to anosognosia, primarily due to the fact that
the literature on anosognosia and dementia is still in its infancy. Briefly, frontotemporal
dementia is characterized by marked behavioral changes associated with a decline in
frontotemporal brain function. A hallmark of this disorder is the lack of awareness of the
behavioral changes, as well as a lack of concern when these changes are discussed with
the patient (Miller & Cummings, 2006). Thus, a lack of awareness for behavioral
changes is a main criterion in its diagnosis. Primary progressive aphasia is another type
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of dementia associated with frontotemporal degeneration, marked by deficits in language
ability (Banks & Weintraub, 2009).
Patients with frontotemporal dementia also demonstrate impaired awareness for
cognitive and behavioral deficits, which is consistent with the role of the frontal lobes as
being involved in self-monitoring and inhibition (Agnew & Morris, 1998). Patients with
primary progressive aphasia typically do not initially demonstrate impaired awareness,
but little is known about the awareness of this population because few studies have
investigated primary progressive aphasia in relation to anosognosia (Agnew & Morris,
1998). A study conducted by Banks and Weintraub (2009) found that patients with
frontotemporal dementia did not significantly differ from patients with Alzheimer’s
dementia in their level of awareness, but that patients with primary progressive aphasia
demonstrated relatively intact levels of awareness. Due to the fact that the
symptomatology between primary progressive aphasia and frontotemporal dementia
begin to overlap as both diseases progress, assessment of awareness early on in treatment
may be a beneficial tool in diagnosis and treatment planning (Banks & Weintraub, 2009)

Anosognosia and Mild Cognitive Impairment
Current conceptualization of dementia views the disorder as a continuum of
impairment with mild cognitive impairment on one end of the spectrum and traditional
dementia on the other, as opposed to a dichotomous diagnostic category. Mild cognitive
impairment (MCI) can be viewed as a sub-clinical precursor to dementia, and factors
predicting conversion to dementia are not well known or understood. The most
promising area of research, and the most flourishing, is the investigation of
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pathognomonic biomarkers beta-amyloid protein () and tau (, which are closely
associated with the progression of Alzheimer’s dementia (Albert et al., 2011). and 
are biological markers for the amyloid plaques and neurofibrillary tangles whose buildup
are thought to be responsible for the neurodegeneration of cortical tissue. The cognitive
dysfunction seen in MCI, and ultimately Alzheimer’s dementia, are attributed to this
neurodegeneration. The following section provides a review of the current literature
relating to MCI diagnosis and its clinical presentation. MCI has received considerable
attention in recent literature and the prognostic value of levels of insight into areas of
impairment as a predictor of conversion to Alzheimer’s dementia is gaining popularity.
Patients with mild cognitive impairment demonstrate impaired awareness for memory
and visuospatial skills, similar to Alzheimer’s dementia patients (Galeone, Pappalardo,
Chieffi, Iavarone, & Carlomagno, 2011; Vogel et al., 2004). In fact, Vogel and
colleagues (2004) found that there was no statistical difference between the level of
unawareness demonstrated by patients with mild cognitive impairment and that of
patients with probable Alzheimer’s dementia. While Clément, Belleville, and Gauthier
(2008) found that there was no difference in overall cognitive complaints in both groups,
numerous studies have found that patients who eventually converted to Alzheimer’s
dementia reported less deficits than their informants did, and that patients who did not
convert had the opposite pattern (Okonkwo et al., 2008, 2009). Patients with mild
cognitive impairment have also been shown to have impaired insight into functional
abilities such as driving, medication management, and financial abilities, which presents
grave concerns for these patients since they are typically in the beginning stages of
treatment and are, by definition, functionally independent (Okonkwo et al., 2008, 2009).
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While anosognosia investigation typically focuses on memory and visuospatial
domains in the MCI and dementia populations, comprehensive evaluation of levels of
awareness and their relationship with actual neuropsychological performance is limited.
Anosognosia is conceptualized as a discrepancy score between informant and patient
predictions of performance, which is problematic in many respects and presents
challenges to the validity of the conclusions produced by these studies (Derouesné et al.,
1999; Okonkwo et al., 2009; Vogel et al., 2004). The current study seeks to explore the
level of awareness in the mild cognitive impairment population using both informant
ratings and actual neuropsychological performance as means of determining anosognosia
in a comprehensive neuropsychological battery.

Mild Cognitive Impairment and Dementia
Diagnostic Criteria for Mild Cognitive Impairment and Dementia
Mild cognitive impairment is a relatively new diagnosis, and was initially created
to give attention to patients who did not meet criteria for dementia but displayed
clinically significant impairment that deserved focused medical care. While the MCI
diagnosis has been discussed in prior literature, it was streamlined by Petersen (2004).
His model proposed four subtypes of MCI that differentiate patients based on the
domain(s) of impairment. The most widely researched and arguably most common
subtype of MCI is the amnestic type single domain, whose hallmark symptom is
impairment in memory and is thought to convert to dementia of the Alzheimer’s type. In
contrast, the MCI non-amnestic type single domain is characterized by impairment in a
non-memory cognitive domain such as language, visuospatial skills, attention and
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concentration, or executive function. This subtype of MCI is the least common and is
thought to convert into Lewy Body dementia or fronto-temporal dementia. The last two
subtypes of MCI both involve multiple areas of impairment, one of which includes
memory impairment and one that does not. They are labeled multiple domain amnestic
type and multiple domain non-amnestic type, and are thought to convert to Alzheimer’s
dementia and Lewy Body dementia, respectively (Petersen, 2004).
A majority of the current literature focuses on the type of MCI due to Alzheimer’s
dementia. These patients exhibit memory impairment but remain functionally
independent, and are seen as the subclinical form of what will eventually progress into
clinical Alzheimer’s dementia (Albert et al., 2011). Dementia and related disorders can
also be viewed along a continuum of functionality, with functionally independent MCI
patients at one end of the spectrum and dementia patients on the other, such that patients
that meet criteria for a diagnosis of dementia are no longer capable of functional
independence (Albert et al., 2011).
While Petersen made great strides in the conceptualization and categorization of
MCI and its subtypes, further exploration of the topic deemed step-by-step diagnostic
criteria that would guide overall MCI diagnosis necessary. Recent efforts have been put
forth to do just that in order to create a standard set of diagnostic criteria for MCI due to
Alzheimer’s dementia. In order to be diagnosed with MCI, a patient must meet the
following four criteria: (1) Have a concern about a change in cognitive status, either from
the patient, family members, caregivers, or a treating clinician, obtained through
thorough clinical evaluation by a skilled clinician. If serial assessments of patients’
cognitive status are available, objective measurement of the changes is helpful. (2)
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Objective cognitive impairment in one or more cognitive domains, one of which being
episodic memory, as obtained by formal clinical neuropsychological evaluation. Patients
with MCI typically score between 1 and 1.5 standard deviations below their same age and
educated peer group, with estimates of premorbid functioning taken into consideration.
(3) Functional independence is the distinguishing criterion between MCI and dementia,
such that MCI patients are still able to complete their activities of daily living and
instrumental activities of daily living with minimal assistance. Activities of daily living
include activities such as dressing, bathing, caring for personal hygiene, and cooking,
whereas instrumental activities of daily living refer to higher-level activities required for
independent living. Examples of instrumental activities of daily living are paying bills on
time, writing checks, or shopping. Patients may demonstrate decreased efficiency on
these tasks, but in order to meet criteria for an MCI diagnosis, they must be able to
complete them with minimal assistance. (4) A lack of a dementia diagnosis (Albert et al.,
2011; McKhann et al., 2011; Petersen, 2004).
With advances in technology come efforts at obtaining biologically driven,
objective markers that are useful in determining etiology and prognosis for various
disorders. As discussed briefly earlier, the area of dementia research is no exception. A
complementary research paradigm for studying MCI has set forth recommendations for
research protocols studying MCI in an effort to guide the field of study into a more
standardized assessment across research groups (Albert et al., 2011). The authors
propose that tracking beta-amyloid protein () and tau (), both of which are biological
markers for Alzheimer’s dementia, can help definitively reflect the progression of
Alzheimer’s dementia and provide support for the contention that MCI due to
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Alzheimer’s dementia is a predementia stage along the continuum of Alzheimer’s disease
(Albert et al., 2011).

Neuropsychological Profiles for Mild Cognitive Impairment and
Dementia
Due to the fact that mild cognitive impairment (MCI) can be viewed as a catch-all
diagnostic entity encompassing multiple types of sub-clinical dementia, the
neuropsychological profiles that accompany each variant of MCI correlate closely with
their dementia counterparts. Petersen (2004) proposed a stepwise dichotomous model of
categorizing the variants of MCI, with the first dichotomous distinction being the
presence of a memory impairment. If memory impairment is present, it follows the
amnestic MCI trajectory with further classification accounting for single domain
impairment or multiple domain impairment. Thus, a patient performing in the impaired
range on verbal or non-verbal measures of memory and within normal limits on all other
neuropsychological domains, using Petersen’s model, would be diagnosed with single
domain amnestic MCI. Amnestic patients demonstrating impairment in multiple domains
can be seen as being closer to the dementia threshold than their single domain MCI
counterparts, as more cognitive impairment is associated with lower functional
independence. Of the patients along this trajectory that demonstrate further cognitive
decline and eventually meet criteria for a diagnosis of dementia, they typically convert to
dementia of the Alzheimer’s type (Albert et al., 2011; Looi & Sachdev, 1999; Pachana,
Boone, Miller, Cummings, & Berman, 1996; Petersen, 2004)
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For diagnosis of patients with intact verbal and visual memory but impairment in
a non-memory cognitive domain, the non-amnestic MCI trajectory is most appropriate.
Non-amnestic MCI can also be further categorized into single domain or multiple domain,
depending on how many impairments are seen on neuropsychological testing (Petersen,
2004). Similar to the amnestic MCI trajectory, the non-amnestic, multiple domain MCI
diagnosis is best viewed as closer to the threshold for a diagnosis of dementia than its
single domain counterpart, with impairments in multiple cognitive domains indicative of
lower levels of functionality. Of the patients that eventually decline to the point of
functional dependence, these patients may convert to one of a number of different types
of dementia (Looi & Sachdev, 1999; Petersen, 2004).
Vascular dementia is the second most commonly diagnosed type of dementia, but
unlike Alzheimer’s dementia, it is less widely studied and lacking clear
neuropsychological profiles consistently produced across studies. Current diagnostic
criteria for vascular dementia include the following: (1) Impaired memory, including
difficulty learning and/or recalling learned information, or the presence of aphasia,
apraxia, agnosia, or impaired executive function, (2) impairment in social or occupational
function, (3) focal neurological signs related to cerebrovascular disease and (4) a lack of
delirium. Due to the diffuse nature of the vasculature in the brain, there is a lack of
consensus regarding the typical neuropsychological profile seen in these patients, most
likely due to the fact that different brain areas can be affected by cerebrovascular disease,
which would lead to heterogeneity of symptoms (Garrett et al., 2004; Looi & Sachdev,
1999; McPherson & Cummings, 1996; Sachdev et al., 2004).
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Many of the non-amnestic dementia diagnoses are still under investigation, and
research regarding the neuropsychological profiles of each is ongoing. Many of the
defining factors that contribute to a diagnosis of a non-amnestic dementia are clinical in
nature, such that behavioral observation and interpretation become equally as important
as neuropsychological test performance. The behavioral variant of frontotemporal
dementia is often associated with cognitive impairment in one or multiple non-memory
domains accompanied by dramatic changes in personality, reduced social pragmatics, and
often times language impairment in the face of intact visuospatial skills (Banks &
Weintraub, 2009; Neary & Snowden, 1996; Pachana et al., 1996). Lewy body dementia,
which can also be seen in conjunction with Alzheimer’s dementia, is associated with
relatively characteristic delusions and hallucinations, with evidence for executive
dysfunction and reduced visuospatial skills (Galasko, Katzman, Salmon, & Hansen,
1996; Salmon et al., 1996)

Neuroanatomical Bases of Anosognosia
While early research on anosognosia for left sided hemiplegia lent itself to a
simplistic neuroanatomical explanation for the localization of anosognosia in right
hemisphere function, the broadening of the anosognostic picture to include different
diagnoses with diverse neuroanatomical involvement has made neuroanatomical
correlations for anosognosia exceedingly complex. Indeed, the accumulation of
anatomical theories used to make sense of the different neurological and neuropsychiatric
populations discussed in the current study would implicate almost every gross brain area
possible in a bilateral fashion. Anosognosia for hemiplegia and hemianopia would
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implicate right temporal and right occipital involvement, while anosognosia for aphasia
would implicate left temporal involvement. Anosognosia for deficits incurred from
traumatic brain injury typically discuss right frontal or bifrontal involvement. Similarly,
anosognosia in schizophrenia is usually associated with bilateral frontal functioning in
the literature (Banks & Weintraub, 2009).
Given that research on anosognosia as a result of focal injury has been
unsuccessful at localizing awareness, it is not surprising that research on disorders
characterized by general cognitive decline such as MCI and dementia have also been
unsuccessful at accounting for anosognostic symptoms in a parsimonious
neuroanatomically based theory. In general, researchers have resigned to the fact that
anosognosia is a complex, multifaceted neurological syndrome that is not well
understood and is still in the beginning stages of research (Gilleen et al., 2010; Kertesz,
2010; McGlynn & Kaszniak, 1991; Prigatano, 1991; Prigatano & Wolf, 2010; Stuss,
1991). Several studies have, however, begun to form the foundation for scientific inquiry
regarding neuroanatomical correlates of dementia. Functional imaging studies in
Alzheimer’s dementia patients revealed hypoperfusion in the prefrontal pathway, which
includes the right prefrontal cortex, inferior parietal lobe, anterior cingulate gyrus, and
limbic system. Further investigation implicated the right post-central gyrus, the right
parietotemporal-occipital association cortex, and the rostral prefrontal cortex (Cutting,
1978; Prigatano & Schacter, 1991). Voxel-based morphometry imaging revealed right
ventromedial prefrontal cortex involvement in patients with a mixed group of individuals
with neurodegenerative disease (Rosen et al., 2010).
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Neuropsychological studies have also attempted to make predictions regarding
anatomical correlates of anosognosia, which not surprisingly point to frontal dysfunction
(Rosen et al., 2010). In general, these studies point to the involvement of prefrontal,
temporal, and limbic structures in anosognosia and Alzheimer’s dementia, but the
variability in protocols used across studies make generalizable conclusions difficult to
obtain (Michon, Deweer, Pillon, Agid, & Dubois, 1994). It is clear that more research
needs to be done on this topic in order to fully understand the neuroanatomical
underpinnings of awareness. To date, a single study has attempted to use imaging to
investigate the neurological correlates of awareness in the MCI population. The authors
utilized functional imaging technology to quantify brain activity while the patient
engaged in a self-appraisal task where they were asked to make yes or no determinations
as to whether a given characteristic (e.g. calm, obnoxious) was self-descriptive. The
researchers found reduced activation in cortical midline structures during tasks of selfappraisal, which they argued attested to the role of cortical midline structures in
awareness of the self, and thus related to anosognosia. More research is necessary in
order to come to meaningful conclusions about the relation of MCI and awareness as it
relates to cortical and subcortical function (Ries et al., 2007).

Methodological Issues Related to Measuring Awareness
An integral first step towards systematic, thorough investigation of anosognosia is
the development of is a robust measure of awareness. Unfortunately, no such measure
currently exists in anosognosia literature. Instead, multiple measures have been
implemented and none are used consistently across studies. The following is a discussion
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of the current methodologies used to quantify awareness, the difficulties associated with
them, and the proposed methodology used in the current study that seeks to address these
issues (Fleming, Strong, & Ashton, 1996).

Clinician Diagnosis
Clinical diagnosis of the presence or absence of anosognosia is relatively simple
and relies solely upon the clinician’s observation of patient behavior. The more objective
the facet of behavior the patient is lacking awareness of, the more straightforward the
diagnosis. Thus, for diagnosis of easily observable deficits or deficits that can readily be
tested bedside, such as hemiplegia and cortical blindness, this method of diagnosis is
reliable and effective. As assessment moves from more concrete to more abstract
domains of cognitive skills or functional activities, however, clinician diagnosis becomes
less helpful simply because clinicians do not have the luxury of spending extended
periods of time with patients. As the deficits for which an individual could potentially be
unaware become less tangible in nature, reliable measurement becomes increasingly
difficult. While it is possible that the presence or absence of a lack of awareness is more
readily detectable, the level of awareness becomes more difficult to quantify (Orfei,
Caltagirone, & Spalletta, 2010).
Structured interviews have been created to address the variability in information
collected during clinician interviews, but still lead to inconsistent results (Cocchini et al.,
2009; Simmond & J. Fleming, 2003; Trudel, Tryon, & Purdum, 1998). Clinicians,
inevitably, will require the input of an informant regarding the patient’s everyday level of
functioning, which can be assessed in relation to the patient’s perception of his/her
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abilities, as a measure of overall awareness. This implies that the informant is the most
accurate rater of the patient’s true ability, which has not been thoroughly investigated or
validated in the literature. An additional problem in this methodology is that the patient
may acknowledge having difficulty in a certain area of functioning, but have no insight
into when the deficit is actually occurring, thus making compensation for the area of
deficit difficult. Thus, when a clinician is questioning the patient and using this as a
measure of awareness, the clinician is assuming that awareness of a deficit will lead to
appropriate compensation for the deficit, which is not always the case. To address this
issue, Crosson and collegues (1989) proposed a theoretical framework that accounted for
various facets of awareness, including intellectual awareness, or the verbal
acknowledgment of a disorder, emergent awareness that becomes evident when the
patient has difficulty completing a task in real time, and anticipatory awareness, in which
the patient is able to appreciate and compensate for the functional impact of a deficit.
These facets of awareness are difficult to account for by clinician interview alone, which
may account for the discrepancy in results across studies employing various measures of
awareness.

Discrepancy between Self and Informant-Reported Ability
To account for the difficulties inherent in clinician diagnosis of anosognosia, a
number of rating scales have been created to assess patient levels of awareness, and
parallel versions have been created to allow for corresponding ratings by an informant.
The patient him/herself, an informant/caregiver, and/or a treating clinician typically
complete these rating scales, and awareness on the part of the patient can be assessed in
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two ways. Discrepancy between patient and informant ratings can be used, as well as
discrepancy between patient and clinician ratings (Crosson et al., 1989). A discrepancy
score is typically created by subtracting the patient’s ratings from that of the informant,
the absolute value of which is used to quantify the patient’s level of awareness (Evans,
Sherer, Nick, Nakase-Richardson, & Yablon, 2005; Flashman & McAllister, 2002; Hart,
Seignourel, & Sherer, 2009; Sherer et al., 1998).
Using this type of comparison as a measure of anosognosia implies that the rating
of the informant or the clinician is unbiased and accurate, because their ratings serve as
the basis of comparison for the patient ratings. Depending on the amount of interaction
the informant has with the patient and how involved he or she is in the patient’s care,
using this method of quantifying levels of awareness is problematic. Levels of concern in
relation to caregiver response bias and has not been addressed in any of the literature to
date, so there is no method of accounting for how this may impact caregiver ratings. In
addition, response bias and recent experience with the patient have the tendency to color
the manner in which both the patient and the informant answer these measures, which
pose a threat to their validity and may unjustly impact the quantity of the discrepancy
seen between informant and patient scores. Also, taking absolute values of the
discrepancy between patient and informant ratings does not account for both over and
under estimation of ability, which artificially restricts the range of scores and can, in turn,
impact the robustness of the statistical results.
Another set of issues that must be addressed when using any type of questionnaire
is the measure’s validity. Measures of validity in neurologic populations are difficult
given their inherent cognitive compromise, and relying on informant measures of
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reliability imposes the same issues of bias previously discussed in using these measures
for quantifying awareness. Thus, these measures are poorly validated in general and are
difficult to validate in the patient populations for which they are intended to measure.
Due to the fact that patients with neurological impairments are completing these
measures, it is assumed that they have the cognitive ability to understand what is being
asked of them and answer the questions accurately. Given their overall cognitive deficits,
this is not always the case. In addition, this is not taken into account in the literature,
which can artificially impact the results derived from studies employing these
methodologies.

Discrepancy between Self-Reported Ability and Actual Performance
Another way of quantifying anosognosia is by comparing patient ratings to actual
neuropsychological performance, which removes the bias associated with using nonparticipant ratings (Fleming, Strong, & Ashton, 1996). Unfortunately, this method of
quantification is less often used in the literature. The variability in rating scales employed
across studies utilizing the discrepancy method, and the reliance upon potentially
inaccurate informant ratings may account for the varied results and lack of consensus
regarding mechanisms of action in the literature.
Barrett and collegues (2005), as discussed earlier, conducted a studying asking
MCI patients to provide estimations of ability before and after a battery of tests were
completed. They found that visuospatial skills were overestimated prior to testing, and
memory skills were overestimated after testing. Thus, the patient’s pretest and posttest
ratings were used in relation to their actual performance on neuropsychological testing to
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determine awareness levels. Although this methodology removes the bias associated
with informant ratings, it does pose a rather pragmatic problem. Patients who have
memory difficulties, as those with MCI due to Alzheimer’s dementia do, may not
remember the battery administered, and thus may not be able to accurately estimate their
performance after the battery is completed. This is particularly problematic for measures
that are earlier in the battery, due to the fact that more time has elapsed when posttest
ratings were collected. Thus, the overestimation of memory complaints may be, in part,
accounted for by memory ability in and of itself. In addition, memory measures are often
multistep in nature, differentiating between types of memory function, such as immediate
and delayed recall, as well as free recall and cued recall or recognition. Without clearly
differentiating between which type of memory the evaluation is referring to, it is difficult
to gain a more fine grained understanding of the specific areas of memory the patient
views him/herself as having difficulty. Lastly, the ratings solicited from the patients were
not tied explicitly to any given measure in the assessment battery, and were instead broad
questions regarding general cognitive domains, such as memory, attention, etc. If
patients are unaware of how these constructs were tested, as well as which tasks
measured each cognitive domain, it may be difficult for the patient to provide accurate
pretest and posttest estimations of ability. For example, the Wisconsin Card Sorting Test
may not be viewed by the patient as a measure of executive function, and may be
misinterpreted as a visuospatial task. Thus, they may rate themselves poorly on posttest
ratings of visuospatial functioning but rate themselves better on executive function tasks.
Thus, while this methodology is moving the body of research in the right direction, it still
leaves room for improvement (Barrett et al., 2005).
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Discrepancy between Self-Predicted, Self-Evaluated, InformantPredicted, and Actual Performance
The current study employs a novel paradigm to assess anosognosia that
incorporates aspects of the previously discussed methodologies and allows for assessment
of the accuracy of each. The current study utilizes a prediction and evaluation model of
assessing anosognosia in a standard neuropsychological evaluation, by obtaining
participant predictions of performance a priori and evaluations of performance a
posteriori before and after each test is administered. Thus, before administering each
measure, the participant is read a brief explanation of the task and asked to predict how
well he/she will do on each measure. Then the given task is completed. After the task is
completed, the patient is asked to evaluate his/her performance on the measure on the
same scale that the prediction was provided on, as a way to remind the patient how he/she
thought he/she would perform prior to engaging in the task. Informant ratings for each
neuropsychological measure are also obtained, using the same description of each
measure given to the patient during the assessment. This will allow for investigation as
to the accuracy of informant ratings in comparison to actual neuropsychological
performance, as well as provide an unbiased measure of anosognosia by comparing
patient prediction of performance to actual performance on neuropsychological measures.
By obtaining these prediction and evaluation ratings immediately before and after each
neuropsychological measure, the impact of memory of the battery is removed, as well as
the ambiguity associated with trying to understand what each measure is measuring. In
addition, it allows for the exploration of the possibility of emergent awareness as a result

31

of poor performance by obtaining evaluations of performance immediately after the
measure is completed.
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CHAPTER TWO
HYPOTHESES

Given the current state of the literature on anosognosia in mild cognitive
impairment, the following hypotheses are proposed:

Hypothesis 1 – Patient Versus Informant Ratings
Given that anosognosia has been documented in the literature in both the MCI and
dementia populations, it is hypothesized that patient and informant predictions of patient
performance will be significantly different (Dekkers, Joosten-Weyn Bannignh, & Eling,
2009; Vogel et al., 2004), regardless of their diagnostic group. The magnitude of
discrepancy and direction of discrepancy will serve as indicators of the degree to which
anosognosia is present.

Hypothesis 2 – Accuracy of Ratings
Research has yet to compare the accuracy of patient’s prediction of their own
performance to that of informant predictions as they relate to true neuropsychological
performance. As it stands, informant predictions are presumed to accurately reflect the
patient’s actual level of ability. It is hypothesized that informant predictions will be more
accurate predictors of the patient’s actual performance than patient predictions. In
addition, informant predictions of patient ability will be more accurate for MCI patients
than dementia patients. Given that dementia patients are less functional, it is likely that
informants will underestimate their actual ability across domains of function that may, in
fact, be less impacted by the severity of their diagnosis. Given that MCI patients are at
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what could be considered a “turning point” in their cognitive function, it is likely that
they will underestimate their actual ability, which can be seen as a reflection of their
concern regarding their changes in cognitive status.
As discussed earlier, domain specific anosognosia has been found for memory ability
(Cosentino, Metcalfe, Butterfield, & Stern, 2009). The current study also hypothesized
that both patient and informant predictions will demonstrate poorer visuospatial
awareness in relation to memory awareness.

Hypothesis 3 – Emergent Awareness by Cognitive Domain
Emergent awareness has not been systematically studied in formal
neuropsychological assessment paradigms. The current study hypothesized that emergent
awareness will vary across cognitive domains, with more emergent awareness seen for
tasks allowing for physical manipulation of objects and/or verbal feedback from the
examiner (i.e. Block Design, Wisconsin Card Sorting Test). It is additionally
hypothesized that this emergent awareness will be greater for MCI patients than dementia
patients.

Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment
As previously stated, the diagnostic utility of anosognosia evaluation has yet to be
researched in the field. As such, the current study hypothesizes that ratios of predicted
performance relative to actual performance (anosognosia prediction ratios) will
demonstrate diagnostic utility, such that diagnostic group membership can be predicted
based on the anosognosia ratios generated throughout the course of the evaluation. In
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addition, it is hypothesized that measures of memory will be most predictive of
diagnostic group than other cognitive measures collected.
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CHAPTER THREE
METHOD

Study Information
Research activity took take place in Loma Linda University Medical Center’s
East Campus Rehabilitation Center’s Department of Neuropsychology and Rehabilitation
Psychology. The data that was used for the current analysis was archived in nature, as
the data is routinely collected as a part of the standard neuropsychological evaluation that
Travis Fogel, Ph.D. conducts for persons with suspected dementia.

Inclusion/Exclusion Criteria
Males and females ages 18-100 who were referred to Loma Linda University
Medical Center’s Rehabilitation Center Department of Neuropsychology and
Rehabilitation Psychology for neuropsychological evaluation were included in the sample.
Exclusion criteria were as follows: (1) Individuals younger than 18 years of age or
older than 100 years of age, as normative data for the neuropsychological tests
administered in the standard evaluation range from ages 18 to 100, thus precluding the
evaluators from attaining standardized scores for patients falling outside that age range.
(2) Patients who were not fluent in the English language were excluded due to the impact
that unfamiliarity with the language may have on patient performance. (3) Patients who
were hearing impaired or vision impaired were excluded due to the auditory and visual
demands needed to engage in the neuropsychological evaluation in a meaningful way.
(4) Lastly, patients with motor impairment in their dominant hand were also excluded due
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to the manual dexterity needed for stimulus manipulation and writing demands needed
for a portion of the neuropsychological measures administered.

Subject Recruitment and Screening
Medical charts of patients who were referred for neuropsychological evaluation
and meet inclusion/exclusion criteria were examined from Loma Linda University
Medical Center’s East Campus Department of Neuropsychology and Rehabilitation
Psychology. The data collected were a part of the standard care practices for the
Department of Neuropsychology and Rehabilitation Psychology; thus an informed
consent waiver and HIPAA privacy waiver was requested.

Participant Characteristics
A total of 49 participants were included in the study, with relevant demographic
characteristics presented in Table 1. As displayed in Table 2, a total of 24 participants
were diagnosed with MCI and 25 participants were diagnosed with dementia using
criteria outlined previously (Albert et al., 2011; McKhann et al., 2011; Petersen, 2004).
Diagnoses were provided by Dr. Travis Fogel, Ph.D. and corroborated by Kyrstle Barrera,
M.A. A total of 23 male and 26 female participants were included in the sample. A total
of 24 patients were excluded from the sample, twenty due to unclear or complicated
clinical presentations or diagnostic rulings, one from reduced effort, two due to diagnosis
not warranted (i.e. “worried-well”), and one due to prominent psychiatric overlay
superimposed on compromised neuropsychological function.
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Table 1
Participant demographic characteristics

Characteristic
Age (m, SD)
40-49
50-59
60-69
70-79
80-89
90+
Total
Gender
Male
Female
Education
< 12 years
12 years
13-15 years
16+ years
Race
White/Caucasian
Black/African
Other
Current Occupation
Not in Labor Force
Unskilled Labor
Semiskilled Labor
Skilled Labor
Managerial/Clerical/Sales
Professional/Technical
Previous Occupation
Not in Labor Force
Unskilled Labor
Semiskilled Labor
Skilled Labor
Managerial/Clerical/Sales
Professional/Technical

MCI

Dementia

Total

n
%
(71, 9.63)
1
4.2
1
4.2
5
20.8
14 58.3
3
12.5
0
0.0
24

n
%
(77, 7.85)
0
0.0
1
4.0
3
12.0
11 44.0
9
36.0
1
4.0
25

n
%
(74, 9.33)
1
2.0
2
4.1
8
16.3
25 51.0
12 24.5
1
2.0
49

13
11

54.2
45.8

10
15

40.0
60.0

23
26

46.9
53.1

0
6
7
11

0.0
25.0
29.2
45.8

3
5
7
10

12.0
20.0
28.0
40.0

3
11
14
21

6.1
22.4
28.6
42.9

15
2
7

62.5
8.3
29.2

20
2
3

80.0
8.0
12.0

35
4
10

71.4
8.2
20.4

20
0
1
0
2
1

83.3
0.0
4.2
0.0
8.3
4.2

23
0
0
0
2
0

92.0
0.0
0.0
0.0
8.0
0.0

43
0
1
0
4
1

87.8
0.0
2.0
0.0
8.2
2.0

0
0
3
2
7
12

0.0
0.0
12.5
8.3
29.2
50.0

4
2
1
1
7
9

16.0
8.0
4.0
4.0
28.0
36.0

4
2
4
3
14
21

8.2
4.1
8.2
6.1
28.6
42.9
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Table 2
Participant diagnostic characteristics

Diagnoses
Mild Cognitive Impairment (MCI)
Amnestic
Single Domain
Multiple Domain
Total
Non-Amnestic
Single Domain
Multiple Domain
Total
MCI Total
Dementia
Alzheimer's Dementia
Mild
Moderate
AD Total
Vascular Dementia
Mild
Moderate
VD Total
Mixed AD/VD
Frontotemporal Dementia
Nonbehavioral Variant
Behavioral Variant
FTD Total
Dementia Total
Total

% of
% of
% of
Diagnosis
Subgroup
Sample
Group

n

1
15
16

6.3
93.8
100.0

4.2
62.5
66.7

2.1
30.6
32.7

3
5
8
24

37.5
62.5
100.0

12.5
20.8
33.3
100.0

6.1
10.2
16.3
49.0

12
2
14

85.7
14.3
100.0

48.0
8.0
56.0

24.5
4.1
28.6

2
1
3
6

66.7
33.3
100.0

8.0
4.0
12.0
24.0

4.1
2.0
6.1
12.2

1
1
2
25
49

50.0
50.0
100

4.0
4.0
8.0
100.0
100.0

2.0
2.0
4.1
51.0
100.0

100.0

Study Design

The following procedures are part of the standard of care for the Department of
Neuropsychology and Rehabilitation Psychology neuropsychological evaluation
procedure for patients referred to Dr. Travis Fogel, Ph.D.
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Background
The patients were initially seen by their primary care physician and were referred
to Dr. Travis Fogel, Ph.D. for a comprehensive neuropsychological evaluation. At the
initial point of contact, a Frequently Asked Question sheet was sent to the patient (see
Appendix A), which included a recommendation to bring a family member or friend to
the evaluation (informant). In instances when an informant was not present, informant
paperwork was given to the patient, who was instructed to have a family member or
friend complete. Each evaluation took approximately 2 – 2.5 hours in its entirety, which

Table 3
Informant characteristics
MCI
Characteristic
Relationship to patient
Spouse
Child
Caregiver
Other Relative
Friend
Declined to respond
Total
Years of acquaintance (m, SD)
Reported familiarity w/patient
Very familiar (provides daily care)
Somewhat familiar (often cares for)
Not very familiar (has minimal contact)
Declined to respond
Total

n

40

%

Dementia
n

%

Total
n

%

14 58.30
8 33.30
0
0.00
2
8.30
0
0.00
0
0.00
24 100.00
(39, 15.07)

13 52.00
9 36.00
0
0.00
2
8.00
0
0.00
1
4.00
25 100.00
(46, 15.62)

27 55.10
17 35.40
0
0.00
4
8.30
0
0.00
1
2.00
49 100.00
(46, 42.97)

23 95.80
0
0.00
1
4.20
0
0.00
24 100.00

18 72.00
4 16.00
0
0.00
3 12.00
25 100.00

41 83.70
4
8.20
1
2.00
3
6.10
49 100.00

included a 30-minute clinical interview with the patient and family member/caregiver,
and a 90 to 120-minute assessment session conducted with the patient individually. Table
3 presents relevant informant characteristics.

Clinical Interview
The clinical interview typically lasted approximately 30 minutes, and Dr. Travis
Fogel, Ph.D., the patient, and the informant(s) were present. Dr. Fogel interviewed the
patient and informant, and gathered clinically relevant information (see Appendix B for
details regarding information collected). The information collected fell within four
domains: (1) demographic information (i.e. age, ethnicity, handedness, years of education,
occupation, etc.), (2) history of cognitive complaints and current cognitive status, (3)
personal medical/psychiatric history, and (4) family medical history. Upon completion of
the clinical interview, the patient began the neuropsychological evaluation. The informant
was asked to wait in the waiting room and was given two forms to complete; the patient
history form and the Neuropsychiatric Inventory (see Appendix C and D, respectively).
These forms were collected from the informant at the conclusion of the evaluation.

Neuropsychological Evaluation
The standard neuropsychological evaluation was approximately 90-120 minutes
long. Either Dr. Fogel, Ph.D. or Kyrstle Barrera, M.A., administered the
neuropsychological measures individually with the patient in a quiet, distraction-free
testing office. The evaluation included administration of the following
neuropsychological measures (see Appendix E):
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1. Modified Mini Mental Status Exam (3MS): A 100 point, global screening of
cognitive function assessing temporal and spatial orientation, attention and working
memory, language, immediate and delayed recall, abstract reasoning, and verbal
fluency (Teng & Chui, 1987).
2. Trail Making Test Form A (Trails A): A speeded measure of attention, scanning,
sequencing and psychomotor speed requiring the connection of numbered circles in
consecutive order (Reitan & Wolfson, 1985).
3. Trail Making Test Form B (Trails B): A speeded measure of attention, scanning,
sequencing, psychomotor speed, mental flexibility, and set shifting requiring the
connection of numbered and lettered circles in order, alternating between consecutive
numbers and letters (i.e. 1-A-2-B-3-C etc.) (Reitan & Wolfson, 1985).
4. Controlled Oral Word Association Test (FAS and Animals): A timed measure of
phonemic and category verbal fluency requiring the generation of as many words as
possible beginning with a given letter of the alphabet (F, A, and S) and as many items
belonging to a given category (animals) in 60 seconds (Benton, Hasmsher, & Sivian,
1994).
5. California Verbal Learning Test – 2nd edition, Short Form (CVLT): List learning
verbal memory test comprised of a 9-item word list containing words from three
categories (fruit, clothing, and tools) tested in free recall, cued recall, recognition
(CVLT Rec), and forced choice (CVLT FC) paradigms at short (CVLT IR) and long
delays (CVLT DR) (Delis, Kramer, Kaplan, & Ober, 2000).
6. Wechsler Adult Intelligence Scale – 3rd edition subtests (Wechsler, 1997)
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a. Block Design (BD): A timed measure of visuospatial and visuoconstructive skill
requiring the use of bicolored blocks (red and white) to reconstruct a given picture.
b. Digit Span (DSF, DSB): A measure of attention, concentration, and working
memory requiring the repetition of verbally presented stings of numbers of
increasing length in both forward and backward sequences.
7. Symbol Digit Modalities Test (SDMT; written version): a timed measure of complex
visual scanning, tracking, perceptual speed, divided attention, and psychomotor
processing requiring the transcription of symbols into numbers given a key (Smith,
1991)
8. Geriatric Depression Scale (GDS): A 30-item self-report inventory assessing feelings
of depression over the past week (Yesavage et al., 1983).
9. Wechsler Memory Scale – 3rd edition subtests (Wechsler, 1997b)
a. Logical Memory I (LMI): A contextual verbal memory measure requiring the
immediate memory of two short stories, the second of which is repeated twice
b. Logical Memory II (LMII): A contextual verbal memory measure requiring the
memory of two short stories after a delay.
10. Judgment of Line Orientation (JLO): A spatial perception and orientation measure
requiring the estimation of the orientation of two lines presented concurrently using a
set of reference lines, similar to a protractor (Benton, Varney, & Hamsher, 1978).
11. Boston Naming Test (BNT): A measure of confrontational naming requiring the
naming of simple, line drawn pictures of common objects and animals (Kaplan,
Goodglass, & S Weintraub, 1983).
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12. Wechsler Test of Adult Reading (WTAR): A measure of premorbid intelligence
requiring the reading and pronouncing of 50 words that have irregular grapheme-tophoneme translations (Wechsler, 1997a).
13. Wisconsin Card Sorting Test-64 Card Version, Live administration (WCST): A test
of abstract concept formation, mental set maintenance and shifting, and the ability to
utilize feedback by properly sorting a deck of 64 cards differing in the color, shape,
and number of symbols (Heaton, 1993)
14. Dot Counting Test (DC): A timed measure of effort requiring the accurate and timely
counting of randomly placed dots on cards (Boone, 2002)
Each neuropsychological assessment measure was administered according to the
standard administration procedures outlined by its respective publisher. Routinely before
the administration of each measure, the examiner verbally presented a brief overview of
the upcoming measure and asked the patient to predict how well he/she would do on the
measure (see Appendix F for script). The patient was given a blue pen and a scale with
“Extremely Well” at the top with a smiling face and “Extremely Poorly” at the bottom
with a frowning face (see Appendix G for sample scales). The patient was asked to base
his/her prediction in comparison to his/her same aged and educated peers, and draw a line
on the scale where he/she expected his/her performance to fall. Once the measure was
administered, the same scale was presented to the patient, which now contained his/her
performance prediction. The patient was given a green pen and asked to draw a line
indicating an evaluation of how well he/she actually performed. Different colored pens
were used to differentiate between the two (prediction and evaluation) values. In addition,
the patient was asked how concerned he/she was about his/her cognitive ability, as well
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as how concerned his/her family was about his/her cognitive ability. The patient
provided this assessment on a similar scale, with “Very Concerned” at the top and “Not
Concerned” at the bottom. The patient provided this assessment both before the
assessment process began and after the entire assessment process was concluded. At the
conclusion of the session, the patient was also asked to provide a rating of how well
he/she thinks he/she performed on the measures administered as a whole using the same
scale used for the individual assessment measures.
At the conclusion of the evaluation, the patient was informed that the information
gleaned from the interview, neuropsychological evaluation, and forms completed by the
informant would be used to compile a chart note, which would be included into the
patient’s medical record. They were informed that the information was available for
review by their referring physician and would be discussed with the patient at their next
follow up appointment, or should the patient desire, via a feedback session with Travis
Fogel, PhD.

Informant Data Collected
Within the patient history form (see Appendix C), informant predictions of patient
performance were collected. Ratings were provided along a 10-point Likert scale such
that lower values indicated less favorable predictions (i.e. 1 = “Relatively Poorly) and
higher values indicated more favorable predictions (i.e. 10 = “Relatively Well”). Items
corresponded exactly to the predictions collected from the patients for each
neuropsychological measure and relevant subsections of measures.
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Variables Captured
Basic demographic information was obtained, as well as relevant historical
information and psychiatric symptomatology, as provided by the informant. Ratings of
concern regarding patient’s cognitive ability on behalf of the family and the patient, from
the perspective of the patient, was obtained before and after the assessment battery was
administered. Patient predictions of performance and evaluations of performance were
obtained before and after each neuropsychological assessment measure, as well as at
different steps on multistep measures when appropriate (see Appendix F for a complete
list of neuropsychological prediction and evaluation measures collected and the script
used to solicit ratings). Actual neuropsychological performance scores were obtained on
each neuropsychological measure administered.
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CHAPTER FOUR
STATISTICAL ANALYSIS

Data Preparation
Prediction and Evaluation Percentages
Prediction and evaluation scores provided by the patient were quantified by
measuring the distance from the bottom of the scale to the response point, rounded down
to the nearest quarter of an inch. Each value was then divided by the total length of the
scale, and then multiplied by 100 to produce a percentage value of each response, such
that:
Prediction or Evaluation =
Percentage

Response Value
Total Possible Value

X

100

For example, a prediction response for the Judgment of Line Orientation placed in the
center of the scale, or a response 6 cm from the bottom of a 12 cm scale, would result in
the following percentage:
Prediction Percentage =

6
12

X

100

=

50.00

Of note, prediction values were also calculated for informant predictions, using the same
mathematical calculation, save for the fact that the scales used for informant predictions
were based on a 10 point Likert scale, with larger values indicated more favorable
predictions. Since informants were not actually present for the neuropsychological
evaluation, evaluation of performance responses were not collected.
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Actual Performance Percentages
Actual performance percentages were calculated using the observed raw score
value for each measure. These scores were then divided by the total possible raw score
and multiplied by 100 to produce a percentage value for each measure, such that:
Actual Performance
Percentage

Observed Raw Score
Total Possible Raw Score

=

X

100

For example, a raw score of 25 on the Judgment of Line Orientation, which has a total of
30 items, would result in the following percentage:
Actual Performance
Percentage

=

25
30

X

100

= 83.33

Anosognosia Prediction and Evaluation Ratios
Anosognosia ratios were calculated by subtracting the predication or evaluation
percentage from the actual performance percentage, and dividing by the sum of the two
values (as seen in Barrett et al., 2005), such that:
Anosognosia
Prediction Ratio

Prediction Percentage - Actual Performance Percentage
=
Prediction Percentage + Actual Performance Percentage
or

Anosognosia
Evaluation Ratio

=

Evaluation Percentage - Actual Performance Percentage
Evaluation Percentage + Actual Performance Percentage
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Given the prediction percentage and actual performance percentage for the two examples
above, the anosognosia prediction ratio would be calculated as follows:
Anosognosia
Prediction Ratio

50.00 – 83.33
=

=

-0.25

50 + 83.33

This analysis allows for a range between -1 and +1, thus accounting for both
overestimations and underestimations of performance. As such, values closer to 0
indicate perfect awareness of actual performance, such that prediction or evaluation
values are commensurate with actual performance. Negative values indicate under
prediction or evaluation of performance relative to actual performance, with increased
discrepancy as values near -1. Positive values indicate over prediction or evaluation of
performance relative to actual performance, with increased discrepancy as values near +1.
As such, this also takes into account the actual cognitive ability of the patient.

Power Analysis
Given the number of data points being collected on each patient, the required
sample size in order to obtain the appropriate power to detect a meaningful difference in
ratings with a medium effect size (Cohen’s d = 0.05, =0.05, =0.8), is a total of 30
participants.

Missing Data
The neuropsychological assessments were clinical in nature, conducted by Kyrstle
Barrera, M.A., or Travis Fogel, Ph.D., and were typically unrestrained by time. Thus, the
only reason a patient would be missing neuropsychological test data would be due to their
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inability to perform the measure. This was most commonly seen with the Judgment of
Line Orientation test, which requires the patient to estimate the orientation of lines based
on a reference set, similar to estimating angle orientation given a protractor as a reference.
In order to keep these patients in the analysis, the lowest possible raw score was inputted
(i.e. a score of zero).

Data Cleaning
Data was cleaned to ensure that the data meet the assumptions required to
complete multivariate analysis of covariance (MANCOVA) and logistic regression
analyses. A wide range of abilities was expected given the nature of mild cognitive
impairment and mild dementia. As such, data that could represent the wide range of
ability seen in these diagnoses was not removed from the sample. Normality was
assessed using boxplots and histograms. Scatterplots and Pearson’s R were used to assess
linearity of the dependent variables. Lastly, homogeneity of variance and covariance
were assessed using Box’s M. Literature regarding significant Box’s M results indicate
that MANCOVA analyses are robust to violations of the assumption of homogeneity of
variance when sample sizes are equal between comparison groups (Field, 2005). As such,
in instances when Box’s M values were significant, data interpretation continued, given
that data was deemed normally distributed via the ancillary measures employed.

Data Analyses
Data was compiled using SPSS version 19 for the Macintosh operating system
(Mac OSX) and analyzed using SPSS version 20.
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Hypothesis 1 – Patient Versus Informant Ratings
In order to investigate the effect of information source on predictions of patient
performance, a one way multivariate analysis of covariance was performed using
information source as the independent variable with two levels, patient and informant
prediction percentages across all 20 neuropsychological measures as the dependent
variable. Pillai’s trace results were analyzed and the effect of age was removed by using
age as a covariate in the analyses. It is important to note that this analysis is unadjusted
for actual performance.

Hypothesis 2 – Accuracy of Ratings
In order to investigate the accuracy of information source and diagnosis on
predictions of patient performance, a two-way multivariate analysis of covariance was
performed using two independent variables: information source with three levels (patient
prediction percentage, informant prediction percentage, and actual performance
percentage) and diagnosis with two levels (MCI and dementia). Dependent variables
included prediction percentages for all 20 neuropsychological measures. Pillai’s trace
results were analyzed and the effect of age was removed by using age as a covariate in
the analyses. It is important to note that this analysis is unadjusted for actual performance.

Hypothesis 3 – Emergent Awareness by Cognitive Domain
In order to investigate the presence of emergent awareness by diagnosis, a doubly
multivariate analysis of covariance was performed using diagnosis group as the betweensubjects independent variable with two levels (MCI and dementia) and time as the
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within-subjects independent variable with two time points (prediction and evaluation).
Dependent variables included prediction and evaluation anosognosia ratios all 20
neuropsychological measures. Pillai’s trace results were analyzed and the effect of age
was removed by using age as a covariate in the analyses. It is important to note that this
analysis is adjusted for actual performance by incorporating actual performance in the
anosognosia ratios for each measure.

Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment
In order to assess the diagnostic utility of anosognosia assessment, a logistic
regression was used on patient prediction anosognosia ratios across all 20
neuropsychological measures to predict diagnostic group membership (MCI versus
dementia). Anosognosia ratios were multiplied by 100 to adjust the data range, changing
the range from -1 to +1 to -100 to +100 to account for the impact of restricted range on
the odds ratio results and interpretability. Initially an exploratory logistic regression was
run by using the Enter method in SPSS, to see if predictive anosognosia ratios, as a group,
reliably predicted diagnostic group membership. Then, a forward logistic regression was
run to elucidate which combination of anosognosia ratios were reliably predictive of
diagnostic group membership.
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CHAPTER FIVE
RESULTS
Hypothesis 1 – Patient Versus Informant Ratings
General Cognitive Ability, Premorbid Function, and Effort
A one-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant) on predictions of patient performance in the domain of
general cognitive ability, premorbid function, and effort, including the 3MS, WTAR, and
DC, while controlling for age (see Table 4 and Figures 1-3). The main effect of
information source indicated a significant effect on the combined DV (Pillai’s
Trace=.441, F(3,79)=20.799, p=.000, multivariate η2=.441). The covariate did not
significantly influence the combined DV (Pillai’s Trace=.033, F(3,79)=.910, p=.440,
multivariate η2=.033). Multivariate results indicated that both 3MS predictions and DC
predictions were significantly effected by information source (F(1,81)=29.022, p=.000,
multivariate η2=.264; F(1,81)=8.090, p=.006, multivariate η2=.091, respectively), while
the WTAR predictions were not (F(1,81)=.560, p=.456, multivariate η2=.007).
Comparison of prediction means indicated that patients provided more favorable
predictions than informants on the 3MS, while patients provided less favorable
predictions than informants on the DC.

Attention, Concentration, and Processing Speed
A one-way MANCOVA was conducted to determine the effect of information source
(patient vs. informant) on predictions of patient performance in the domain of attention,
concentration, and processing speed, including Trails A, DSF, DSB, and the SDMT,
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while controlling for age (see Table 5 and Figures 4-7). The main effect of information
source indicated a significant effect on the combined DV (Pillai’s Trace=.216,
F(4,85)=5.843, p=.000, multivariate η2=.216). The covariate did not significantly
influence the combined DV (Pillai’s Trace=.079, F(4,85)=1.811, p=.134, multivariate
η2=.079). Multivariate results indicated that Trails A predictions were significantly
effected by information source (F(1,88)=13.560, p=.000, multivariate η2=.134), while
DSF, DSB, and SDMT predictions were not (F(1,88)=2.876, p=.093, multivariate
η2=.032; F(1,88)=.064, p=.801, multivariate η2=.001; F(1,88)=.089, p=.767, η2=.001).
Comparison of prediction means indicated that patients provided more favorable
predictions than informants on Trails A.

Table 4
Mean scores and standard deviations for the domain of general
cognitive ability, premorbid function, and effort for patient and
informant predictions of performance percentages, and
multivariate analysis of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,81)
p
η2
3MS
29.02
0.000 0.26
Patient
45 63.03 22.46
Informant
39 39.74 16.46
Total
84 52.22 22.98
WTAR
0.56
0.456 0.01
Patient
45 43.04 27.89
Informant
39 38.97 20.36
Total
84 41.15 24.62
DC
8.09
0.006 0.09
Patient
45 38.27 22.78
Informant
39 52.56 22.91
Total
84 44.90 23.81
Note: F(3,79)=20.799, p=.000, η2=.441
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Figure 1. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Modified Mini
Mental Status Examination (3MS)

Figure 2. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Wechsler Test of
Adult Reading (WTAR)
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Figure 3. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Dot Counting Test
(DC)

Table 5
Mean scores and standard deviations for the domain of attention, concentration,
and processing speed for patient and informant predictions of performance
percentages, and associated multivariate analysis of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,88)
p
η2
Trails A
13.56
0.000
0.13
Patient
49 57.47 21.89
Informant
42 41.19 20.02
Total
91 49.96 22.47
DSF
2.88
0.093
0.03
Patient
49 39.89 22.62
Informant
42 32.62 17.95
Total
91 36.54 20.81
DSB
0.06
0.801
0.00
Patient
49 26.44 22.26
Informant
42 27.62 19.10
Total
91 26.98 20.76
SDMT
0.09
0.767
0.00
Patient
49 37.15 23.14
Informant
42 35.71 21.43
Total
91 36.49 22.26
Note: F(4,85)=5.843, p=.000, η2=.216
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Figure 4. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Trail Making Test
Part A (Trails A)

Figure 5. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Digit Span Forward
(DSF)
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Figure 6. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Digit Span Backward
(DSB)

Figure 7. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Symbol Digit
Modalities Test (SDMT)
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Language
A one-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant) on predictions of patient performance in the domain of
language, including FAS, Animals, and the BNT, while controlling for age (see Table 6
and Figures 8-10). The main effect of information source did not indicated a significant
effect on the combined DV (Pillai’s Trace=.041, F(3,87)=1.241, p=.300, multivariate
η2=.041).

Table 6
Mean scores and standard deviations for the domain of language
for patient and informant predictions of performance
percentages, and associated multivariate analysis of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,92)
p
η2
FAS
0.06
0.808 0.00
Patient
48 48.05 21.75
Informant
44 47.05 18.25
Total
92 47.57 20.05
Animals
0.81
0.370 0.01
Patient
48 48.00 22.19
Informant
44 52.27 23.61
Total
92 50.04 22.86
BNT
2.42
0.123 0.03
Patient
48 54.42 23.17
Informant
44 62.05 23.78
Total
92 58.07 23.65
Note: F(3,87)=1.241, p=.300, η2=.041

59

Figure 8. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for FAS

Figure 9. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Animals
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Figure 10. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Boston Naming
Test (BNT)

Visuoperception and Visuoconstruction
A one-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant) on predictions of patient performance in the domain of
visuoperception and visuoconstruction, including the JLO and BD, while controlling for
age (see Table 7 and Figures 11-12). The main effect of information source did not
indicate a significant effect on the combined DV (Pillai’s Trace=.08, F(2,88)=2.692,
p=.073, multivariate η2=.058).

Memory
A one-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant) on predictions of patient performance in the domain of
memory, including the CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI and LMII,
while controlling for age (see Table 8 and Figures 13-18). The main effect of information
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Table 7
Mean scores and standard deviations for the domain of
visuoperception and visuoconstruction for patient and informant
predictions of performance percentages, and associated
multivariate analysis of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,89)
p
η2
JLO
1.50
0.224 0.02
Patient
49 49.81 24.76
Informant
43 43.49 24.48
Total
92 46.85 24.70
BD
1.32
0.254 0.01
Patient
49 44.89 23.93
Informant
43 50.47 22.25
Total
92 47.50 23.20
Note: F(2,88)=2.692, p=.073, η2=.058

Figure 11. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Judgment of Line
Orientation (JLO)
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Figure 12. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Block Design

source indicated a significant effect on the combined DV (Pillai’s Trace=.252,
F(6,77)=4.321, p=.001, multivariate η2=.252). The covariate did not significantly
influence the combined DV (Pillai’s Trace=.110, F(6,77)=1.590, p=.162, multivariate
η2=.110). Multivariate results indicated that the CVLT FC and LMII predictions were
significantly effected by information source (F(1,82)=6.039, p=.016, multivariate
η2=.069; F(1,82)=3.999, p=.049, multivariate η2=.047, respectively), while CVLT IR,
CVLT DR, CVLT Rec, and LMII predictions were not (F(1,82)=.764, p=.385,
multivariate η2=.009; F(1,82)=.047, p=.829, multivariate η2=.001; F(1,82)=.026, p=.872,
multivariate η2=.000; F(1,82)=3.218, p=.077, multivariate η2=.038, respectively).
Comparison of prediction means indicated that patients provided more favorable
predictions than informants on CVLT FC, but less favorable predictions than informants
on LMII.
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Table 8
Mean scores and standard deviations for the domain of memory
for patient and informant predictions of performance
percentages, and associated multivariate analysis of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,82)
p
η2
CVLT-IR
0.76
0.385 0.01
Patient
48 29.29 20.01
Informant
37 33.24 19.30
Total
85 31.01 19.68
CVLT-DR
0.05
0.829 0.00
Patient
48 24.75 22.10
Informant
37 23.78 16.39
Total
85 24.33 19.71
CVLT-Rec
0.03
0.872 0.00
Patient
48 33.60 24.67
Informant
37 32.70 20.09
Total
85 33.21 22.67
CVLT-FC
6.04
0.016 0.07
Patient
48 46.96 23.82
Informant
37 35.68 17.72
Total
85 42.05 21.99
LMI
3.22
0.077 0.04
Patient
48 44.46 23.37
Informant
37 36.22 17.22
Total
85 40.87 21.20
LMII
4.00
0.049 0.05
Patient
48 21.13 20.24
Informant
37 29.46 16.99
Total
85 24.75 19.24
Note: F(6,77)=4.321, p=.001, η2=.252
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Figure 13. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the California Verbal
Learning Test Immediate Recall (CVLT IR)

Figure 14. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the California Verbal
Learning Test Delayed Recall (CVLT DR)
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Figure 15. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the California Verbal
Learning Test Recognition (CVLT Rec)

Figure 16. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the California Verbal
Learning Test Forced Choice Recognition (CVLT FC)
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Figure 17. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Logical Memory I
(LMI)

Figure 18. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for Logical Memory II
(LMII)

Executive Function
A one-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant) on predictions of patient performance in the domain of
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executive function, including the WCST and Trails B, while controlling for age (see
Table 9 and Figures 19-20). The main effect of information source indicated a significant
effect on the combined DV (Pillai’s Trace=.156, F(2,88)=8.147, p=.001, multivariate
η2=.156). The covariate did not significantly influence the combined DV (Pillai’s
Trace=.004, F(2,88)=.182, p=.834, multivariate η2=.004). Multivariate results indicated
that both the WCST and Trails B predictions were significantly effected by information
source (F(1,92)=616.384, p=.000, multivariate η2=.155; F(1,92)=4.845, p=.030,
multivariate η2=.052, respectively). Comparison of prediction means indicated that
patients provided more favorable predictions than informants on both the WCST and
Trails B.

Table 9
Mean scores and standard deviations for the domain of
executive function for patient and informant predictions of
performance percentages, and associated multivariate analysis
of covariance
Information
Prediction
MANCOVA
Source
n Mean SD
F(1,92)
p
η2
WCST
16.38 0.000 0.16
Patient
49 50.37 24.92
Informant
43 30.93 20.21
Total
92 41.28 24.72
Trails B
4.85
0.030 0.05
Patient
49 45.80 26.42
Informant
43 34.88 19.93
Total
92 40.70 24.11
Note: F=(2,88)=8.147, p=.001, η2=.156
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Figure 19. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Wisconsin Card
Sorting Test (WCST)

Figure 20. Patient and informant prediction of performance percentages and actual
performance percentage (±SD) for MCI and dementia patients for the Trail Making Test
Part B (Trails B)
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Hypothesis 2 – Accuracy of Ratings
General Cognitive Ability, Premorbid Function, and Effort
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
applicable) in the domain of general cognitive ability, premorbid function, and effort,
including the 3MS, WTAR, and DC, while controlling for age (see Table 10 and Figures
1-3). As presented in Table 11, the main effect of information source indicated a
significant effect on the combined DV (Pillai’s Trace=.74, F(6,238)=23.39, p=.000,
η2=.37). The main effect of diagnosis group indicated a significant effect on the
combined DV (Pillai’s Trace=.09, F(3,118)=3.69, p=.014, η2=.09). The interaction effect
between information source and diagnosis group also indicated a significant effect on the
combined DV (Pillai’s Trace=.18, F(6,238)=3.93, p=.001, η2=.09). The covariate did not
significantly influence the combined DV (Pillai’s Trace=.03, F(3,118)=1.15, p=.333,
multivariate η2=.03).
Univariate ANOVA results are presented in Table 12. Results indicated that all
three DVs (3MS, WTAR, and DC) predictions/performances were significantly effected
by information source (F(2,120)=52.18, p=.000, partial η2=.47; F(2,120)=6.86, p=.002,
partial η2=.010; F(2,120)=21.33, p=.000, partial η2=.026, respectively). Results indicated
that the 3MS and DC were also significantly effected by diagnosis group (F(1,120)=5.06,
p=.026, partial η2=.04; F(1,120)=10.05, p=.002, partial η2=.08, respectively), but the
WTAR was not (F(1,120)=1.47, p=.227, partial η2=.01). In addition, the interaction effect
between information source and diagnosis group was significant for the 3MS
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Table 10
Mean scores and standard deviations for the domain of
general cognitive ability, premorbid function, and effort
for patient and informant predictions of performance
percentages and actual performance percentages for MCI
and dementia patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n Mean SD
3MS
MCI
22 55.58 19.87
19 45.79 17.74
Dementia 23 70.16 22.88
20 34.00 13.14
Total
45 63.03 22.46
39 39.74 16.46
WTAR
MCI
22 39.96 28.30
19 43.68 23.62
Dementia 23 45.99 27.79
20 34.50 16.05
Total
45 43.04 27.89
39 38.97 20.36
DC
MCI
22 39.27 22.17
19 62.11 21.49
Dementia 23 37.31 23.80
20 43.50 20.84
Total
45 38.27 22.78
39 52.56 22.91
Performance
Total
n Mean SD
n Mean SD
3MS
MCI
21 86.33 6.94
62 63.00 23.33
Dementia 22 68.14 14.26
65 58.35 23.80
Total
43 77.02 14.47
127 60.62 23.59
WTAR
MCI
21 62.86 16.45
62 48.86 25.17
Dementia 22 50.82 21.32
65 44.09 23.17
Total
43 56.70 19.83
127 46.42 24.19
DC
MCI
21 73.37 7.09
62 57.82 23.13
Dementia 22 59.80 20.99
65 46.83 23.71
Total
43 66.43 17.07
127 52.19 23.98
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Table 11
Multivariate analysis of covariance for the domain of cognitive ability,
premorbid function, and effort for patient and informant prediction
percentages and actual performance percentages for MCI and dementia
patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.03
1.15
3
118 0.333
0.03
Source
0.74 23.39
6
238 0.000
0.37
Diagnosis
0.09
3.69
3
118 0.014
0.09
Source * Diagnosis 0.18
3.93
6
238 0.001
0.09

Table 12
Univariate analysis of covariance for the domain of general cognitive ability, premorbid
function, and effort for patient and informant prediction percentages and actual
performance percentages for MCI and dementia patients
Main Effect of
Main Effect of
Source x Diagnosis
Source
Diagnosis
Interaction
2
2
Measure F(2,120)
p
η
F(1,120)
p
η
F(2,120)
p
η2
3MS
52.18
.000 0.47
5.06
.026 0.04
12.08
.00 0.17
0
WTAR
6.86
.002 0.10
1.47
.227 0.01
1.95
.14 0.03
7
DC
21.33
.000 0.26
10.05
.002 0.08
1.88
.15 0.03
7
Note: ABC= Significant Multivariate Analyses

(F(2,120)=6.86, p=.000, partial η2=.017) but not the WTAR or DC (F(2,120)=1.95,
p=.147, partial η2=.010; F(2,120)=1.88, p=.157, partial η2=.03, respectively).
Pairwise comparison data are presented in Table 13. Comparison of
prediction/performance means for the 3MS indicated that both patients and informants
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predicted lower performance than the patients actually performed, informants predicted
lower performance for dementia patients than MCI patients, and dementia patients
performed worse than MCI patients. In general, predictions/performances were lower
across all sources of information for the dementia group than the MCI group. Comparison
of prediction/performance means for the WTAR indicated that informants and patients
provided similar predictions of performance, and both predicted lower performance than
patients actually performed. In addition, informants predicted that dementia patients
would perform worse than MCI patients. Comparison of prediction/performance means
for the DC indicated that informants and patients predicted that patients would perform
worse than they actually did, with patients predicting lower performance than informants

Table 13
Pairwise comparisons for the domain of general cognitive ability, premorbid function,
and effort for patient and informant prediction percentages and actual performance
percentages for MCI and dementia patients
Source
Diagnosis
Source x Diagnosis
p
p
p
3MS
Pt x Inf
0.000
MCI x Dem
0.026
Pt x Diag
ns
Pt x AP
0.000
Inf x Diag
0.004
Inf x AP
0.000
AP x Diag
0.000
WTAR
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
0.017
0.047
Inf x Diag
Inf x AP
0.002
AP x Diag
ns
DC
Pt x Inf
0.004
MCI x Dem
0.002
Pt x Diag
ns
Pt x AP
0.000
0.014
Inf x Diag
Inf X AP
0.008
0.010
AP x Diag
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons
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did. Informants predicted than dementia patients would perform worse than MCI patients,
and dementia patients did, in fact, perform worse than MCI patients.

Attention, Concentration, and Processing Speed
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
applicable) in the domain of attention, concentration, and processing speed, including
Trails A, DSF, DSB, and the SDMT, while controlling for age (see Table 14 and Figures
4-7). As presented in Table 15, the main effect of information source indicated a
significant effect on the combined DV (Pillai’s Trace=.38, F(8,262)=7.71, p=.000,
η2=.19). The main effect of diagnosis group indicated a significant effect on the
combined DV (Pillai’s Trace=.13, F(4,130)=4.79, p=.00001, η2=.13). The interaction
effect between information source and diagnosis group also indicated a significant effect
on the combined DV (Pillai’s Trace=.11, F(8,262)=1.98, p=.049, η2=.06). The covariate
did not significantly influence the combined DV (Pillai’s Trace=.05, F(4,130)=1.74,
p=.146, multivariate η2=.05).
Univariate ANOVA results are presented in Table 16. They indicated that Trails
A and DSF predictions/performances were significantly effected by information source
(F(2,133)=16.77, p=.000, partial η2=.20; F(2,133)=11.47, p=.000, partial η2=.15,
respectively) while DSB and SDMT were not (F(2,133)=.36, p=.696, partial η2=.01;

74

Table 14
Mean scores and standard deviations for the domain of attention,
concentration, and processing speed for patient and informant
predictions of performance percentages and actual performance
percentages for MCI and dementia patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n
Mean
SD
Trails A
MCI
24 56.80 23.84
22 47.27 19.56
Dementia
25 58.12 20.32
20 34.50 18.77
Total
49 57.47 21.89
42 41.19 20.02
DSF
MCI
24 37.46 24.63
22 38.18 20.85
Dementia
25 42.23 20.73
20 26.50 11.82
Total
49 39.89 22.62
42 32.62 17.95
DSB
MCI
24 23.30 19.42
22 30.91 18.49
Dementia
25 29.45 24.71
20 24.00 19.57
Total
49 26.44 22.26
42 27.62 19.10
SDMT
MCI
24 37.28 24.88
22 40.91 23.08
Dementia
25 37.02 21.87
20 30.00 18.35
Total
49 37.15 23.14
42 35.71 21.43
Performance
Total
n Mean SD
n
Mean
SD
Trails A
MCI
24 81.23 7.03
70 62.18 23.01
Dementia
25 54.45 34.46
70 50.06 27.47
Total
49 67.56 28.29
140 56.12 25.97
DSF
MCI
24 54.69 16.51
70 43.59 22.15
Dementia
25 47.00 12.38
70 39.44 17.70
Total
49 50.77 14.91
140 41.52 20.09
DSB
MCI
24 35.42 14.82
70 29.84 18.14
Dementia
25 23.71 13.63
70 25.84 19.74
Total
49 29.45 15.27
140 27.84 19.00
SDMT
MCI
24 51.88 18.42
70 43.42 22.83
Dementia
25 24.60 18.38
70 30.58 20.12
Total
49 37.96 22.83
140 37.00 22.39
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Table 15
Multivariate analysis of covariance for the domain of attention, concentration,
and processing speed for patient and informant prediction percentages and
actual performance percentages for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.05
1.74
4
130 0.146
0.05
Source
0.38
7.71
8
262 0.000
0.19
Diagnosis
0.13
4.79
4
130 0.001
0.13
Source * Diagnosis 0.11
1.98
8
262 0.049
0.06

F(2,133)=.20, p=.821, partial η2=.00, respectively). Results indicated that the Trails A
and SDMT were significantly effected by diagnosis group (F(1,133)=15.05, p=.000,
partial η2=.10, F(1,133)=11.97, p=.001, partial η2=.08, respectively), while DSF and DSB
were not (F(1,133)=1.73, p=.191, partial η2=.01; F(1,133)=.92, p=.340, partial η2=.01,
respectively). In addition, the interaction effect between information source and diagnosis
group was significant for Trails A and SDMT (F(2,133)=4.92, p=.009, partial η2=.07;
F(2,133)=5.09, p=007, η2=.07) but not DSF or DSB (F(2,133)=2.50, p=.86, partial η2=.04,
F(2,133)=2.94, p=.056, partial η2=.04, respectively).
Pairwise comparison data are presented in Table 17. Comparison of
prediction/performance means for Trails A indicated that patients provided less favorable
predictions than informants, and that informants predicted that patients would perform
worse than they actually did. In general, predictions/performances were lower across all
sources of information for the dementia group than the MCI group. In addition,
informants predicted that dementia patients would perform worse than MCI patients, and
dementia patients actually did perform worse than MCI patients. Comparison of
prediction/performance means for DSF indicated that patients and informants provided
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Table 16
Univariate analysis of covariance for the domain of attention, concentration, and
processing speed for patient and informant prediction percentages and actual
performance percentages for MCI and dementia patients
Main Effect of
Main Effect of
Source x Diagnosis
Source
Diagnosis
Interaction
F(2,133
F(1,133
F(2,133
Measure
)
p
η2
)
p
η2
)
p
η2
Trails A
16.77 .000 0.20
15.05
.000 0.10
4.92
.009 0.07
DSF
11.47 .000 0.15
1.73
.191 0.01
2.50
.086 0.04
DSB
0.36
.696 0.01
0.92
.340 0.01
2.94
.056 0.04
SDMT
0.20
.821 0.00
11.97
.001 0.08
5.09
.007 0.07
Note: ABC= Significant Multivariate Analyses

Table 17
Pairwise comparisons for the domain of attention, concentration, and processing speed
for patient and informant prediction percentages and actual performance percentages for
MCI and dementia patients
Source
Diagnosis
Source x Diagnosis
p
p
p
Trails A
Pt x Inf
0.002
MCI x Dem
0.000
Pt x Diag
ns
Pt x AP
ns
0.018
Inf x Diag
Inf x AP
0.000
AP x Diag
0.001
DSF
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
0.012
0.033
Inf x Diag
Inf x AP
0.000
AP x Diag
0.046
DSB
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
ns
ns
Inf x Diag
Inf x AP
ns
AP x Diag
0.006
SDMT
Pt x Inf
ns
MCI x Dem
0.001
ns
Pt x Diag
Pt x AP
ns
Inf x Diag
ns
Inf x AP
ns
AP x Diag
0.000
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons

77

similar predictions, and both predicted that patients would perform worse than they
actually did. Comparison of prediction/performance means for SDMT indicated that, in
general, predictions/performances were lower for the dementia group than the MCI group.
In addition, dementia patients actually did perform worse than MCI patients.

Language
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
applicable) in the domain of language, including FAS, Animals, and the BNT, while
controlling for age (see Table 18 and Figures 8-10). As presented in Table 19, the main
effect of information source indicated a significant effect on the combined DV (Pillai’s
Trace=.26, F(6,266)=6.51, p=.000, η2=.13). The main effect of diagnosis group indicated
a significant effect on the combined DV (Pillai’s Trace=.07, F(3,132)=3.29, p=.023,
η2=.07). The interaction effect between information source and diagnosis group did not
indicate a significant effect on the combined DV (Pillai’s Trace=.08, F(6,266)=1.89,
p=.083, η2=.04). The covariate did not significantly influence the combined DV (Pillai’s
Trace=.01, F(4,130)=1.74, p=.146, multivariate η2=.05).
Univariate ANOVA results are presented in Table 20. The results indicated that
Animals and BNT predictions/performances were significantly effected by information
source (F(2,134)=4.80, p=.010, partial η2=.07; F(2,134)=6.93, p=.001, partial η2=.09,
respectively) while FAS was not (F(2,132)=.46, p=.632, partial η2=.01). Results indicated
that Animals and BNT predictions/performances were significantly effected by diagnosis
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Table 18
Mean scores and standard deviations for the domain of
language for patient and informant predictions of
performance percentages and actual performance
percentages for MCI and dementia patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n Mean SD
FAS
MCI
23 45.56 24.42
22 54.55 17.11
Dementia 25 50.35 19.19
22 39.55 16.47
Total
48 48.05 21.75
44 47.05 18.25
Animals
MCI
23 45.07 23.55
22 62.27 23.69
Dementia 25 50.69 20.99
22 42.27 19.26
Total
48 48.00 22.19
44 52.27 23.61
BNT
MCI
23 54.26 25.40
22 68.18 22.18
Dementia 25 54.57 21.45
22 55.91 24.23
Total
48 54.42 23.17
44 62.05 23.78
Performance
Total
n Mean SD
n Mean SD
FAS
MCI
24 47.25 16.55
69 49.01 19.77
Dementia 25 41.12 24.76
72 43.84 20.86
Total
49 44.12 21.15
141 46.37 20.43
Animals
MCI
24 46.67 20.04
69 51.11 23.41
Dementia 25 32.00 15.87
72 41.63 20.14
Total
49 39.18 19.32
141 46.27 22.24
BNT
MCI
24 78.06 18.99
69 66.98 24.10
Dementia 25 63.33 16.18
72 58.02 20.81
Total
49 70.54 18.95
141 62.40 22.85

group (F(1,134)=8.57, p=.004, partial η2=.06, F(1,134)=6.36, p=.013, partial η2=.05,
respectively), while FAS was not (F(1,134)=3.12, p=.080, partial η2=.02). In addition, the
interaction effect between information source and diagnosis group was significant for
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Animals (F(2,134)=5.04, p=.008, partial η2=.07) but not FAS or BNT (F(2,134)=2.80,
p=.064, partial η2=.04, F(2,134)=1.69, p=.189, partial η2=.02, respectively). Pairwise
comparisons are presented in Table 21. Comparison of prediction/performance means for
FAS indicated that informants predicted worse performance for MCI patients than
dementia patients. Comparison of prediction/performance means for Animals indicated
that dementia patients, in general, received less favorable predictions than MCI patients,

Table 19
Multivariate analysis of covariance for the domain of language for patient
and informant prediction percentages and actual performance percentages for
MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.01
0.33
3
132 0.800
0.01
Source
0.26
6.51
6
266 0.000
0.13
Diagnosis
0.07
3.29
3
132 0.023
0.07
Source * Diagnosis 0.08
1.89
6
266 0.083
0.04

Table 20
Univariate analysis of covariance for the domain of language for patient and informant
prediction percentages and actual performance percentages for MCI and dementia
patients
Source x Diagnosis
Main Effect of
Main Effect of
Interaction
Source
Diagnosis
2
2
Measure F(2,134)
p
η
F(1,134)
p
η
F(2,134)
p
η2
FAS
0.46
.632 0.01
3.12
.080 0.02
2.80
.064 0.04
Animals
4.80
.010 0.07
8.57
.004 0.06
5.04
.008 0.07
BNT
6.93
.001 0.09
6.36
.013 0.05
1.69
.189 0.02
Note: ABC= Significant Multivariate Analyses
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regardless of source. In addition, informants rated dementia patients less favorably than
MCI patients, and dementia patients did, indeed, perform worse than MCI patients.
Comparison of prediction/performance means for the BNT indicated that informants
predicted lower performance for patients than patients as a whole actually performed.
Dementia patients, overall, received lower predictions than MCI patients, regardless of
source. Lastly, dementia patients predicted less favorable performance than their MCI
counterparts, and dementia patients did, in fact, perform worse than MCI patients.

Table 21
Pairwise comparisons for the domain of language for patient and informant prediction
percentages and actual performance percentages for MCI and dementia patients
Source
Source x Diagnosis
Diagnosis
p
p
p
FAS
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
ns
0.001
Inf x Diag
Inf x AP
ns
ns
AP x Diag
Animals
Pt x Inf
ns
MCI x Dem
0.004
Pt x Diag
ns
Pt x AP
ns
0.001
Inf x Diag
Inf x AP
0.009
AP x Diag
0.010
BNT
Pt x Inf
ns
MCI x Dem
0.013
Pt x Diag
0.010
Pt x AP
0.001
ns
Inf x Diag
Inf x AP
ns
AP x Diag
0.010
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons
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Visuoperception and Visuoconstruction
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
applicable) in the domain of visuoperception and visuoconstruction, including the JLO
and BD, while controlling for age (see Table 22 and Figures 11-12). As presented in
Table 23, the main effect of information source indicated a significant effect on the
combined DV (Pillai’s Trace=.37, F(4,268)=15.34, p=.000, η2=.19). The main effect of
diagnosis group indicated a significant effect on the combined DV (Pillai’s Trace=.13,
F(2,133)=9.47, p=.000, η2=.13). The interaction effect between information source and
diagnosis group also indicated a significant effect on the combined DV (Pillai’s
Trace=.13, F(4,268)=4.53, p=.001, η2=.06). The covariate did not significantly influence
the combined DV (Pillai’s Trace=.02, F(2,133)=1.16, p=.316, multivariate η2=.02).
Univariate ANOVA results are presented in Table 24. They indicated that BD
predictions/performances were significantly effected by information source
(F(2,134)=22.89, p=.000, partial η2=.25) while the JLO was not (F(2,134)=2.12, p=.124,
partial η2=.03). Results indicated that both the JLO and BD predictions/performances
were significantly effected by diagnosis group (F(1,134)=13.31, p=.000, partial η2=.09,
F(1,134)=14.66, p=.000, partial η2=.10, respectively). In addition, the interaction effect
between information source and diagnosis group was significant for the JLO and BD as
well (F(2,134)=7.20, p=.001, partial η2=.10; F(2,134)=4.81, p=.010, η2=.07).
Pairwise comparisons are presented in Table 25. Comparison of
prediction/performance means for the JLO indicated that dementia patients, overall,
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Table 22
Mean scores and standard deviations for the domain of
visuoperception and visuoconstruction for patient and
informant predictions of performance percentages and
actual performance percentages for MCI and dementia
patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n Mean SD
JLO
MCI
24 46.22 24.27
22 52.73 25.67
Dementia 25 53.24 25.23
21 33.81 19.36
Total
49 49.81 24.76
43 43.49 24.48
BD
MCI
24 44.50 25.70
22 61.82 18.93
Dementia 25 45.26 22.63
21 38.57 19.31
Total
49 44.89 23.93
43 50.47 22.25
Performance
Total
n Mean SD
n Mean SD
JLO
MCI
24 66.94 16.65
70 55.37 23.81
Dementia 25 39.33 27.55
71 42.60 25.56
Total
49 52.86 26.59
141 48.94 25.44
BD
MCI
24 32.78 9.71
70 45.93 22.41
Dementia 25 17.00 13.72
71 33.33 22.38
Total
49 24.73 14.24
141 39.58 23.19

Table 23
Multivariate analysis of covariance for the domain of visuoperception and
visuoconstruction for patient and informant prediction percentages and actual
performance percentages for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.02
1.16
2
133 0.316
0.02
Source
0.37 15.34
4
268 0.000
0.19
Diagnosis
0.13
9.47
2
133 0.000
0.13
Source * Diagnosis 0.13
4.53
4
268 0.001
0.06
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Table 24
Univariate analysis of covariance for the domain of visuoperception and
visuoconstruction for patient and informant prediction percentages and actual
performance percentages for MCI and dementia patients
Main Effect of
Main Effect of
Source x Diagnosis
Source
Diagnosis
Interaction
2
2
Measure F(2,134)
p
η
F(1,134)
p
η
F(2,134)
p
η2
JLO
2.12
.124 0.0
13.31
.000 0.09
7.20
.001
0.10
3
BD
22.88
.000 0.2
14.66
.000 0.10
4.81
.010
0.07
5

Table 25
Pairwise comparisons for the domain of visuoperception and visuoconstruction for
patient and informant prediction percentages and actual performance percentages for
MCI and dementia patients
Source
Diagnosis
Source x Diagnosis
p
p
p
JLO
Pt x Inf
ns
MCI x Dem
0.000
Pt x Diag
ns
Pt x AP
ns
0.013
Inf x Diag
Inf x AP
ns
0.000
AP x Diag
BD
Pt x Inf
ns
MCI x Dem
0.000
Pt x Diag
ns
Pt x AP
0.000
0.000
Inf x Diag
Inf x AP
0.000
0.000
AP x Diag
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons

received less favorable predictions than MCI patients regardless of information source. In
addition, informants rated dementia patients less favorably than MCI patients, and
dementia patients did, in fact, demonstrate lower performance than MCI patients.
Comparison of predication/performance means for BD indicated that, although patient
and informant predictions were similar, patients predicted more favorable performance
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than they were actually able to perform. Dementia patients, as a whole, received less
favorable predictions than their MCI counterparts, regardless of source of information.
Lastly, informants predicted lower performance for dementia patients than MCI patients,
and dementia patients did, in fact, performed lower than MCI patients did.

Memory
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
applicable) in the domain of memory, including the CVLT IR, CVLT DR, CVLT Rec,
CVLT FC, LMI and LMII, while controlling for age (see Table 26 and Figures 13-18).
As presented in Table 27, the main effect of information source indicated a significant
effect on the combined DV (Pillai’s Trace=1.02, F(12,246)=21.38, p=.000, η2=.51). The
main effect of diagnosis group did not indicate a significant effect on the combined DV
(Pillai’s Trace=.06, F(6,122)=1.31, p=.259, η2=.06). The interaction effect between
information source and diagnosis group indicated a significant effect on the combined
DV (Pillai’s Trace=.25, F(12,246)=2.96, p=.001, η2=.13). The covariate did not
significantly influence the combined DV (Pillai’s Trace=.02, F(6,122)=1.05, p=.396,
multivariate η2=.05).
Univariate ANOVA results are presented in Table 28. They indicated that all
predictions/performance values (CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI, and
LMII) were significantly effected by information source (F(2,134)=22.89, p=.000, partial
η2=.25). Results indicated that both the CVLT IR and CVLT FC
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Table 26
Mean scores and standard deviations for the domain of
memory for patient and informant predictions of
performance percentages and actual performance
percentages for MCI and dementia patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n Mean SD
CVLT-IR
MCI
23 27.04 18.83
19 36.84 21.10
Dementia 25 31.36 21.20
18 29.44 16.97
Total
48 29.29 20.01
37 33.24 19.30
CVLT-DR
MCI
23 21.93 20.06
19 27.37 19.68
Dementia 25 27.35 23.93
18 20.00 11.38
Total
48 24.75 22.10
37 23.78 16.39
CVLT-Rec
MCI
23 34.40 25.06
19 33.68 19.21
Dementia 25 32.87 24.81
18 31.67 21.49
Total
48 33.60 24.67
37 32.70 20.09
CVLT-FC
MCI
23 50.54 24.61
19 38.95 16.96
Dementia 25 43.67 23.07
18 32.22 18.33
Total
48 46.96 23.82
37 35.68 17.72
LMI
MCI
23 42.51 27.17
19 39.47 15.45
Dementia 25 46.26 19.64
18 32.78 18.73
Total
48 44.46 23.37
37 36.22 17.22
LMII
MCI
23 16.91 14.09
19 35.79 18.65
Dementia 25 25.01 24.24
18 22.78 12.27
Total
48 21.13 20.24
37 29.46 16.99
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Table 26 continued
Mean scores and standard deviations for the domain of
memory for patient and informant predictions of
performance percentages and actual performance
percentages for MCI and dementia patients continued
Information Source
Diagnosis
Performance
Total
Group
n Mean SD
n Mean SD
CVLT-IR
MCI
24 54.63 21.21
66 39.89 23.32
Dementia 25 24.00 20.71
68 28.15 19.96
Total
49 39.00 25.87
134 33.93 22.39
CVLT-DR
MCI
24 51.85 20.64
66 34.37 24.00
Dementia 25 31.56 23.06
68 26.95 21.20
Total
49 41.50 23.98
134 30.61 22.84
CVLT-Rec
MCI
24 85.49 10.06
66 52.77 31.18
Dementia 25 72.00 12.70
68 46.94 27.68
Total
49 78.61 13.25
134 49.81 29.49
CVLT-FC
MCI
24 98.15 5.35
66 64.52 31.19
Dementia 25 91.11 14.70
68 58.08 31.90
Total
49 94.56 11.59
134 61.25 31.60
LMI
MCI
24 36.11 15.07
66 39.31 20.09
Dementia 25 19.68 9.61
68 32.92 19.80
Total
49 27.73 14.96
134 36.07 20.13
LMII
MCI
24 25.08 18.72
66 25.32 18.57
Dementia 25 9.20 9.92
68 18.61 18.35
Total
49 16.98 16.78
134 21.91 18.69

predictions/performances were significantly effected by diagnosis group (F(1,127)=6.53,
p=.012, partial η2=.05, F(1,127)=4.01, p=.047, partial η2=.03, respectively) while the
CVLT DR, CVLT Rec, LMI and LMII were not (F(1,127)=2.49, p=.117, partial η2=.02,
F(1,127)=2.97, p=.087, partial η2=.02, F(1,127)=2.59, p=.110, partial η2=.02,
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F(1,127)=3.43, p=.06, partial η2=.03, respectively). In addition, the interaction effect
between information source and diagnosis group was significant for the CVLT IR, CVLT
DR, LMI and LMII (F(2,127)=9.40, p=.000, partial η2=.13; F(2,127)=4.72, p=.011,
η2=.07, F(2,127)=3.64, p=.029, partial η2=.05; F(2,127)=6.83, p=.002, η2=.10,
respectively), but not for the CVLT Rec or CVLT FC (F(2,127)=1.39, p=.253, partial
η2=.02; F(2,127)=0.00, p=.999, η2=.00, respectively).
Pairwise comparison data are presented in Table 29. Comparison of
prediction/performance means for the CVLT IR indicated that patients provided less
favorable predictions than they were actually able to perform, and dementia patients
received less favorable ratings regardless of the source of information. In addition,
dementia patients did, in fact, perform more poorly than MCI patients. Comparison of
prediction/performance means for the CVLT DR indicated that patients provided lower
predictions than they were actually able to perform, and that dementia patients displayed
lower performance than their MCI counterparts. Comparison of prediction/performance
means for the CVLT Rec indicated that patients provided less favorable predictions than
they were actually able to perform, and that dementia patients performed worse than MCI
patients. Comparison of prediction/performance means for the CVLT FC indicated that
both patients and informants provided less favorable predictions than patients were
actually able to perform, and that dementia patients received less favorable ratings
regardless of information source. In addition, dementia patients demonstrated a lower
level of performance than their MCI counterparts. Comparison of prediction/performance
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Table 27
Multivariate analysis of covariance for the domain of memory for patient and
informant prediction percentages and actual performance percentages for
MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.05
1.05
6
122 0.396
0.05
Source
1.02 21.38
12
246 0.000
0.51
Diagnosis
0.06
1.31
6
122 0.259
0.06
Source * Diagnosis 0.25
2.96
12
246 0.001
0.13

Table 28
Univariate analysis of covariance for the domain of memory for patient and informant
prediction percentages and actual performance percentages for MCI and dementia
patients
Main Effect of
Main Effect of
Source x Diagnosis
Diagnosis
Source
Interaction
2
2
Measure
F(2,127)
p
η
F(1,127)
p
η
F(2,127)
p
η2
CVLT-IR
3.11
.048 0.05
6.53
.012 0.05
9.40
.000 0.13
CVLT-DR
11.26
.000 0.15
2.49
.117 0.02
4.72
.011 0.07
CVLT-Rec
83.06
.000 0.57
2.97
.087 0.02
1.39
.253 0.02
CVLT-FC
131.20 .000 0.67
4.01
.047 0.03
0.00
.999 0.00
LMI
9.71
.000 0.13
2.59
.110 0.02
3.64
.029 0.05
LMII
5.29
.006 0.08
3.43
.066 0.03
6.83
.002 0.10

for LMI indicated that, although patients and informants provided similar ratings, they
both underestimated patient’s actual performance. In addition, dementia patients
performed worse than MCI patients. Lastly, comparison of prediction/performance means
for LMII indicated that informants provided more favorable predictions than patients
were actually able to perform. In addition, informants rated dementia patients less
favorably than MCI patients, and dementia patients did, indeed, perform worse than MCI
patients.
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Table 29
Pairwise comparisons for the domain of memory for patient and informant prediction
percentages and actual performance percentages for MCI and dementia patients
Source
Diagnosis
Source x Diagnosis
p
p
p
CVLT-IR
Pt x Inf
ns
MCI x Dem
0.012
Pt x Diag
ns
Pt x AP
0.044
ns
Inf x Diag
Inf x AP
ns
AP x Diag
0.000
CVLT-DR
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
0.000
ns
Inf x Diag
Inf x AP
0.000
AP x Diag
0.018
CVLT-Rec
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
0.000
ns
Inf x Diag
Inf x AP
0.000
AP x Diag
0.010
CVLT-FC
Pt x Inf
0.015
MCI x Dem
0.047
Pt x Diag
ns
Pt x AP
0.000
ns
Inf x Diag
Inf x AP
0.000
AP x Diag
0.010
LMI
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
0.000
ns
Inf x Diag
Inf x AP
ns
AP x Diag
0.001
LMII
Pt x Inf
ns
MCI x Dem
ns
Pt x Diag
ns
Pt x AP
ns
Inf x Diag
0.002
Inf x AP
0.005
AP x Diag
0.005
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons

Executive Function
A two-way MANCOVA was conducted to determine the effect of information
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs.
dementia) on predictions of patient performance (or actual performance, when
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applicable) in the domain of executive function, including the WCST and Trails B, while
controlling for age (see Table 30 and Figures 19-20). As presented in Table 31, the main
effect of information source indicated a significant effect on the combined DV (Pillai’s
Trace=.29, F(4,268)=11.31, p=.000, η2=.14). The main effect of diagnosis group also
indicated a significant effect on the combined DV (Pillai’s Trace=.08, F(2,133)=6.08,
p=.003, η2=.08). Lastly, the interaction effect between information source

Table 30
Mean scores and standard deviations for the domain of
executive function for patient and informant predictions of
performance percentages and actual performance
percentages for MCI and dementia patients
Information Source
Diagnosis
Patient
Informant
Group
n Mean SD
n Mean SD
WCST
MCI
24 41.61 24.08
22 37.27 24.53
Dementia 25 58.78 23.15
21 24.29 11.65
Total
49 50.37 24.92
43 30.93 20.21
Trails B
MCI
24 46.50 27.18
22 41.36 22.53
Dementia 25 45.13 26.21
21 28.10 14.36
Total
49 45.80 26.42
43 34.88 19.93
Performance
Total
n Mean SD
n Mean SD
WCST
MCI
24 48.24 19.30
70 42.52 22.83
Dementia 25 45.06 16.83
71 43.75 22.69
Total
49 46.62 17.96
141 43.14 22.68
Trails B
MCI
24 37.38 26.88
70 41.76 25.62
Dementia 25 13.15 20.17
71 28.83 24.84
Total
49 25.02 26.45
141 35.25 25.96
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and diagnosis group indicated a significant effect on the combined DV (Pillai’s
Trace=.12, F(4,268)=4.09, p=.003, η2=.06). The covariate did not significantly influence
the combined DV (Pillai’s Trace=.00, F(2,133)=.05, p=.952 multivariate η2=.00).
Univariate ANOVA results are presented in Table 32. They indicated that both
the WCST and Trails B predictions/performances were significantly effected by
information source (F(2,134)=11.31, p=.000, partial η2=.14; F(2,134)=9.30, p=.000,
partial η2=.12). Results indicated that Trails B predictions/performance was significantly
effected by diagnosis group (F(1,134)=9.61, p=.002, partial η2=.07) while WCST was not
(F(1,134)=.02, p=.879, partial η2=.00). Lastly, the interaction effect between information
source and diagnosis group was significant for the WCST (F(2,134)=6.51, p=.002, partial
η2=.09), but not Trails B (F(2,134)=2.88, p=.060, η2=.04).
Pairwise comparison data are presented in Table 33. Comparison of
prediction/performance means for the WCST indicate that informants provided lower
predictions of performance than patients provided and than patients were actually able to
perform. In addition, MCI patients predicted that they would perform worse than

Table 31
Multivariate analysis of covariance for the domain of executive function for
patient and informant prediction percentages and actual performance
percentages for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Age
0.00
0.05
2
133 0.952
0.00
Source
0.29 11.31
4
268 0.000
0.14
Diagnosis
0.08
6.08
2
133 0.003
0.08
Source * Diagnosis 0.12
4.09
4
268 0.003
0.06
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Table 32
Univariate analysis of covariance for the domain of executive function for patient and
informant prediction percentages and actual performance percentages for MCI and
dementia patients
Main Effect of
Main Effect of
Source x Diagnosis
Source
Diagnosis
Interaction
2
2
Measure
F
p
η
F
p
η
F
p
η2
WCST
11.31 .000 0.14
0.02
.879 0.00
6.51
.002 0.09
Trails B
9.30
.000 0.12
9.61
.002 0.07
2.88
.060 0.04
Note: ABC= Significant Multivariate Analyses

Table 33
Pairwise comparisons for the domain of executive function for patient and informant
prediction percentages and actual performance percentages for MCI and dementia
patients
Source
Diagnosis
Source x Diagnosis
p
p
p
WCST
Pt x Inf
0.000
MCI x Dem
ns
Pt x Diag
0.037
Pt x AP
ns
0.027
Inf x Diag
Inf x AP
0.001
ns
AP x Diag
Trails B
Pt x Inf
ns
MCI x Dem
0.002
Pt x Diag
ns
Pt x AP
0.000
Inf x Diag
0.042
Inf x AP
ns
AP x Diag
0.003
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag =
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise
Comparisons

dementia patients, while informants predicted that dementia patients would perform
worse than MCI patients. Lastly, dementia and MCI patients performed similarly.
Comparison of prediction/performance means for Trails B indicated that, although
patients and informants provided similar ratings, patients provided more favorable
predictions than they were actually able to perform. In addition, dementia patients
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received less favorable ratings than MCI patients, regardless of the information source.
Lastly, informants predicted that dementia patients would perform less favorably than
MCI patients, and dementia patients did, in fact, perform worse than their MCI
counterparts.

Hypothesis 3 – Emergent Awareness by Cognitive Domain
General Cognitive Ability, Premorbid Function, and Effort
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of
general cognitive ability, premorbid function, and effort, including the 3MS, WTAR, and
DC, while controlling for age (see Table 34 and Figures 21-23). As presented in Table 35,
the between subjects main effect of diagnosis group indicated a significant effect on the
combined DV (Pillai’s Trace=.22, F(3,38)=3.60, p=.022, multivariate η2=.22). The
within-subjects main effect of time did not indicate a significant effect on the combined
DV (Pillai’s Trace=.05, F(3,38)=.64, p=.596, multivariate η2=.05). The interaction effect
between diagnosis group and time did not indicate a significant effect on the combined
DV (Pillai’s Trace=.16, F(3,38)=2.32, p=.091, multivariate η2=.16). The covariate did not
significantly influence the combined DV (Pillai’s Trace=.03, F(3,38)=.03, p=.805,
multivariate η2=.03).
Univariate ANOVA results are presented in Table 36, and indicated that 3MS
anosognosia ratios were significantly effected by diagnosis group (F(1,40)=10.90, p=.002,
partial η2=.21), while the WTAR and DC anosognosia ratios were not (F(1,40)=1.16,
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p=.288, partial η2=.03; F(1,40)=.093, p=.340, partial η2=.01, respectively). Comparison
of 3MS anosognosia ratio means indicated that anosognosia ratios for MCI patients were
lower than those of dementia patients, indicating that MCI patients had the tendency to
provide less favorable predictions of their performance relative to their actual
performance in comparison to the dementia group.

Attention, Concentration, and Processing Speed
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time

Table 34
Mean scores and standard deviations for the domain of general cognitive ability,
premorbid function, and effort for patient prediction anosognosia ratios for MCI
and dementia patients
Time
Diagnosis
Prediction
Evaluation
Total
Group
n Mean SD
n Mean SD
n Mean SD
3MS
MCI
21 -0.24 0.19
21 -0.30 0.28
42 -0.27 0.19
Dementia 22 0.02 0.19
22 -0.12 0.23
44 -0.05 0.19
Total
43 -0.11 0.23
43 -0.21 0.27
86 -0.16 0.03
WTAR
MCI
21 -0.30 0.35
21 -0.16 0.32
42 -0.23 0.08
Dementia 22 -0.10 0.38
22 -0.11 0.42
44 -0.10 0.08
Total
43 -0.20 0.37
43 -0.13 0.37
86 -0.17 0.05
DC
MCI
21 -0.35 0.31
21 -0.14 0.29
42 0.22 0.08
Dementia 22 -0.21 0.46
22 0.00 0.34
44 0.03 0.08
Total
43 -0.28 0.39
43 -0.07 0.32
86 0.13 0.05
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Figure 21. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Modified Mini Mental Status Examination (3MS)

Figure 22. Prediction and evaluation ratios (±SD) for the Wechsler Test of Adult Reading
(WTAR)
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Figure 23. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Dot Counting Test (DC)

Table 35
Multivariate analysis of covariance analysis for the domain of general cognitive
ability, premorbid function, and effort for patient prediction and evaluation
anosognosia ratios for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Between
Intercept
0.04
0.53
3
38
0.665 0.04
Age
0.03
0.33
3
38
0.805 0.03
Diagnosis
0.22
3.60
3
38
0.022 0.22
Within
Time
0.05
0.64
3
38
0.596 0.05
Time*Age
0.06
0.87
3
38
0.465 0.06
Time*Diagnosis
0.16
2.32
3
38
0.091 0.16
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Table 36
Univariate analysis of covariance analysis for the domain of general cognitive
ability, premorbid function, and effort for patient prediction and evaluation
anosognosia ratios for MCI and dementia patients
Main Effect of
Time x Diagnosis
Main Effect of
Time
Interaction
Diagnosis
2
2
Measure
F(1,40)
p
η
F(1,40)
p
η
F(1,40)
p
η2
3MS
0.07
.791 0.00
10.90
.002 0.21
1.05
.313 0.03
WTAR
1.04
.314 0.03
1.16
.288 0.03
7.18
.011 0.15
DC
0.41
.526 0.01
0.93
.340 0.02
0.00
.979 0.00

(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of
attention, concentration, and processing speed, including Trails A, DSF, DSB, and the
SDMT, while controlling for age (see Table 37 and Figures 24-27). As presented in Table
38, the between subjects main effect of diagnosis group indicated a significant effect on
the combined DV (Pillai’s Trace=.29, F(4,42)=4.23, p=.006, multivariate η2=.29). The
within-subjects main effect of time did not indicate a significant effect on the combined
DV (Pillai’s Trace=.05, F(4,42)=.56, p=.692, multivariate η2=.05). The interaction effect
between diagnosis group and time did not indicate a significant effect on the combined
DV (Pillai’s Trace=.06, F(4,42)=.062, p=.654, multivariate η2=.06). The covariate did not
significantly influence the combined DV (Pillai’s Trace=.05, F(7,42)=.056, p=.693,
multivariate η2=.05).
Univariate ANOVA results are presented in Table 39, and indicated that Trails A,
DSB, and SDMT anosognosia ratios were significantly effected by diagnosis group
(F(1,45)=9.58, p=.003, partial η2=.18; F(1,45)=5.84, p=.020, partial η2=.11;
F(1,45)=12.04, p=.001, partial η2=.21, respectively), while DSF anosognosia ratios were
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Table 37
Mean scores and standard deviations for the domain of attention, concentration,
and processing speed for patient prediction anosognosia ratios for MCI and
dementia patients
Time
Diagnosis
Prediction
Evaluation
Total
Group
n Mean SD
n
Mean
SD
n Mean SD
Trails A
MCI
24 -0.21 0.24
24 -0.17 0.19
48 -0.18 0.08
Dementia 24 0.15 0.48
24
0.20
0.45
48 0.16 0.08
Total
48 -0.03 0.42
48
0.02
0.39
96 -0.01 0.05
DSF
MCI
24 -0.25 0.44
24 -0.15 0.34
48 -0.22 0.07
Dementia 24 -0.11 0.30
24 -0.11 0.36
48 -0.09 0.07
Total
48 -0.18 0.38
48 -0.13 0.35
96 -0.16 0.05
DSB
MCI
24 -0.29 0.44
24 -0.16 0.46
48 -0.25 0.10
Dementia 24 0.00 0.60
24
0.15
0.50
48 0.11 0.10
Total
48 -0.14 0.54
48 -0.01 0.50
96 -0.07 0.07
SDMT
MCI
24 -0.25 0.41
24 -0.07 0.32
48 -0.16 0.08
Dementia 24 0.20 0.50
24
0.30
0.39
48 0.25 0.08
Total
48 -0.02 0.51
48
0.12
0.40
96 0.05 0.05

Figure 24. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Trail Making Test Part A (Trails A)
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Figure 25. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Digit Span Forward (DSF)

Figure 26. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Digit Span Backward (DSB)
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Figure 27. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Symbol Digit Modalities Test (SDMT)

Table 38
Multivariate analysis of covariance analysis for the domain of attention, concentration,
and processing speed for patient prediction and evaluation anosognosia ratios for MCI
and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Between Intercept
0.03 0.36
4
42
0.838
0.03
Age
0.05 0.56
4
42
0.693
0.05
Diagnosis
0.29 4.23
4
42
0.006
0.29
Within
Time
0.05 0.56
4
42
0.692
0.05
Time*Age
0.08 0.86
4
42
0.495
0.08
Time*Diagnosis
0.06 0.62
4
42
0.654
0.06
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Table 39
Univariate analysis of covariance analysis for the domain of attention,
concentration, and processing speed for patient prediction and evaluation
anosognosia ratios for MCI and dementia patients
Main Effect of
Time x Diagnosis
Main Effect of
Time
Interaction
Diagnosis
2
2
Measure F(1,45)
p
η
F(1,45)
p
η
F(1,45)
p
η2
Trails A
0.04
.844 0.00
9.58
.003 0.18
0.03
.872 0.00
DSF
0.01
.915 0.00
1.74
.194 0.04
1.32
.257 0.03
DSB
1.69
.200 0.04
5.84
.020 0.11
0.19
.667 0.00
SDMT
0.47
.497 0.01
12.04
.001 0.21
1.06
.308 0.02

not (F(1,45)=1.74, p=.194, partial η2=.04). Comparison of anosognosia ratio means for
all three significant subtests (Trails A, DSB, and SDMT) indicated that anosognosia
ratios for MCI patients were lower than those of dementia patients, indicating that MCI
patients had the tendency to provide less favorable predictions of their performance
relative to their actual performance in comparison to their dementia patient counterparts.

Language
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of
language, including FAS, Animals, and the BNT, while controlling for age (see Table 40
and Figures 28-30). As presented in Table 41, the between subjects main effect of
diagnosis group did not indicate a significant effect on the combined DV (Pillai’s
Trace=.14, F(3,43)=2.33, p=.088, multivariate η2=.14). The within-subjects main effect
of time did not indicate a significant effect on the combined DV (Pillai’s Trace=.06,
F(3,43)=.86, p=.471, multivariate η2=.06). The interaction effect between diagnosis
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Table 40
Mean scores and standard deviations for the domain of language for
prediction anosognosia ratios for MCI and dementia patients
Diagnosis
Prediction
Evaluation
Total
Group
n Mean SD
n Mean SD
n Mean
FAS
MCI
23 -0.05 0.36 23 -0.21 0.36 46 -0.15
Dementia 25 0.14 0.30 25 -0.05 0.29 50 0.06
Total
48 0.05 0.34 48 -0.13 0.33 96 -0.04
Animals
MCI
23 -0.04 0.34 23 -0.18 0.39 46 -0.11
Dementia 25 0.20 0.32 25 0.01 0.41 50 0.10
Total
48 0.09 0.35 48 -0.08 0.41 96 0.00
BNT
MCI
23 -0.21 0.25 23 -0.19 0.23 46 -0.20
Dementia 25 -0.09 0.22 25 -0.07 0.26 50 -0.08
Total
48 -0.15 0.24 48 -0.13 0.25 96 -0.14

patient

SD
0.06
0.06
0.04
0.07
0.07
0.05
0.05
0.05
0.03

Figure 28. Prediction and evaluation ratios (±SD) for MCI and dementia patients for FAS
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Figure 29. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Animals

Figure 30. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Boston Naming Test (BNT)
group and time did not indicate a significant effect on the combined DV (Pillai’s
Trace=.02, F(3,43)=0.29, p=.833, multivariate η2=.02). The covariate did not
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significantly influence the combined DV (Pillai’s Trace=.04, F(3,43)=.64, p=.592,
multivariate η2=.04). Univariate ANOVA results are presented in Table 42, though they
are uninterpretable.

Visuoperception and Visuoconstruction
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to determine the
effect of diagnosis group (between subjects, MCI vs. dementia) and time (within-subjects,
prediction vs. evaluation) on anosognosia ratios in the domain of visuoperception and

Table 41
Multivariate analysis of covariance analysis for the domain of language for
prediction and evaluation anosognosia ratios for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
Between Intercept
0.04 0.54
3
43
0.659
Age
0.04 0.64
3
43
0.592
Diagnosis
0.14 2.33
3
43
0.088
Within
Time
0.06 0.86
3
43
0.471
Time*Age
0.03 0.39
3
43
0.760
Time*Diagnosis
0.02 0.29
3
43
0.833

patient

η2
0.04
0.04
0.14
0.06
0.03
0.02

Table 42
Univariate analysis of covariance analysis for the domain of language for patient
prediction and evaluation anosognosia ratios for MCI and dementia patients
Main Effect of
Main Effect of
Time x Diagnosis
Time
Diagnosis
Interaction
Measure F(1,45)
p
η2
F(1,45)
p
η2
F(1,45)
p
η2
FAS
2.37
.131 0.05
5.46
.024 0.11
0.53
.471
0.01
Animals
1.03
.315 0.02
4.08
.049 0.08
0.63
.433
0.01
BNT
0.04
.841 0.00
3.30
.076 0.07
0.06
.801
0.00
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visuoconstruction, including the JLO and BD, while controlling for age (see Table 43 and
Figures 31-32). As presented in Table 44, the between subjects main effect of diagnosis
group indicated a significant effect on the combined DV (Pillai’s Trace=.21,
F(2,43)=5.71, p=.006, multivariate η2=.21). The within-subjects main effect of time did
not indicate a significant effect on the combined DV (Pillai’s Trace=.07, F(2,43)=.1.50,
p=.235, multivariate η2=.07). The interaction effect between diagnosis group and time did
not indicate a significant effect on the combined DV (Pillai’s Trace=.06, F(2,43)=1.31,
p=.281, multivariate η2=.06). The covariate did not significantly influence

Table 43
Mean scores and standard deviations for the domain of visuoperception and
visuoconstruction for patient prediction anosognosia ratios for MCI and dementia
patients
Time
Diagnosis
Prediction
Evaluation
Total
Group
n Mean
SD
n
Mean
SD
n
Mean
SD
JLO
MCI
24 -0.22
0.33
24
-0.10
0.22
48
-0.18
0.08
Dementia 23 0.21
0.50
23
0.18
0.50
46
0.21
0.08
Total
47 -0.01
0.47
47
0.03
0.41
94
0.02
0.06
BD
MCI
24 0.06
0.31
24
-0.20
0.38
48
-0.08
0.08
Dementia 23 0.43
0.37
23
0.12
0.60
46
0.28
0.09
Total
47 0.24
0.39
47
-0.04
0.52
94
0.10
0.06
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Figure 31. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Judgment of Line Orientation (JLO)

Figure 32. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Block Design
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Table 44
Multivariate analysis of covariance analysis for the domain of visuoperception and
visuoconstruction for patient prediction and evaluation anosognosia ratios for MCI and
dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Between Intercept
0.02
0.37
2
43
0.694
0.02
Age
0.02
0.35
2
43
0.709
0.02
Diagnosis
0.21
5.71
2
43
0.006
0.21
Within
Time
0.07
1.50
2
43
0.235
0.07
Time*Age
0.04
0.93
2
43
0.401
0.04
Time*Diagnosis
0.06
1.31
2
43
0.281
0.06

Table 45
Univariate analysis of covariance analysis for the domain of visuoperception and
visuoconstruction for patient prediction and evaluation anosognosia ratios for MCI
and dementia patients
Main Effect of
Time x Diagnosis
Main Effect of
Time
Interaction
Diagnosis
2
2
Measure F(1,44)
p
η
F(1,44)
p
η
F(1,44)
p
η2
JLO
2.21
.144 0.05
10.37
.002 0.19
2.01
.163 0.04
BD
1.17
.284 0.03
8.71
.005 0.17
0.43
.516 0.01

the combined DV (Pillai’s Trace=.02, F(2,43)=.35, p=.709, multivariate η2=.02).
Univariate ANOVA results are presented in Table 45, and indicated that both JLO
and BD anosognosia ratios were significantly effected by diagnosis group (F(1,44)=10.37,
p=.002, partial η2=.19; F(1,44)=8.71, p=.005, partial η2=.17, respectively). Comparison
of prediction means for both measures indicated that anosognosia ratios for MCI patients
were lower than those of dementia patients, indicating that MCI patients had the tendency
to provide less favorable predictions of their performance relative to their actual
performance than their dementia group counterparts.
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Memory
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of
memory, including the CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI and LMII,
while controlling for age (see Table 46 and Figures 33-38). As presented in Table 47, the
between subjects main effect of diagnosis group indicated a significant effect on the
combined DV (Pillai’s Trace=.33, F(6,39)=3.23, p=.011, multivariate η2=.33). The
within-subjects main effect of time did not indicate a significant effect on the combined
DV (Pillai’s Trace=.17, F(6,39)=1.33, p=.596, multivariate η2=.17). The interaction
effect between diagnosis group and time did not indicate a significant effect on the
combined DV (Pillai’s Trace=.16, F(6,39)=1.19, p=.033, multivariate η2=.16). The
covariate did not significantly influence the combined DV (Pillai’s Trace=.12,
F(6,39)=.92, p=.494, multivariate η2=.12).
Univariate ANOVA results are presented in Table 48, and indicated that CVLT
IR, LMI and LMII anosognosia ratios were significantly effected by diagnosis group
(F(1,44)=10.16, p=.003, partial η2=.19; F(1,44)=12.20, p=.001, partial η2=.22;
F(1,44)=6.96, p=.011, partial η2=.14, respectively), while CVLT DR, CVLT Rec, and
CVLT FC anosognosia ratios were not (F(1,44)=3.61, p=.064, partial η2=.08;
(F(1,44)=.03, p=.874, partial η2=.00; F(1,44)=0.00, p=.961, partial η2=.00, respectively).
Comparison of prediction means indicated that anosognosia ratios for MCI patients were
lower than those of dementia patients for all three significant measures (CVLT IR, LMI
and LMII), indicating that MCI patients had the tendency to provide less favorable
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Table 46
Mean scores and standard deviations for the domain of memory
anosognosia ratios for MCI and dementia patients
Diagnosis
Prediction
Evaluation
Group
n
Mean
SD
n
Mean
SD
CVLT-IR
MCI
23
-0.35
0.42
23
-0.30
0.39
Dementia 24
0.23
0.64
24
0.16
0.65
Total
47
-0.05
0.61
47
-0.06
0.58
CVLT-DR
MCI
23
-0.42
0.47
23
-0.47
0.47
Dementia 24
-0.03
0.58
24
-0.19
0.51
Total
47
-0.23
0.56
47
-0.33
0.50
CVLT-Rec
MCI
23
-0.50
0.31
23
-0.39
0.30
Dementia 24
-0.47
0.30
24
-0.38
0.32
Total
47
-0.48
0.30
47
-0.39
0.31
CVLT-FC
MCI
23
-0.36
0.25
23
-0.21
0.26
Dementia 24
-0.40
0.26
24
-0.26
0.18
Total
47
-0.38
0.25
47
-0.23
0.22
LMI
MCI
23
0.00
0.40
23
-0.26
0.39
Dementia 24
0.36
0.35
24
0.12
0.48
Total
47
0.18
0.42
47
-0.06
0.47
LMII
MCI
23
-0.06
0.63
23
-0.02
0.62
Dementia 24
0.49
0.48
24
0.40
0.51
Total
47
0.22
0.62
47
0.19
0.60
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for patient prediction

n

Total
Mean

SD

46
48
94

-0.33
0.20
-0.06

0.12
0.11
0.08

46
48
94

-0.42
-0.13
-0.28

0.11
0.10
0.07

46
48
94

-0.44
-0.43
-0.44

0.06
0.06
0.04

46
48
94

-0.31
-0.31
-0.31

0.05
0.05
0.03

46
48
94

-0.15
0.25
0.05

0.08
0.08
0.05

46
48
94

-0.02
0.42
0.20

0.12
0.11
0.08

Figure 33. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
California Verbal Learning Test Immediate Recall (CVLT IR)

Figure 34. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
California Verbal Learning Test Delayed Recall (CVLT DR)
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Figure 35. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
California Verbal Learning Test Recognition (CVLT Rec)

Figure 36. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
California Verbal Learning Test Forced Choice Recognition (CVLT FC)

112

Figure 37. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Logical Memory I (LMI)

Figure 38. Prediction and evaluation ratios (±SD) for MCI and dementia patients for
Logical Memory II (LMII)
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Table 47
Multivariate analysis of covariance analysis for the domain of memory for
prediction and evaluation anosognosia ratios for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
Between Intercept
0.17
1.36
6
39
0.254
Age
0.12
0.92
6
39
0.494
Diagnosis
0.33
3.23
6
39
0.011
Within
Time
0.17
1.33
6
39
0.269
Time*Age
0.19
1.56
6
39
0.185
Time*Diagnosis
0.16
1.19
6
39
0.33

patient

η2
0.17
0.12
0.33
0.17
0.19
0.16

Table 48
Univariate analysis of covariance analysis for the domain of memory for patient
prediction and evaluation anosognosia ratios for MCI and dementia patients
Main Effect of
Time x Diagnosis
Main Effect of
Time
Interaction
Diagnosis
2
2
Measure
F(1,44)
p
η
F(1,44)
p
η
F(1,44)
p
η2
CVLT-IR
3.93
.054 0.08
10.16
.003 0.19
5.06
.029 0.10
CVLT-DR
0.92
.342 0.02
3.61
.064 0.08
0.63
.432 0.01
CVLT-Rec
2.93
.094 0.06
0.03
.874 0.00
0.06
.803 0.00
CVLT-FC
0.00
.989 0.00
0.00
.961 0.00
0.06
.803 0.00
LMI
0.74
.393 0.02
12.20
.001 0.22
0.45
.505 0.01
LMII
0.00
.965 0.00
6.96
.011 0.14
1.22
.276 0.03

predictions of their performance relative to their actual performed in comparison to their
dementia group counterparts.

Executive Function
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of
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executive function, including the WCST and Trails B, while controlling for age (see
Table 49 and Figures 39-40). As presented in Table 50, the between subjects main effect
of diagnosis group indicated a significant effect on the combined DV (Pillai’s Trace=.21,
F(2,45)=6.04, p=.005, multivariate η2=.21). The within-subjects main effect of time did
not indicate a significant effect on the combined DV (Pillai’s Trace=.00, F(2,45)=.09,
p=.916, multivariate η2=.00). The interaction effect between diagnosis group and time did
not indicate a significant effect on the combined DV (Pillai’s Trace=.03, F(2,45)=.64,
p=.534, multivariate η2=.03). The covariate did not significantly influence the combined
DV (Pillai’s Trace=.02, F(2,45)=.56, p=.578, multivariate η2=.02).
Univariate ANOVA results are presented in Table 51, and indicated that Trails B
anosognosia ratios were significantly effected by diagnosis group (F(1,44)=10.70, p=.002,
partial η2=.19), while WCST anosognosia ratios were not (F(1,44)=3.18, p=.081, partial
η2=.06). Comparison of Trails B anosognosia ratio means indicated that anosognosia
ratios for MCI patients were lower than those of dementia patients, indicating that MCI

Table 49
Mean scores and standard deviations for the domain of executive function for patient
prediction anosognosia ratios for MCI and dementia patients
Time
Diagnosis
Prediction
Evaluation
Total
Group
n
Mean
SD
n
Mean
SD
n
Mean
SD
WCST
MCI
24
-0.13
0.39
24
-0.27
0.37
48
-0.19
0.06
Dementia 25
0.12
0.26
25
-0.17
0.37
50
-0.04
0.06
Total
49
-0.01
0.35
49
-0.22
0.37
98
-0.12
0.04
Trails B
MCI
24
0.19
0.59
24
0.21
0.59
48
0.18
0.11
Dementia 25
0.69
0.45
25
0.65
0.47
50
0.70
0.11
Total
49
0.45
0.57
49
0.44
0.57
98
0.44
0.07
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Figure 39. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Wisconsin Card Sorting Test (WCST)

Figure 40. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the
Trail Making Test Part B (Trails B)
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Table 50
Multivariate analysis of covariance analysis for the domain of executive function for
patient prediction and evaluation anosognosia ratios for MCI and dementia patients
Hypothesis Error
Effect
Value
F
df
df
Sig.
η2
Between Intercept
0.07
1.71
2
45
0.193 0.07
Age
0.02
0.56
2
45
0.578 0.02
Diagnosis
0.21
6.04
2
45
0.005 0.21
Within
Time
0.00
0.09
2
45
0.916 0.00
Time*Age
0.01
0.29
2
45
0.751 0.01
Time*Diagnosis
0.03
0.64
2
45
0.534 0.03

Table 51
Univariate analysis of covariance analysis for the domain of executive function for
patient prediction and evaluation anosognosia ratios for MCI and dementia patients
Main Effect of
Time x Diagnosis
Main Effect of
Time
Interaction
Diagnosis
2
2
Measure F(1,46)
p
η
F(1,46)
p
η
F(1,46)
p
η2
WCST
0.06
.806 0.00
3.18
.081 0.06
0.82
.370
0.02
Trails B
0.09
.767 0.00
10.70
.002 0.19
0.70
.406
0.02

patients had the tendency to provide less favorable predictions of their performance
relative to their actual performance than the dementia group.

Hypothesis 4
Logistic Regression – Enter Method
A logistic regression was conducted using the enter method to determine if
predictive anosognosia ratios for all 20 neuropsychological measures across six cognitive
domains, and age were predictors of diagnostic group membership (MCI vs. dementia,
see Table 52). A test of the full model with all predictors against a constant-only model
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was statistically significant, χ2 (21, N=42)=58.129, p=.000, indicating that the predictors,
as a set, reliably distinguished between patients diagnosed with MCI and those diagnosed
with dementia. Regression results indicated the overall model fit of the 21 predictors was
impressive, such that it predicted group membership with 100% accuracy (-2 Log
Likelihood=.000, Hostmer and Lemeshow χ2 (7, N=42)=.000, p=1.00). Results also
indicated that anosognosia ratios for the 3MS, Trails A, Animals, CVLT IR, BD, CVLT
DR, CVLT Rec, LMI, JLO, and WTAR contributed to differential diagnosis between
MCI and dementia groups (Exp(B)=4.882E+070; Exp(B)=9.501E+039; 3.612E+038;
Exp(B)=3.906E+11; Exp(B)=2.297E+31; Exp(B)=160739907; Exp(B)=76.999; 20.562;
Exp(B)=9.843E+27; Exp(B)=5.239E+18, respectively).

Logistic Regression – Forward Method
A forward logistic regression was conducted to determine the most predictive set
of anosognosia ratios for diagnostic group membership, using the same set of predictors
as the first logistic regression (20 neuropsychological measures across six domains, and
age). The anosognosia ratios for the 3MS and LMII were the only two predictors to enter
the model (see Table 53). Regression results indicated the overall model of fit for the two
predictors was questionable (-2 Log Likelihood=32.545, Hostmer and Lemeshow χ2 (8,
N=42)=18.421, p=.018) but was statistically reliable in distinguishing between diagnostic
groups, χ2 (1, N=42)=7.264, p=.007. Regression results also indicated that the model
impressively predicted group membership, with 85% accuracy for the MCI group and
81.8% accuracy for the dementia group, for an overall accuracy of 83.3%. These results
indicate that anosognosia ratios for the 3MS and LMII, in isolation of the rest of the
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anosognosia ratios, were significant predictors of diagnostic group membership and
reliably distinguished between MCI and dementia groups.

Table 52
Summary of simultaneous logistic regression analysis predicting
diagnostic group membership
B
SE
Exp(B)
p
Measure
1.000
-1.02
4618.03
0.36
Age
General Cognitive Ability, Premorbid Function, and Effort
3MS
.999
1.63
1459.22
5.09
WTAR
.999
0.64
885.24
1.89
.999
-1.13
1598.60
0.32
DC
Attention, Concentration, and Processing Speed
.999
0.92
865.57
2.51
Trails A
1.000
-0.11
2274.33
0.89
DSF
1.000
-0.20
1707.89
0.82
DSB
.999
-0.21
293.19
0.81
SDMT
Language
.999
-0.91
981.04
0.40
FAS
.998
0.89
405.97
2.43
Animals
1.000
-0.01
1182.65
0.99
BNT
Visuoperceptual and Visuoconstructional
1.000
0.25
487.19
1.29
JLO
1.000
0.72
1155.55
2.06
BD
Memory
1.000
0.27
1086.87
1.31
CVLT IR
1.000
0.19
533.32
1.21
CVLT DR
1.000
0.04
896.89
1.04
CVLT Rec
.999
-0.91
735.45
0.40
CVLT FC
1.000
0.03
918.30
1.03
LMI
1.000
-0.08
813.39
0.92
LMII
Executive Function
1.000
-0.09
378.08
0.91
WCST
1.000
-0.05
1044.84
0.95
Trails B
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Table 53
Summary of forward logistic regression analysis predicting
diagnostic group membership
B
SE
Exp(B)
p
Measure
.082
.028
1.085
.003
3MS
LMII
.020
.009
1.021
.021
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CHAPTER SIX
DISCUSSION

The current study sought to standardize the assessment of anosognosia using a
clinically relevant, easily replicable protocol that could readily be incorporated into
existing routine assessments of patients with cognitive complaints related to mild
cognitive impairment and dementia diagnoses. In addition, investigation into the
relationships between patient predicted performance, informant predicted performance,
and actual performance were performed in order to assess the validity of current
anosognosia assessment procedures using informant input as the benchmark for
assessment of presence and severity of anosognosia (Evans et al., 2005; Flashman &
McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et al., 1998). The study also
sought to investigate the relationship between informant and patient performance as they
relate to actual performance, a methodology seldom used in current anosognosia
literature (Fleming, Strong, & Ashton, 1996; Barrett et al., 2005). Emergent awareness,
which is currently unexamined in anosognosia literature, was assessed by investigating
the difference between predictions of performance and evaluations of performance before
and after each neuropsychological measure, respectively, to examine changes in
awareness after having completed a measure. Lastly, the ability to predict diagnosis based
on patient predictions of performance relative to actual performance was assessed.

Hypothesis 1 – Patient Versus Informant Ratings
It was hypothesized that a significant difference would be present between patient
and informant predictions of patient performance, such that patients would estimate their
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performance more favorably than would their respective informants. Analysis compared
patient and informant prediction percentages, irrespective of actual performance, for each
domain of neuropsychological function.

General Cognitive Ability, Premorbid Function, and Effort
Patient and informant ratings were significantly different for the domain of
general cognitive ability, premorbid ability, and effort, with patients providing more
favorable predictions than informants for a measure of general cognition (3MS).
Interestingly, patients had the tendency to provide less favorable predictions on a
measure of effort asking patients to quickly count a series of cards with dots on them
(DC). It is possible that the difference seen between these two ratings is due to an effect
of order, because the 3MS is given first in the neuropsychological battery and the DC is
administered last, thus possibly reflecting a tendency to provide less favorable ratings
throughout the course of the evaluation. Patients and informants provided similar
predictions of patient ability to read a list of irregular words (WTAR). Thus, patients
provided differentially favorable predictions of their general cognitive ability, but less
favorable predictions of their ability to perform simple speeded counting tasks.

Attention, Concentration, and Processing Speed
Patients and informants provided significantly different ratings for the domain of
attention, concentration and processing speed. Patients demonstrated the tendency to rate
themselves more favorably on a measure of speeded visual attention (Trails A) than their
informant counterparts. Patients and informants provided similar predictions of ability of
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verbal attention and working memory (DSF and DSB, respectively) and psychomotor
processing speed (SDMT). Thus, patients provided differentially favorable predictions
of their performance on speeded visual attention tasks (Trails A), but not for tasks
reflective of verbal attention and concentration or psychomotor processing speed.

Language
Both groups provided similar ratings for the language domain. There were no
differences found in patient and informant ratings on phonemic and semantic fluency
ability (FAS and Animals, respectively) or confrontational naming (BNT). Thus, patients
did not provide differentially favorable predictions of their language skills.

Visuoperception and Visuoconstruction
Both groups provided similar ratings for the visuospatial domain. No differences
were found in patient and informant predictions of ability for visuoperceptual and
speeded visuoconstructional ability (JLO and BD, respectively). Thus, patients did not
provide differentially favorable predictions of their visuospatial skills.

Memory
Patient and informant ratings were found to be significantly different for the
memory domain. Patients more favorably rated their ability to recognize previously
presented discrete information in forced choice format (CVLT FC). Interestingly, patients
were found to rate themselves less favorably on delayed contextual memory for stories
(LMII) than their informant counterparts. No differences were found between patient and
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informant predictions for immediate or delayed recall of discrete information (CVLT IR,
CVLT DR, respectively), yes/no recognition ability for previously presented discrete
information (CVLT Rec), or immediate recall of contextual information (LMI). Thus,
patients had the tendency to provide differentially more favorable predictions of their
forced choice recognition ability, but differentially less favorable predictions of their
delayed contextual memory. In addition, they did not provide differentially favorable
predictions of ability on other facets of memory, including discrete immediate, delayed,
and recognition memory, or immediate contextual memory.

Executive Function
Lastly, the groups were found to provide significantly different ratings for the
domain of executive function. Patients provided differentially more favorable predictions
of their performance in novel, ambiguous problem solving (WCST) as well as in speeded
mental set shifting (Trails B). Thus, on measures of executive function, patients had the
tendency to provide differentially favorable predictions of their performance than their
informant counterparts.

Conclusions
In sum, the hypothesis that patients would provide significantly more favorable
predictions of their neuropsychological performance ability received mixed support
across cognitive domains, with support in the areas of general cognitive ability, speeded
visual attention, forced choice recognition memory, and executive function as a whole.
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The reverse pattern of patient and informant ratings between the 3MS and Trails
A is interesting, given that patients provided more favorable responses than informants
when asked about their general cognitive ability, while the reverse was seen when asked
to serially connect 25 numbers on a page, a measure of speeded visual processing. It is
likely that the manner in which the 3MS measures “general cognitive ability” is
conceptually different than what is implied when the lay public thinks about general
cognitive skills, and thus the way in which the question was worded may not have
translated well to the general public. The reverse pattern of ratings seen in Trails A also
provides evidence for the idea that patients do not consistently provide more favorable
predictions of their performance than their informant counterparts. This was also seen on
a measure of delayed memory for contextual information. The fact that patients failed to
consistently rate themselves more favorably across all measures, as well as across all
domains of function, falls in line with research previously conducted, however the
domains within which anosognosia was apparent differed. Barrett and colleagues (2005)
found that anosognosia was present primarily for visuospatial function in Alzheimer’s
dementia patients. It is possible that the heterogeneous diagnostic sample employed in the
current study diluted the impact of anosognosia seen in dementia, such that the pattern of
anosognosia seen in their study is specific to Alzheimer’s dementia and not dementia as a
whole. The current study found that patients and informants provided commensurate
predictions within the domains of language and visuospatial skills.
Previous anosognosia research traditionally measures anosognosia for memory as
a single construct, but neuropsychological tests assess different aspects of memory,
which would make it difficult for patients to provide reliable predictions and evaluations
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of their performance on memory measures (Barrett et al., 2005; Carr, Gray, Baty, & J. C.
Morris, 2000; Derouesné et al., 1999). The current study conducted multistep ratings of
different aspects of memory, parallel with the method of measuring memory skills used
in traditional neuropsychological assessment. As such, patients were asked for prediction
and evaluation ratings for immediate and delayed portions memory, as well as yes/no
recognition memory and forced choice memory for previously presented information.
Interestingly, differences in patterns of responding were seen across memory measures,
with patients rating themselves more favorably on forced choice recognition paradigms
than informants, and less favorably on delayed recall for contextual information. No
differences were found for immediate, delayed, and yes/no recognition memory for
discrete information or on immediate memory for contextual information. In addition,
patients rated themselves less favorably on delayed recall for contextual information than
informants. Thus, “memory” is clearly not a unitary construct, and more fine-grained
analysis of anosognosia within this domain is warranted.
Additionally, the fact that patients rated themselves less favorably on measures of
delayed recall for contextual information relative to their informant counterparts speaks
to the real world frustration that many family members and caregivers of MCI and
dementia patients face. Informants predict, and likely expect, that patients remember
more contextual information, or presented in story format as opposed to discrete lists,
than patients predict they will. Thus, it is likely that these family members and caregivers
are providing information to patients with this idea in mind, which likely leads to a
disconnect between patient and caregiver expectations of patient ability. In addition, the
current analysis also revealed that patients tend to overestimate their ability to solve
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problems, as discussed below, and likely lack the insight to make appropriate
compensations for their memory ability.
Lastly, patients rated themselves consistently more favorably on measures of
executive function. This may be related to the fact that these types of measures, by
definition, are novel and require the patient to perform tasks that are not typically asked
of them. Thus, patients have little experience with these types of tasks to provide a basis
for prediction of their ability. This is often clinically evident during the
neuropsychological evaluation process, such that patients are often surprised and/or
perplexed by the difficulties they encounter when attempting these tasks.

Hypothesis 2 – Accuracy of Ratings
Research to date has yet to compare the accuracy of patient predictions of their
performance or informant predictions of patient performance relative to actual
performance ability. It was hypothesized that there would be significant differences
between information sources (patient prediction, informant prediction, and actual
performance), with informant predictions more accurate than patient predictions.
Accuracy of patient and informant predictions were assessed relative to patient’s actual
performance on each measure. In addition, it was hypothesized that there would be
significant differences between informant predictions based on diagnosis groups, such
that the accuracy of informant ratings would be better for MCI patients than dementia
patients. Lastly, domain specific awareness was hypothesized to be accurate for memory
ability, but poor for visuospatial ability for both patient and informant predictions.
Analysis employed patient predictions and informant predictions (both irrespective of
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actual performance), as well as actual performance for MCI and dementia patients for
each domain of neuropsychological function.

General Cognitive Ability, Premorbid Function, and Effort
Significant differences were found between information sources and diagnosis
group for the domains of general cognitive ability, premorbid function, and effort. An
interaction effect was found for a measure of general cognitive ability (3MS), with
significant overall differences observed for both source of information and diagnosis. For
both MCI and dementia groups, informants significantly underestimated patient general
cognitive ability relative to actual performance, and they predicted dementia patient
performance significantly lower than MCI patient performance. Lastly, MCI patients
performed significantly better than their dementia counterparts. Thus, patients were
actually better predictors of their performance than informants for patient general
cognitive ability, regardless of their diagnosis. It is possible that this finding speaks to the
limited ecological validity of neuropsychological assessment measures in their sensitivity
to everyday functional capacity. While patients may, indeed, have areas of preserved
cognitive function, if their ability to compensate for general areas of weakness is
impaired, the likelihood of informants to be able to accurately predict their actual ability
is limited.
For a measure of premorbid function (WTAR), an interaction effect was seen
between source of information and diagnosis, with significant overall differences also
seen between information sources. No significant overall differences were seen for
diagnosis group. Patients and informants both underestimated patient actual performance,
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with informants predicting significantly lower performance for dementia patients than
MCI patients. There was no difference in performance between MCI and dementia
patients on this measure. Thus, MCI and dementia patients had similar levels of estimated
premorbid function, but both were inaccurate predictors of their performance.
On a measure of effort (DC), significant overall differences were seen for source
of information and diagnosis group. No interaction effect was observed. Patients and
informants provided significantly different predictions, with patient predictions
significantly lower than informant predictions. Both patients and informants predictions
were significantly lower than actual performance. Informants rated MCI patient
performance more favorably than dementia patient performance, and MCI patients
performed better than dementia patients. Thus, both patients and informants were
inaccurate predictors of performance. As discussed previously, it is possible that this
finding is reflective of emergent awareness across the course of the entire evaluation,
since the DC is given last in the battery. Thus, patients may be more cautious in their
ratings on this measure by virtue of having performed several other measures prior.

Attention, Concentration, and Processing Speed
Significant differences were found between source of information and diagnosis
group for the domain of attention, concentration, and processing speed. On a measure of
visual attention, scanning, and processing speed (Trails A), there was a significant
interaction between source of information and diagnosis, with significant overall
differences for both source and diagnosis. Patient and informant predictions were
significantly different, with patients providing more favorable responses. Significant
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differences were found between informant predictions and actual performance, with
informants underestimating patient performance. Informants predicted significantly lower
performance for dementia than MCI patients, with dementia patients actually performing
worse on this task than MCI patients. Thus, patients were actually better predictors of
their ability on Trails A than informants, regardless of their diagnosis.
On a measure of simple verbal attention (DSF), significant differences were seen
for information source. No significant interaction effect or overall difference for
diagnosis group was observed. Patient and informant ratings were similar to one another,
and both were significantly lower than actual performance. Informants rated MCI patient
performance more favorably than dementia patients, and MCI patients actually performed
better than dementia patients. Thus, both patients and informants were poor predictors of
patient performance on this measure of simple attention.
On a measure of verbal attention and working memory (DSB), no significant
interaction effects were found between information source and diagnosis, and nor overall
differences for source of information or group were found. Thus, patients and informants
were accurate predictors of actual performance, and MCI and dementia patients
performed similarly on this working memory task.
On a measure of processing speed (SDMT), a significant interaction effect was
seen between information source and diagnosis group, and significant overall differences
were seen between groups. Both patients and informants provided similar predictions,
and both were accurate predictors of actual performance. MCI patients performed
significantly better than their dementia counterparts. Thus, both patients and informants
were accurate predictors of patient performance on this processing speed task.
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Language
Significant differences were found between sources of information as well as
between diagnosis group. On a measure of phonemic verbal fluency (FAS), informants
predicted less favorable performance for dementia patients than MCI patients. On a
measure of semantic verbal fluency (Animals), dementia patients received less favorable
ratings than their dementia counterparts across all sources of information, including
actual performance. In addition, informants rated dementia patients significantly less
favorably than MCI patients. Lastly, on a measure of confrontational naming (BNT),
informants predicted that patients would perform significantly worse than they actually
did perform, regardless of diagnosis. Dementia patients, overall, received lower
predictions than MCI patients regardless of the source of information. Lastly, dementia
provided predictions that were significantly lower than the MCI patients, and dementia
patients did, in fact, perform worse than their MCI counterparts. Thus, patients were
more accurate predictors of their actual semantic fluency ability than informants, while
the reverse was true for confrontational naming ability.

Visuoperception and Visuoconstruction
Significant differences were found between sources of information and diagnosis
group for the visuoperception and visuoconstruction domain. On a measure of
visuoperception (JLO), significant interaction was found between information source and
diagnosis group, with significant overall differences seen between diagnosis groups. Both
informant and patient predictions were similar to actual performance. Informants
predicted significantly lower performance for dementia patients than MCI patients, and
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dementia patients performed significantly worse than their MCI counterparts. Thus, both
patients and informants were accurate predictors of actual performance for both MCI and
dementia patients.
On a measure of visuoconstruction (BD), a significant interaction was found
between source of information and diagnosis, and significant overall differences were
seen between information sources and between diagnosis groups. Patients and
informants provided similar predictions, and both informant and patient predictions
significantly overestimated patient actual performance. Informants provided significantly
lower performance for dementia patients than MCI patients, and dementia patients
actually performed significantly worse than their MCI counterparts. Thus, both patients
and informants were poor predictors of visuoconstructional ability.

Memory
Significant differences were found between source of information and diagnosis
group for the memory domain. On a measure of immediate memory for discrete
information (CVLT IR), a significant interaction effect was found between source of
information and diagnosis group, with significant overall differences found between
sources of information as well as between diagnosis groups. Patient predictions were
significantly lower than their actual performance, regardless of their diagnosis. MCI
patients performed significantly better than their dementia group counterparts. Thus,
patients were poor predictors of their immediate memory ability for discrete information
regardless of their diagnosis, while informant ratings were accurate for both groups.

132

On a measure of delayed recall for discrete information (CVLT DR), a significant
interaction effect was found between source of information and diagnosis group, with
significant overall differences found between sources of information but not between
diagnosis groups. Patients and informant predictions were similar and both significantly
lower than patient actual performance. MCI patients performed significantly better than
dementia patients. Thus, both patients and informants were poor predictors of patient
performance, regardless of diagnosis.
On a measure of recognition (CVLT Rec), a significant difference was found
between sources of information. No significant interaction effect or overall differences
between diagnosis groups were observed. Both patients and informants significantly
underestimated patient ability relative to their actual performance. Additionally, MCI
patients performed better than dementia patients. Thus, both patients and informants were
poor predictors of patient ability, regardless of diagnosis.
On a measure of forced choice recognition (CVLT FC), significant differences
were found for both source of information and diagnosis. No significant interaction effect
was observed. Patient and informant predictions were significantly different. Though
both informants and patients significantly underestimated patient performance for both
MCI and dementia patients, the extent to which informants underestimated performance
was significantly lower than that of patients’. MCI patients performed significantly better
than dementia patients. Thus, both patients and informants were poor predictors of
patient’s forced choice recognition ability.
On a measure of immediate memory for contextual information (LMI), a
significant interaction effect between source of information and diagnosis group was seen,

133

with significant overall differences seen between source of information. There was no
significant overall difference observed between diagnosis groups. Patient and informant
predictions were similar regardless of diagnosis, with both significantly overestimating
patient actual performance. MCI patients performed significantly better than dementia
patients. Thus, patients and informants were both poor predictors of patient actual ability
for immediate memory for contextual information.
On a measure of delayed memory for contextual information (LMII), a significant
interaction was seen between source of information and diagnosis group, and a
significant overall difference was seen between information sources. No significant
overall difference was observed in between diagnosis groups. Though patient and
informant ratings were similar, informants significantly overestimated patient
performance relative to actual performance, and predicted significantly better
performance in MCI patients than in dementia patients. MCI patients performed
significantly better than dementia patients. Thus, patients were more accurate predictors
of their performance on measures of delayed contextual memory than informants, with
informants predicting better performance than the patients actually performed.

Executive Function
Significant differences were found between source of information and diagnosis
group for the executive function domain. On a measure of novel, ambiguous problem
solving (WCST), a significant interaction effect was found between sources of
information and diagnosis group, with significant overall differences between sources of
information. No significant overall differences were seen between diagnosis groups.
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Patient and informant predictions were significantly different, with patient predictions
similar to actual performance and informant predictions significantly lower than actual
performance. Dementia patients provided more favorable responses than their MCI
counterparts, whereas informant predictions were more favorable for MCI patients than
dementia patients. MCI patients actually performed similarly to dementia patients. Thus,
patients were better predictors of their actual performance than informants were, with
informants underestimating patient performance on novel, ambiguous problem solving.
On a measure of speeded mental set shifting (Trails B), a significant overall effect
was found for source of information, and a significant overall effect was also found for
diagnosis group. No interaction effect was observed. Informants and patients provided
similar predictions, but patient predictions were significantly higher than actual
performance. Patient predictions were similar regardless of diagnosis group, but
informants had the tendency to provide more favorable estimations for MCI patients than
dementia patients. MCI patients performed better than dementia patients. Thus, patients
were more accurate predictors of performance than informants for tasks requiring
speeded mental set shifting.

Conclusions
In sum, the hypothesis that informants were more accurate predictors of patient
performance received little support. Out of 20 cognitive measures, informants were only
more accurate predictors of patient performance on two, immediate memory for discrete
information and confrontational naming. On five measures, informant and patient
predictions were both commensurate with actual performance, including measures of
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auditory working memory, psychomotor processing speed, phonemic verbal fluency, and
a measure of visuoperception.
On seven measures, informant and patient predictions were equally poor
estimations of patient ability, with both sources of information underestimating actual
patient performance. These measures included a measure of premorbid ability, a measure
of effort, a measure of simple auditory attention, a measure of visuoconstruction, and
three measures of memory (delayed recall for discrete information, yes/no recognition
ability, and forced choice recognition ability). On a measure of immediate memory for
contextual information, informant and patient predictions were equally poor estimations
of patient ability, with both sources overestimating actual performance.
Importantly, on six measures, informants were less accurate predictors of patient
ability than patients were. These measures included measures of general cognitive ability,
visual attention, semantic verbal fluency, and delayed recall of contextual information,
novel problem solving, and speeded mental set shifting. Of note, informants provided
more favorable predictions than did patients on both immediate and delayed memory for
contextual information.
This set of findings provides consistent, potentially alarming evidence for the
notion that informant reports of patient ability are not universally accurate, and in fact are
more often inaccurate in relation to actual patient performance. The underlying
explanation for this discrepancy is likely multifactorial and dependent upon a number of
factors, including the relationship between the informant and patient (i.e. child vs. spouse
vs. caregiver), the amount and nature of time spent with the patient (i.e. living together vs.
visiting regularly vs. visiting on holidays), the cognitive status of the informant, and the
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context within with the initial referral was placed that may create bias with respect to the
informant’s perception of the patient’s ability. Thus, the current trend in anosognosia
literature across neurological diagnoses to use informant ratings as the “benchmark” for
assessing anosognosia is problematic (Evans, Sherer, Nick, Nakase-Richardson, &
Yablon, 2005; Flashman & McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et
al., 1998). In fact, the current study showed that patients are often better reporters of
their own ability than informants are, regardless of the severity of their diagnosis (MCI vs
dementia). Thus, a patient could potentially be evaluated as having anosognosia when, in
fact, their informant is providing unjustifiably low reports of their function, while their
own reported functioning is actually commensurate with their actual function. It is
important to note that the current study is investigating the accuracy of reports of
neuropsychological function, while informants may be more focused on functional ability.
This is likely an important factor to consider when formulating anosognosia measures,
such that informant predictions are relative to real world functionality, not
neuropsychological performance. Lastly, this analysis provides evidence for the superior
sensitivity of discrepancy between patient predictions and actual performance than that of
the discrepancy between informant and patient predictions in determining anosognosia of
cognitive ability.
It is certainly possible, and logically conceivable, that informant ratings are
negatively biased just by the nature of their relationship to the patient. Clinically,
informants are typically spouses or other family members that are intimately connected to
the patient, and often also have the responsibility of “filling in the gaps” with regard to
patients’ everyday functioning, both of which can naturally negatively skew their view of
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patient ability. This idea is supported by the fact that informant ratings are consistently
lower for dementia patients than MCI patients, even on tasks where their actual
performances are commensurate with one another.

Hypothesis 3 – Emergent Awareness by Cognitive Domain
Emergent awareness has not been systematically studied in formal
neuropsychological assessment paradigms. It was hypothesized that emergent awareness
would vary across cognitive domains, with more emergent awareness seen for tasks
allowing for physical manipulation of objects and/or verbal feedback from the examiner
(i.e. BD and WCST, respectively). It was additionally hypothesized that this emergent
awareness would be greater in MCI patients than dementia patients. Data was analyzed
using anosognosia ratios of patient predicted performance to actual performance taken
prior to administration of each measure, and anosognosia ratios of patient evaluations of
performance to actual performance taken subsequent to administration of each measure.

General Cognitive Ability, Premorbid Function, and Effort
No significant differences were found between time of rating for anosognosia
ratios for measures of cognitive ability, premorbid function, and effort, though significant
differences were found between diagnostic groups. On a measure of general cognitive
ability, MCI patients had the tendency to provide less favorable predictions and
evaluations of their performance relative to their actual performance in comparison to the
dementia group. Thus, MCI patients significantly underestimated their ability in
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comparison to their dementia counterparts, which may be indicative of a general
increased sensitivity to their general cognitive function than dementia patients.

Attention, Concentration, and Processing Speed
No significant differences were found between time of evaluation for anosognosia
ratings for anosognosia ratios for measures of attention, concentration, and processing
speed, but significant differences were found between diagnostic groups. On measures of
speeded visual attention, working memory, and processing speed, MCI patients rated
themselves less favorably both pre and post testing than dementia patients, which may
also be indicative of a general increased sensitivity to their functioning in these areas
relative to dementia patients.

Language
No significant differences were found between time of evaluation and diagnosis
group for anosognosia ratios for measures of language ability. Thus, there were no
differences between pre and post ratings for MCI and dementia patients relative to actual
performance on measures of language.

Visuoperception and Visuoconstruction
No significant differences were found between time of evaluation for anosognosia
ratios for measures of visuoperception and visuoconstruction, but there was a significant
difference between diagnostic groups. On both measures, MCI patients had the tendency
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to underestimate their performance relative to their actual performance, regardless of the
time in which the rating was collected.

Memory
No significant differences were found between time of evaluation for anosognosia
ratios for measures of memory, but there was a significant effect between diagnostic
groups. On a measure of immediate recall of discrete information, as well as immediate
and delayed memory for contextual information, MCI patients had the tendency to
provide less favorable ratings of their performance, regardless of the time in which the
rating was solicited, compared to their dementia counterparts. This may also be indicative
of an increased sensitivity to their cognitive function in this area.

Executive Function
No significant differences were found between time of evaluation for anosognosia
ratios for measures of executive function, but significant effects were found between
diagnostic groups. On a measure of speeded mental set shifting, MCI patients had the
tendency to provide less favorable ratings of their performance, regardless of time, than
their dementia counterparts.

Conclusions
In sum, there was no evidence of emergent awareness across time (pre and post
assessment) in any cognitive domain assessed for either MCI patients or dementia
patients. This is inconsistent with previous research (Barrett et al., 2005) and the nature
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of the lack of appreciable differences is unclear. The fact that previous research typically
uses Likert scales, requiring patients to provide ordinal responses, and the current study
employed visual scales, where patients provided their responses along an unmarked line,
led to difficulty quantifying meaningful change before and after assessment. In other
words, Likert scales provide a structural context in which to provide responses, with
clearly delineated markers between ratings that may lend themselves easier to making
appreciably distinct ratings pre and post assessment. The nature of the currently
employed scales was to release the patient from that very structure imposed by Likert
scales, but may have left the determination of “appreciable changes” between prediction
and evaluation ratings to the discretion of the respondent. Thus, while a one-inch
difference in ratings for one patient may mean the same decrement in performance that a
three-inch difference in ratings may mean to a different patient.
A second influencing factor may be the confrontational nature of the prediction
and evaluation paradigm used in the current study. Since patients provided their
prediction and evaluation responses on the same sheet of paper, they are confronted with
their predicted performance ratings at the time that they are asked to provide their
evaluation of performance ratings. Previous studies lack the confrontational nature in
their pre and post assessment, which may also contribute to the disparity in results seen
across studies (Evans, Sherer, Nick, Nakase-Richardson, & Yablon, 2005; Flashman &
McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et al., 1998).
There was, however, significant effects of diagnostic group across all domains
except for language, with MCI patients consistently providing less favorable ratings of
their performance relative to their actual performance, regardless of the time in which the
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ratings were collected. This provides evidence for the fact that MCI patients are
anosognostic with regard to their cognitive function in the negative direction, such that
they consistently underpredict and underevaluate their actual performance. However, the
hypothesis that emergent awareness would differ across cognitive domains received no
support.

Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment
It was hypothesized that measures of anosognosia across the entire evaluation
would be reliably predictive of group membership, and thus diagnostically informative. It
was also hypothesized that anosognosia measures of memory would be the best
predicting measures of diagnostic group membership.

Logistic Regression – Enter Method
In order to investigate the possibility of predicting diagnosis group based on
emergent awareness over the course of the evaluation, a logistic regression was
performed using the enter method and force entering all 21 anosognosia prediction ratios
for neurocognitive measures and age for both MCI and dementia patients. Statistical
analyses revealed that MCI and dementia diagnoses could be reliably predicted based on
anosognosia ratios with 100% accuracy for both groups.

Logistic Regression – Forward Method
In order to investigate the possibility of predicting diagnosis group based on
predictive anosognosia ratios for specific measures, a second logistic regression was
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performed using for forward method, such that only predictors that significantly
accounted for variance in anosognosia ratios entered the model. The 21 anosognosia
prediction ratios for neurocognitive measures and age were entered into the analysis. Two
iterations were completed, with the anosognosia prediction ratios for general cognitive
function (3MS) and delayed contextual memory (LM II) remaining in the model. MCI
group membership was predicted with 85% accuracy, and dementia group membership
was predicted with 81.8% accuracy based on the model. Thus, group membership can be
reliably predicted using only predictive anosognosia ratios for general cognitive function
measures and delayed contextual memory. With respect to predictive anosognosia ratios
for general cognitive ability, MCI patients had the tendency to provide less favorable
estimations of their performance relative to their actual performance, while dementia
patients provided more accurate predictions relative to their actual performance ability.
For delayed contextual memory, MCI patients had the tendency to provide slightly less
favorable predictions relative to their actual ability, while dementia patients had the
tendency to provide largely more favorable predictions of their performance relative to
their actual performance.

Conclusions
No prior published study to date has utilized regression models to predict group
membership based on measures of anosognosia. The current regression analyses provide
both strong and convincing evidence for the clinical relevance of anosognosia assessment
in diagnosis of MCI and dementia. The fact that, by using the 21 prediction anosognosia
ratios, it was possible to predict group membership in the current sample with 100%
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accuracy speaks to the clinical sensitivity of discrepancies between patient predicted and
actual performance and the importance of including awareness assessment in the clinical
standard of care for neuropsychological work-ups secondary to complaints of dementiarelated symptomatology.
In addition, the predictive power of two single measures of anosognosia, such that
MCI and dementia diagnosis was predicted with such high rates of accuracy in the
current sample is equally compelling. It is conceptually fitting that awareness of ability
on a measure of general cognitive ability, in conjunction with that of a measure of long
term contextual memory, would accurately predict diagnostic group membership. Since
general cognitive status is highly related to patient functional ability, and functional
ability is the single differential diagnostic criterion between MCI and dementia diagnosis,
it is parsimonious that this predictive anosognosia rating would explain a large amount of
the variance between diagnostic groups. Similarly, since contextual memory measures are
often viewed as increasingly complex in relation to discrete memory measures, and that
memory complaints also constitute a diagnostic criterion in both MCI and dementia
evaluations, it is also logical that this measure of predictive anosognosia would also
explain a large amount of variance between diagnostic groups.

General
The current study provides evidence for the notion that anosognosia is
multifaceted construct, and not an “all or none” phenomenon, such that patients display
anosognosia for specific areas of cognitive function while maintaining preserved
awareness in other domains of cognitive function. It also provides novel evidence to
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show that informant predictions of patient ability are not uniformly accurate, and that
patient predictions of their own ability may be more accurate measures of their actual
ability. Importantly, the current study provides evidence for the fact that, while there is
much debate in the literature regarding the presence of anosognosia in MCI populations,
that there were numerous areas measures of awareness across multiple cognitive domains
that failed to show differences between patient and informant ratings, meaning to say that
MCI and dementia patients showed similar levels of awareness and similar levels of
anosognosia across different areas of cognitive function. Lastly, the current study speaks
to the clinical utility and unique value of anosognosia assessment in MCI and dementia
evaluation, as well as the predictive power of anosognosia ratings in isolation.
While the current study provides novel and informative results, there are a
number of limiting factors that could potentially confound its results. First, the relatively
small sample size used in the study (n=49) could potentially inadvertently accentuate any
significant differences between groups. Also, diagnostic categories were collapsed across
different types of MCI and dementia, which lead to heterogeneous populations within
each group. By increasing the overall study sample, thus bolstering the number of
contributing diagnoses, would be helpful in providing finer distinctions within each
overarching diagnostic group, and allow for more detailed analysis investigating
differences between various types of MCI and dementia with well-documented
differences in neuropathology. Second, the current study did not employ
counterbalancing techniques to prevent the impact of order of test administration on the
results. While unlikely, it is conceivably possible that the nature of the results are related
to the order in which neuropsychological tests were administered, independent of the
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nature of the tests themselves. Third, given the nature of the populations studied, the age
range of the sample was relatively restricted in comparison to the lifespan. As such, it is
possible that the current results are reflective of simple cohort effects between elderly
adults, who are also more likely to be diagnosed with dementia, and their younger
counterparts, who are more likely to be diagnosed with MCI. Thus, it is possible that the
nature of the upbringing of these different generations of patients may lend themselves to
simple cohort differences related to awareness, introspection, education, and employment.
The horizon for future research is plentiful, with novel evidence providing new
pathways to pursue. First, future research could conduct a similar study and employ a
healthy control group, which would provide for additional comparisons. It would also be
helpful to include clinician predictions of patient performance using the current paradigm,
which is also used in current literature as a benchmark for evaluating patient awareness.
It would be interesting to investigate the cognitive status of the informant as well, as they
relate to more similar or more discordant ratings of patient ability. Second, given that the
current study found informants to be poor predictors of patient performance, future
research could also investigate differences in accuracy across different types of
informants, such as spouses, children, and caregivers. Given the various relationships
informants may have with the patient, it is possible that the bias associated with patientinformant interactions is qualitatively different depending on who the informant is. Lastly,
it would be interesting to systematically investigate the relationship between levels of
anosognosia in MCI patients and their associated diagnostic trajectory to see if
anosognosia evident early on is predictive of conversion to dementia.
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APPENDIX A
LLUMC FREQUENTLY ASKED QUESTIONS SHEET

Loma Linda University Medical Center
Department of Neuropsychology
FAQ Sheet
Welcome, I am Dr. Travis Fogel, Director of the Department of Neuropsychology. You
have been referred by your physician for neuropsychological assessment. If you are like
most individuals, you have many questions about our services. I have prepared the
following Frequently Asked Questions (FAQ) and am hopeful that this will answer many
of your questions.
What is your address?
Department of Neuropsychology
Outpatient Rehabilitation Center
11406 Loma Linda Drive, South Entrance
Loma Linda, CA 92354
How can I reach you?
For appointments, please contact our scheduler, Melissa Abraham at (909) 558-4000, ext.
66142. If you need to reach me directly, you can also call my direct office line at (909)
558-4000, ext. 66105. You may also reach me by email at: tfogel@llu.edu.
Where are your offices located?
Our offices are located in the Outpatient Rehabilitation Center (ORC) or Ambulatory
Care Services. This is a single-story peach-colored building about one mile east of the
main hospital. Below are directions from the 10 Freeway. Our reception area is at the
South Entrance of the building (middle of the building facing away from Barton Road).
DIRECTIONS FROM LOS ANGELES:
10 Freeway East
Take Mountain View Ave. exit
Turn RIGHT onto Mountain View Ave. (stay on this for about 2 miles)
Turn RIGHT onto Barton Rd. at light (as you turn, a gas station will be on your right)
Turn LEFT onto Loma Linda Dr. (this will be the first traffic light after taking a right on
Barton)
Turn RIGHT into the Outpatient Rehabilitation Center (a peach-colored single-story
Spanish style building immediately before some condo-type homes -- about 400 yards
after turning onto the road)
Enter SOUTH ENTRANCE (it will be facing away from Barton Road toward a small
wall with condos on the other side)
Check in with the receptionist and I will be paged.

154

DIRECTIONS FROM PALM SPRINGS:
10 Freeway West
Take Mountain View Ave. exit
Turn LEFT onto Mountain View Ave. (stay on this for about 2 miles)
Turn RIGHT onto Barton Rd. at light (as you turn, a gas station will be on your right)
Turn LEFT onto Loma Linda Dr. (this will be the first traffic light after taking a right on
Barton)
Turn RIGHT into the Outpatient Rehabilitation Center (a peach-colored single-story
Spanish style building immediately before some condo-type homes -- about 400 yards
after turning onto the road)
Enter SOUTH ENTRANCE (it will be facing away from Barton Road toward a small
wall with condos on the other side)
Check in with the receptionist and I will be paged.
Why was I referred to see a neuropsychologist?
Your physician has referred you for a neuropsychological evaluation. This evaluation
may be of help in:

ealth care provider(s), and/or,

What is a neuropsychologist?
A neuropsychologist is a licensed psychologist specializing in the area of brain-behavior
relationships. Although a neuropsychologist has a doctoral degree in psychology, he or
she does not just focus on emotional or psychological problems. The neuropsychologist
has additional training in the specialty field of clinical neuropsychology. That means a
neuropsychologist is educated in brain anatomy, brain function, and brain injury or
disease. The neuropsychologist also has specialized training in administering and
interpreting the specific kinds of tests included in your neuropsychological evaluation. As
a part of the required education, a neuropsychologist also has years of practical
experience working with people who have had problems involving the brain.
What will happen during my first appointment and what should I bring?
The first appointment will consist of a 60-90 minute clinical interview. Some very brief
preliminary testing also may be conducted at the very end of the interview in order to
help develop the subsequent test battery. You are more than welcome to bring someone
with you to this appointment. Such a person can provide valuable supplementary
information about you (for example, their observations regarding your condition or
clarification of dates).
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It is also very helpful to prepare a list of your medications, current medical providers, and
chronology of events. This chronology might include the date of onset of your condition,
dates of any hospitalizations, and dates of any significant changes in your symptoms. It is
also helpful to obtain copies of any medical records you might possess. I can make a
copy of these records at the office. You do not need to bring any MRI films with you.
Please be on time to your appointment. Unlike physicians who may have many
overlapping appointments during their clinic hours, we block off the scheduled time for
you alone. That is, the time slot is reserved for you and you alone. As such, we are unable
to extend the appointment beyond the allotted time if you arrive late.
What will happen after the first appointment?
After the first appointment, if it is deemed appropriate, you will be scheduled for
neuropsychological testing, to occur at a later date.
How long does the testing last?
The length of this testing can vary greatly and depends on the nature of the referral
question and many other factors. Sometimes the evaluation will last only a couple of
hours. More frequently, the evaluation will last all day (6-8 hours). As examples, the test
battery for persons referred to see me as part of their pre-surgical epilepsy evaluation
requires about 6-8 hours. Persons referred for dementia evaluations may only require 1-3
hours. For longer test batteries, we may divide testing into a couple of different days.
What will happen during testing?
Testing involves taking paper-and-pencil measures or answering questions of a wide
range of mental abilities including your memory, attention and concentration, processing
speed, language skills, visuospatial skills, cognitive flexibility, planning, and
organization. Questionnaires may also be given to assess your coping skills. I also may
give you questionnaires to provide persons who know you well in order to obtain their
impressions about certain aspects of your neuropsychological functioning.
Is there anything I need to do to prepare for the day of testing?
Get plenty of rest. Otherwise the testing may simply reflect how tired you were rather
than your optimal performance. Bring your glasses and hearing aids if you typically use
them. Take your medications as you normally would. Dress comfortably. Bring a jacket
or sweater as temperatures can vary. Feel free to also bring drinks or snacks. We will take
rest breaks periodically. This is not an endurance contest; I want you to be at your best so
that I can obtain accurate and meaningful results. If testing will last all day, we will break
for about one hour for lunch. There are restaurants within walking distance. Lastly, if
someone drives you to your appointment, there is no need for them
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to stay. Third party observers are not allowed to be present in the room during testing,
and they will be asked to wait outside. It is perfectly fine for persons to drop you off and
leave. However, I would recommend that you have some way to reach them in case we
end early.
Who will administer the battery?
Typically I administer the test battery. I also have three doctoral neuropsychology interns
whom may perform portions of the battery. These are individuals whom I have selected
to train with me for one year as part of their doctoral training through Loma Linda
University’s Department of Psychology.
What happens after the testing is completed?
After you complete testing, in some ways, my work just begins. The test data will be
scored and interpreted. A formal neuropsychological evaluation report will then be
prepared. Included in this report will be a summary of your history of illness, pertinent
background, test performance, interpretation of findings, and recommendations. This
report will then be sent to the physician who referred you. Typically you and I will then
meet for a formal feedback session to review the results and my recommendations. This
feedback session lasts about an hour. You are welcome to bring whomever you would
like to this feedback session.
I look forward to working with you and believe you will find the evaluation experience
rewarding.

Travis G. Fogel, Ph.D., ABPP-CN
Neuropsychologist, PSY 17746
Director, Department of Neuropsychology and Rehabilitation Psychology
Assistant Professor, Physical Medicine and Rehabilitation
Loma Linda University Medical Center
OFFICE: (909) 558-4000, ext. 66105
FAX: (909) 558-6418
EMAIL: tfogel@llu.edu
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Loma Linda University Medical Center
Department of Neuropsychology
Here is a checklist of things to bring with you to your first appointment.

al records (I can make copies of your copies during the
interview).

purpose for seeing them)

change in symptoms, etc.).
Date of Appointment: _________________________
Time of Appointment: _________________________
Appointment with: Dr. Travis Fogel____________
Referred By: _________________________
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APPENDIX B
DEMOGRAPHIC AND PATIENT HISTORY VARIABLES COLLECTED

Marital Status:
Ethnicity:
Years Married:
Education:
Informant Present: ☐ No ☐ Yes – If yes, Relationship to Patient?
Subjective
complaints
☐ Yes
☐ No

If yes, describe.

Collateral
complaints
☐ Yes
☐ No

Onset:

Language:
D.Hand:
Years Known?
If yes, description of complaints and
from whom?

Onset:

Current Living Arrangement

☐ Alone ☐ Alone w/Nursing ☐ w/Spouse ☐ w/Children ☐ w/Roommate ☐
Assisted Living
☐ Skilled Nursing Facility

☐ Other (Please List)

Premorbid Occupation
PERSONAL MEDICAL HISTORY
If yes, how many? Severity?
TBI/LOC
☐ Yes ☐ No
If yes, how many? Residual effects?
Stroke
☐ Yes ☐ No
If yes, please list:
Medical Diagnoses
☐ Yes ☐ No
If yes, please list type and date:
Surgery
☐ Yes ☐ No
If yes, please list type and date:
Neurologic Diagnosis
☐ Yes ☐ No
If yes, please list type and date:
ADD /LD Diagnosis
☐ Yes ☐ No
If yes, please list type, date, and duration:
Psychiatric Treatment
☐ Yes ☐ No
Cigarette Use
Currently Smoking? ☐ Yes ☐ No
If yes, please list quantity and duration:
☐ Yes ☐ No
Alcohol Use
☐ Yes ☐ No

Currently Drinking?

Illicit Drug Use
☐ Yes ☐ No

Currently Using?

☐ Yes ☐ No

If yes, please list quantity and duration:

☐ Yes ☐ No

If yes, please list quantity and duration:

FAMILY MEDICAL HISTORY
If yes, please list type:
Medical Disorders

☐ Yes ☐ No

Neurologic Disorders
☐ Yes ☐ No
Notes

If yes, please list type:

159

APPENDIX C
INFORMANT PACKET – PATIENT HISTORY FORM
For how long have you known the patient? _____ Relationship: ____________________
Patient Occupation/Former Occupation: ____________ Patient Education (Years) _____
Please answer the following questions to the best of your ability. If you don’t know the
answer, just check “Don’t know”. The questionnaire is long, but it serves several
important purposes; it stimulates you to think about your own observations in greater
depth and detail and helps you to include information you might not have thought
important. And it will be read.
1. Was onset of problem with memory, language, or daily function sudden __ or gradual
__?
2. Has there been a steady progression _______, abrupt decline _______, or no
progression _______?
No

Yes

Don’t
Know

Is there a problem with:
MEMORY
3.

Remembering people’s names

_____

_____

_____

4.

Recognizing familiar faces

_____

_____

_____

5.

Finding way indoors

_____

_____

_____

6.

Finding way on familiar streets

_____

_____

_____

7.

Remembering a short list of items

_____

_____

_____

8.

More confusion late in the day

_____

_____

_____

_____

_____

_____

_____

_____

_____

11. Trouble with household tasks

_____

_____

_____

12. Trouble handling money

_____

_____

_____

13. Doesn't grasp situations or explanations

_____

_____

_____

14. Difficulty at work (check if NA _____)

_____

_____

_____

EXPRESSION
9.

Finding the right word

10. Understanding words
DAILY FUNCTIONING

Don’t
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15. Trouble dressing or caring for self

No
_____

Yes
_____

Know
_____

16. Trouble feeding self

_____

_____

_____

17. Trouble controlling bladder and bowels

_____

_____

_____

18. More irritable

_____

_____

_____

19. Less interested

_____

_____

_____

20. Less sensitive to others

_____

_____

_____

21. Loss of social graces or manners

_____

_____

_____

22. Loss of initiative

_____

_____

_____

23. Physical violence

_____

_____

_____

24. Developed odd habits or interests

_____

_____

_____

25. Excessive daytime sleepiness

_____

_____

_____

26. Vivid dreams; dreams seem real

_____

_____

_____

27. Violent movement/talking in sleep

_____

_____

_____

28. Overeating/Consuming sweets

_____

_____

_____

29. Appetite loss

_____

_____

_____

30. Eating nonfood substances

_____

_____

_____

31. More suspicious

_____

_____

_____

32. Delusions or false beliefs

_____

_____

_____

33. Hallucinations (sight, sound, odor)

_____

_____

_____

34. Illusions; mistakes one thing for another

_____

_____

_____

35. Thinks others are doubles or imposters

_____

_____

_____

36. Talks of suicide or attempts suicide

_____

_____

_____

37. Aware of having a problem

_____

_____

_____

PERSONALITY

SLEEPING AND EATING

THINKING

Don’t
No

Yes

Know

38. Poor hearing

_____

_____

_____

39. Poor eyesight

_____

_____

_____

OTHER PROBLEMS
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40. High cholesterol

_____

_____

_____

41. Stroke(s)

_____

_____

_____

42. High blood pressure

_____

_____

_____

43. Heart attack

_____

_____

_____

44. Abnormal heart beat

_____

_____

_____

45. Unexplained falls

_____

_____

_____

46. Parkinson disease (shaking, shuffling gait)

_____

_____

_____

47. Fainting spells

_____

_____

_____

48. Head injury with loss of consciousness

_____

_____

_____

49. Seizure or epilepsy

_____

_____

_____

50. Brain tumor

_____

_____

_____

51. Diabetes

_____

_____

_____

52. High or low thyroid function

_____

_____

_____

53. Treated for mental/emotional problems

_____

_____

_____

a.

Diagnosis _____________________________________________

b.

Hospitalized?

54. Down Syndrome

No _____ Yes _____
No _____ Self _____ Family Member ______

55. Other medical problems
_____________________________________________________________________
56. Drugs: medication for memory?

_____

a.

_____________________________________________

b.

_____________________________________________

c.

_____________________________________________

d.

_____________________________________________

_____

_____

Don’t
No
_____

57. Drugs: medication for calming?
a.

_____________________________________________

b.

_____________________________________________

c.

_____________________________________________
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Yes
_____

Know
_____

d.

_____________________________________________

e.

Side Effects (specify) _______________________________________

58. Illegal street drugs?
a.

_____

_____

_____

_____

_____

Other drug abuse/dependence (prescription, etc)?
___________________________________

59. Alcohol Use
a.

_____

Current number of ounces per week? __________

60. Alcohol Abuse

_____

_____

_____

61. Toxic chemical exposure

_____

_____

_____

a.

Type _______________________________________

62. Syphilis

_____

_____

_____

_____

_____

_____

_____

_____

_______________
63. Other infection (HIV, hepatitis, etc)
a.

Specify _______________________________________

64. Cancer (other than skin)

_____

a.

Type _______________________________________

b.

Treatment:
Surgery _____

None _____

Radiation ______

Chemotherapy _____

Other _____

65. Cataract surgery or other eye surgery

_____

_____

_____

66. Surgery with general anesthesia

_____

_____

_____

_____

_____

a.

_____________________________________________

b.

_____________________________________________

c.

_____________________________________________

d.

_____________________________________________

67. CAT scan or MRI (Head)

_____

Don’t
No
_____

a.

Allergies

b.

Type _______________________________________

68. Anyone in family with similar problem
a.

_____

Yes
_____

Know
_____

_____

_____

Relationship to patient _______________________________________
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69. Ever had psychiatric neurological exam
a.

_____

_____

_____

Diagnosis _______________________________________

70. Name and address of doctors seen for same or similar purpose
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
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INFORMANT PREDICTION OF PATIENT PERFORMANCE
In general, how concerned are you about the patient’s overall cognitive skills/thinking
ability? Please circle your answer on the following scale.
1
2
Not Concerned

3

4
5
6
About Average

7

8

9
10
Very Concerned

Based on your knowledge of the patient, please answer the following questions. Please
compare the patient to his/her same aged peers using the following scale:
1
2
Relatively Poorly

3

4

5
6
About Average

7

8

9
10
Relatively Well

1. Overall, how do you think the patient’s general cognitive (thinking) ability compares
with his/her same aged peers? _____
2. How well do you think the patient could initially memorize a list of 9 words if we
read the list out loud to him/her several times? _____
3. How well do you think the patient would remember those words after about 10
minutes? _____
4. If we were to read a list of more words to the patient, some of which were on the
original list and some of which were new words, how well do you think the patient
would be able to recognize the words from the original list? _____
5. If we were then to give the patient two words at a time, one of which was on the
original list and one of which wasn’t, how accurately do you think the patient would
be able to pick out the word from the list? _____
6. If we were to ask the patient to initially memorize two short stories, how well do you
think he/she would do compared to his/her same aged peers? _____
7. How well do you think the patient would remember those stories after 25 minutes?
_____
8. If we were to give the patient a set of blocks and ask him/her to arrange them so that
they matched a picture, how well do you think he/she would do compared to his/her
same aged peers? _____
9. How well do you think the patient could visually judge the angle of two lines if given
a reference like a protractor (assume he/she cannot place the protractor directly over
the lines given)? _____
10. If we were to show the patient a series of pictures of objects and asked him/her to
name them, how well do you think he/she would do? _____
11. If we were to give the patient a letter of the alphabet and ask him/her to come up with
as many words as he/she could within one minute, how well do you think he/she
would do? _____
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12. If we were to ask the patient to name as many animals as he/she could in one minute,
how well do you think he/she would do? _____
13. If we were to read the patient a string of numbers and asked him/her to repeat them
back to us in the same order that they were read, how well do you think he/she would
do? _____
14. If we were to read the patient a string of numbers and asked him/her to repeat them
back to us in the reverse order that they were read (backwards), how well do you
think he/she would do? _____
15. If we were to give the patient a key that showed a list of shapes that corresponded to
numbers and asked him/her to substitute the appropriate numbers for a row of shapes
as quickly as he/she could, how well do you think he/she would do? _____
16. If we were to give the patient a sheet with 25 randomly placed numbers and asked
him/her to connect them in order as fast as he/she could, how well do you think
he/she would do? _____
17. If we were to give the patient a sheet with 25 randomly placed numbers AND letters
and asked him/her to connect them by alternating between connecting numbers and
letters in order (i.e. 1-A-2-B-3-C, etc) as fast as he/she could, how well do you think
he/she would do? _____
18. If we were to give the patient a test that assessed his/her ability to problem solve in
new ways without really knowing where to start, how well do you think he/she would
do? _____
19. If we were to give the patient a list of uncommon words to pronounce out loud, how
well do you think he/she would do? _____
20. In general, how depressed do you think the patient is? _____
21. If we were to show the patient a series of cards, each with dots on them, how quickly
do you think he/she would be able to count the dots on the card and tell us his/her
answer? _____
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LEVEL OF FUNCTION SCALE
Please circle the patient’s current level of function at these tasks of everyday life.

Independent,
as good as
ever

Independent,
not as good
as past

Work
responsibilities

0

1

Needs
prompting
or
reminding
to perform
task
2

Hobbies

0

1

2

3

4

Household
chores

0

1

2

3

4

Shopping for
needs

0

1

2

3

4

Driving

0

1

2

3

4

Appointments

0

1

2

3

4

Finding one’s
things

0

1

2

3

4

Dressing

0

1

2

3

4

Washing and
Grooming

0

1

2

3

4

Eating

0

1

2

3

4

Toileting

0

1

2

3

4

Other:

0

1

2

3

4

Other:

0

1

2

3

4

Is there anything else you’d like to mention?
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Needs
hands-on
help or
step-bystep
directions
3

Can’t do,
depends
on others
to do
4

APPENDIX D
INFORMANT PACKET – PATIENT PSYCHIATRIC HISTORY

For how long have you known the patient? __________ Relationship:
_________________________
How would you rate your knowledge of the patient?
 Very familiar/provides daily care
 Somewhat familiar/often cares for
 Not very familiar, has minimal interaction with
If you do not live with the patient, how many hours per week do you see him/her?
_______________
Please indicate whether the patient has displayed any of the behaviors listed below within
the past four weeks. If you answer yes to any of the following questions, please continue
to the page noted to answer follow up questions related to that item.
A. Delusions: Does the patient have beliefs that you know are not true? For example,
insisting that people are trying to harm him/her. Has he/she said that family members are
not who they say they are, or that the house is not their home? (Please do not include
suspicious activity, please only indicate true beliefs on the part of the patient.)
 No (If no, please proceed to B)
 Yes (If yes, please see additional related questions)
 Not applicable
B. Hallucinations: Does the patient have hallucinations such as false visions or voices?
Does he/she see, hear, or experience things that are not present? By this, we do not mean
just mistaken beliefs such as stating that someone who has died is still alive; rather we are
asking if the patient actually has abnormal experiences of sounds or visions.
 No (If no, please proceed to C)
 Yes (If yes, please see additional related questions)
 Not applicable
C. Agitation/Aggression: Does the patient have periods when he/she refuses to cooperate
or won’t let people help him/her? Is he/she hard to handle?
 No (If no, please proceed to D)
 Yes (If yes, please see additional related questions)
 Not applicable
D. Depression/Dysphoria: Does the patient seem sad or depressed? Does he/she say that
he/she feels sad or depressed?
 No (If no, please proceed to E)
 Yes (If yes, please see additional related questions)
 Not applicable
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E. Anxiety: Is the patient very nervous, worried, or frightened for no reason? Does he/she
seem very tense or fidgety? Is he/she afraid to be apart from you?
 No (If no, please proceed to F)
 Yes (If yes, please see additional related questions)
 Not applicable
F. Elation/Euphoria: Does the patient seem too cheerful or too happy for no reason? We
don’t mean the normal happiness that comes from seeing friends, receiving presents, or
spending time with family members. We are asking if he/she has a persistent and
abnormally good mood or finds humor where others do not.
 No (If no, please proceed to G)
 Yes (If yes, please see additional related questions)
 Not applicable
G. Apathy/Indifference: Does the patient sit quietly without paying attention to things
going on around him/her? Has he/she lost interest in the world around him/her? Has
he/she lost interest in doing things or lack motivation for participating in activities? Is it
difficult to involve him/her in conversation or in doing chores?
 No (If no, please proceed to H)
 Yes (If yes, please see additional related questions)
 Not applicable
H. Disinhibition: Does the patient seem to act impulsively without thinking? Does he/she
do or say things that are not usually done or said in public? Does he/she say things that
are embarrassing to you or others?
 No (If no, please proceed to I)
 Yes (If yes, please see additional related questions)
 Not applicable
I. Irritability/Lability: Does that patient get irritated and easily disturbed? Are his/her
moods very changeable? Is he/she abnormally impatient? We do not mean frustration
over memory loss or inability to perform usual tasks; we are interested to know if the
patient has abnormal irritability, impatience, or rapid emotional changes different from
his/her usual self.
 No (If no, please proceed to J)
 Yes (If yes, please see additional related questions)
 Not applicable
J. Aberrant Motor Behavior: Does the patient pace, do things over and over such as
opening closets or drawers, or repeatedly pick at things, or wind string or threads?
 No (If no, please proceed to K)
 Yes (If yes, please see additional related questions)
 Not applicable
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K. Sleep: Does the patient have difficulty sleeping (aside from getting up once or twice to
go to the restroom and falling back asleep immediately)? Is he/she up at night? Does
he/she wander at night, get dressed, or disturb your sleep?
 No (If no, please proceed to L)
 Yes (If yes, please see additional related questions)
 Not applicable
L. Appetite and Eating Disorders: Has the patient had any changes in appetite, weight, or
eating habits? Has there been any change in type of food he/she prefers? (Please mark
Not Applicable if the patient is incapacitated and has to be fed.)
 No (If no, please stop here)
 Yes (If yes, please see additional related questions)
 Not applicable
CONTINUED FROM QUESTION A: DELUSIONS
1. Does the patient believe that he/she is in danger – that others are planning to hurt
him/her?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient believe that others are stealing from him/her?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient believe that his/her spouse is having an affair?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient believe that unwelcome guests are living in his/her house?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient believe that his/her spouse or others are not who they claim to
be?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient believe that his/her home is not his/her home?
☐ No ☐ Yes ☐ Not Applicable
7. Does the patient believe that family members plan to abandon him/her?
☐ No ☐ Yes ☐ Not Applicable
8. Does the patient believe that television or magazine figures are actually present in
the home/room?
☐ No ☐ Yes ☐ Not Applicable
If yes, does he/she try to talk or interact with them? ☐ No ☐ Yes
9. Does the patient believe any other unusual things that have not been covered
here?
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☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
10. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
11. How severe do you consider the patient’s symptoms?
 Mild – delusions are present but seem harmless, and do not upset the patient
that much
 Moderate – delusions are stressful and upsetting to the patient and cause
unusual or strange behavior
 Marked – delusions are very stressful and upsetting to the patient and cause a
major amount of unusual or strange behavior
12. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION B: HALLUCINATIONS
1. Does the patient describe hearing voices or act as if he/she hears voices?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient talk to people who are not there?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient describe seeing things not seen by others, or behave as he/she is
seeing things not seen by others (i.e. people, animals, lights, etc.)?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient report smelling odors not smelled by others?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient describe feeling things on his/her skin, or otherwise appear to be
feeling things crawling or touching him/her?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient describe tastes that are without known cause?
☐ No ☐ Yes ☐ Not Applicable
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7. Does the patient describe any other unusual sensory experiences?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
9. How severe do you consider the patient’s symptoms?
 Mild – hallucinations are present but seem harmless, and do not upset the
patient that much
 Moderate – hallucinations are distressing and disruptive
 Marked – hallucinations are very disruptive and are a major source of
behavioral disturbance (medications may be required to control them)
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely

CONTINUED FROM QUESTION C: AGITATION/AGGRESSION
1. Does the patient get upset when people are trying to care for him/her to resist
activities such as bathing or changing clothes?
☐ No ☐ Yes ☐ Not Applicable
2. Is the patient stubborn, having to have things his/her way?
☐ No ☐ Yes ☐ Not Applicable
3. Is the patient uncooperative, resistive to help from others?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient have any other behaviors that make him/her hard to handle?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient shout or curse angrily?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient slam doors, kick furniture, or throw things?
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☐ No

☐ Yes

☐ Not Applicable

7. Does the patient attempt to hurt or hit others?
☐ No ☐ Yes ☐ Not Applicable
8. Does the patient have any other aggressive or agitated behavior?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
9. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
10. How severe do you consider the patient’s symptoms?
 Mild – behavior is disruptive but can be managed with redirection or
assurance
 Moderate – behaviors are disruptive and difficult to redirect or control
 Marked – agitation is very disruptive and a major source of difficulty; there
may be a threat of personal harm. Medications are often required.
11. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION D: DEPRESSION/DYSPHORIA
1. Does the patient have periods of tearfulness or sobbing that seem to indicate
sadness?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient say or act as if he/she is sad or in low spirits?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient put him/herself down or say that he/she feels like a failure?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient say that he/she is a bad person or deserves to be punished?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient seem very discouraged or say that he/she has no future?
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☐ No

☐ Yes

☐ Not Applicable

6. Does the patient say he/she is a burden to the family or that the family would be
better off without him/her?
☐ No ☐ Yes ☐ Not Applicable
7. Does the patient express a wish for death or talk about killing him/herself?
☐ No ☐ Yes ☐ Not Applicable
8. Does the patient show any other signs of depression or sadness?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
9. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
10. How severe do you consider the patient’s symptoms?
 Mild – depression is distressing, but usually responds to redirection or
reassurance
 Moderate – depression is distressing, depressive symptoms are spontaneously
voiced by the patient and difficult to alleviate
 Marked – depression is very distressing and a major source of suffering for
the patient
11. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION E: ANXIETY
1. Does the patient say that he/she is worried about planned events?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient have periods of feeling shaky, unable to relax, or feeling
excessively tense?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient have periods of or complain of shortness of breath, gaping, or
sighing for no reason other than nervousness?
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☐ No

☐ Yes

☐ Not Applicable

4. Does the patient complain of butterflies in his/her stomach, or of racing or
pounding of the heart in association with nervousness?
☐ No ☐ Yes ☐ Not Applicable
If yes, is this associated with a medical condition?
☐ No ☐ Yes
5. Does the patient avoid certain places or situations that make him/her more
nervous such as riding in the car, meeting with friends, or being in crowds?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient become nervous or upset when separated from you or his/her
caregiver?
☐ No ☐ Yes ☐ Not Applicable
If yes, does he/she cling to you to keep from being separated?
☐ No ☐ Yes
7. Does the patient show any other signs of anxiety?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
9. How severe do you consider the patient’s symptoms?
 Mild – anxiety is stressful, but usually responds to redirection or reassurance
 Moderate – anxiety is stressful, anxiety symptoms are spontaneously voiced
by the patient and difficult to alleviate
 Marked – anxiety is very distressing and a major source of suffering
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
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CONTINUED FROM QUESTION F: ELATION/EUPHORIA
1. Does the patient appear to feel good or to be too happy, different from his/her
usual self?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient find humor and laugh at things that others do not find funny?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient seem to have a childish sense of humor with a tendency to giggle
or laugh inappropriately (such as when something unfortunate happens to others)?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient tell jokes or make remarks that have little humor?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient play childish pranks such as pinching or playing “keep away” for
the fun of it?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient “talk big” or claim to have more abilities or wealth than is true?
☐ No ☐ Yes ☐ Not Applicable
If yes, does he/she cling to you to keep from being separated?
☐ No ☐ Yes
7. Does the patient show any other signs of feeling to good or being too happy?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
9. How severe do you consider the patient’s symptoms?
 Mild – the patient is too happy at times
 Moderate – the patient is too happy at times, and this sometimes causes
strange behavior
 Marked – the patient is almost always too happy and finds nearly everything
to be funny
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
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 Moderately
 Severely
 Very severely or extremely

CONTINUED FROM QUESTION G: Apathy/Indifference
1. Does the patient seem less spontaneous and less active than usual?
☐ No ☐ Yes ☐ Not Applicable
2. Is the patient less likely to initiate a conversation?
☐ No ☐ Yes ☐ Not Applicable
3. Is the patient less affectionate or lacking in emotions when compared to his/her
usual self?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient contribute less to household chores?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient seem less interested in the activities and plans of others?
☐ No ☐ Yes ☐ Not Applicable
6. Has the patient lost interest in friends and family members?
☐ No ☐ Yes ☐ Not Applicable
7. Is the patient less enthusiastic about his/her usual interests?
☐ No ☐ Yes ☐ Not Applicable
8. Does the patient show any other signs that he/she doesn’t care about doing new
things?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
9. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
10. How severe do you consider the patient’s symptoms?
 Mild – apathy is notable but produces little interference with daily routines;
only mildly different from the patient’s usual behavior; the patient responds to
suggestion to engage in activities
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 Moderate – apathy is very evident; may be overcome with coaxing and
encouragement; responds spontaneously only to powerful events such as visits
from close relatives or family members
 Marked – apathy is very evident and usually fails to respond to any
encouragement or external events
11. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION H: DISINHIBITION
1. Does the patient act impulsively without appearing to consider the consequences?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient talk to total strangers as if he/she knew them?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient say things to people that are insensitive or hurt their feelings?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient say crude things or make sexual remarks that they would not
usually have said?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient talk openly about very personal or private matters not usually
discussed in public?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient take liberties or touch or hug others in a way that is out of
character for him/her?
☐ No ☐ Yes ☐ Not Applicable
7. Does the patient show any other signs of loss of control of his/her impulse?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
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9. How severe do you consider the patient’s symptoms?
 Mild – disinhibitiion is notable, but usually responds to redirection and
guidance
 Moderate – disinhibition is very evident and difficult to overcome by the
caregiver
 Marked – disinhibition usually fails to respond to any intervention by the
caregiver and is a source of embarrassment or social distress
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION I: IRRITABILITY/LABILITY
1. Does the patient have a bad temper, “flying off the handle” easily over little
things?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient rapidly change moods from one to another, being fine one minute
and angry the next?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient have sudden flashes of anger?
☐ No ☐ Yes ☐ Not Applicable
4. Is the patient impatient, having trouble coping with delays or waiting for planned
activities?
☐ No ☐ Yes ☐ Not Applicable
5. Is the patient cranky and irritable?
☐ No ☐ Yes ☐ Not Applicable
6. Is the patient argumentative and difficult to get along with?
☐ No ☐ Yes ☐ Not Applicable
7. Does the patient show any other signs of irritability?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
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 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
9. How severe do you consider the patient’s symptoms?
 Mild – irritability or lability is notable but usually responds to redirection and
reassurance
 Moderate – irritability and lability are very evident and difficult to overcome
by the caregiver
 Marked – irritability and lability are very evident, they usually fail to respond
to any intervention by the caregiver, and they are a major source of distress
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION J: ABBERANT MOTOR BEHAVIOIR
1. Does the patient pace around the house without purpose?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient rummage around opening and unpacking drawers or closets?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient repeatedly put on and take off clothing?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient have repetitive activities or “habits” that he/she performs over
and over?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient engage in repetitive activities such as handling buttons, picking,
wrapping string, etc?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet
or tap his/her fingers a lot?
☐ No ☐ Yes ☐ Not Applicable
7. Does the patient do any other activities over and over?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
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8. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
9. How severe do you consider the patient’s symptoms?
 Mild – abnormal motor activity is notable but produces little interference with
daily routines
 Moderate – abnormal motor activity is very evident; can be overcome by the
caregiver
 Marked – abnormal motor activity is very evident, it usually fails to respond
to any intervention by the caregiver and is a major source of distress
10. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION K: SLEEP
1. Does the patient have difficulty falling asleep?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient get up during the night (do not count if the patient gets up once
or twice per night only to go to the bathroom and falls back asleep immediately)?
☐ No ☐ Yes ☐ Not Applicable
3. Does the patient wander, pace, or get involved in inappropriate activities at night?
☐ No ☐ Yes ☐ Not Applicable
4. Does the patient awaken you during the night?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient wake up at night, dress, and plan to go out, thinking that it is
morning and time to start the day?
☐ No ☐ Yes ☐ Not Applicable
6. Does the patient wake up too early in the morning (earlier than was his/her habit)?
☐ Yes ☐ No ☐ Not Applicable
7. Does the patient sleep excessively during the day?
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☐ No

☐ Yes

☐ Not Applicable

8. Does the patient have any other night-time behaviors that bother you that haven’t
been asked about here?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
9. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
10. How severe do you consider the patient’s symptoms?
 Mild – night-time behaviors occur but they are not particularly disruptive
 Moderate – night-time behaviors occur and disturb the patient and the sleep of
the caregiver; more than one type of night-time behavior may be present
 Marked – night-time behaviors occur; several types of behavior may be
present; the patient is very distressed during the night and the caregiver’s
sleep is markedly disturbed
11. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
CONTINUED FROM QUESTION L: APPETITE AND EATING DISORDERS
1. Does the patient have poor appetite (loss of appetite)?
☐ No ☐ Yes ☐ Not Applicable
2. Does the patient have an abnormally good appetite (increase in appetite)?
☐ No ☐ Yes ☐ Not Applicable
3. Has the patient lost weight?
☐ No ☐ Yes ☐ Not Applicable
4. Has the patient gained weight?
☐ No ☐ Yes ☐ Not Applicable
5. Does the patient have unusual eating behavior, such as putting too much food in
his/her mouth at once?
☐ No ☐ Yes ☐ Not Applicable
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6. Has the patient had a change in the kind of food he/she likes, such as wanting too
many sweets or other specific types of food?
☐ No ☐ Yes ☐ Not Applicable
7. Has the patient developed eating behaviors, such as eating exactly the same types
of food each day, or eating the food in exactly the same order?
☐ No ☐ Yes ☐ Not Applicable
8. Have there been any other changes in appetite or eating that haven’t been asked
about here?
☐ No ☐ Yes ☐ Not Applicable
If so, please describe (use the back of this page if necessary):
9. How frequently does the patient experience these symptoms?
 Occasionally – less than once per week
 Often – about once per week
 Frequently – several times per week, but less than every day
 Very Frequently – once or more per day
10. How severe do you consider the patient’s symptoms?
 Mild – appetite changes are present but usually responds well to redirection
and reassurance
 Moderate – appetite changes are very evident and difficult to overcome by the
caregiver
 Marked – appetite changes are very evident, they usually fail to respond to
any intervention by the caregiver, and they are a major source of distress
11. How emotionally distressing do you find this behavior?
 Not at all
 Minimally
 Mildly
 Moderately
 Severely
 Very severely or extremely
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APPENDIX E
NEUROPSYCHOLOGICAL BATTERY ORDER OF
ADMINISTRATION

NOTE: Use BLUE pen for predictions, and GREEN pen for evaluations
"Throughout the testing process today, I am going to ask you some questions that require
you to estimate how well you would do on a certain task compared to people your same
age and education level that haven’t had complaints about their thinking ability. Please
draw a line on this scale indicating where you think your performance would fall, with
the very top of the line being extremely well (point) and the very bottom of the line being
extremely poorly (point). Remember that you are rating yourself in comparison to the
average person your same age and education."
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.

Concern (PRE) (1)
Read SCRIPT Above
WCST Prediction (2)
3MS Prediction (3)
3MS
3MS Evaluation (3)
Trails A Prediction (4)
Trails A
Trails A Evaluation (4)
Trails B Prediction (5)
Trails B
Trails B Evaluation (5)
FAS Prediction (6)
FAS
FAS Evaluation (6)
Animals Prediction (7)
Animals
Animals Evaluation (7)
CVLT Immediate Recall (IR) Prediction (8)
CVLT Immediate Free Recall
CVLT Short Delay Free Recall
CVLT Immediate Recall (IR) Evaluation (8)
Block Design (BD) Prediction (9)
Block Design
Block Design (BD) Evaluation (9)
CVLT Delayed Recall (DR) Prediction (10)
CVLT Long Delay Free Recall
CVLT Long Delay Cued Recall
CVLT Delayed Recall (DR) Evaluation (10)
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30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.

CVLT Recognition Prediction (11)
CVLT Long Delay Recognition
CVLT Recognition Evaluation (11)
SDMT Prediction (12)
SDMT – Written
SDMT Evaluation (12)
GDS Prediction (13)
GDS
GDS Evaluation (13)
CVLT Forced Choice Prediction (14)
CVLT Forced Choice
CVLT Forced Choice Evaluation (14)
Logical Memory I (LMI) Prediction (15)
Logical Memory I
Logical Memory I (LMI) Evaluation (15)
Logical Memory II (LMII) Pre-Prediction (16)
Digit Span Forward (DS-F) Prediction (17)
Digit Span Forward
Digit Span Forward (DS-F) Evaluation (17)
Digit Span Backward (DS-B) Prediction (18)
Digit Span Backward
Digit Span Backward (DS-B) Evaluation (18)
Judgment of Line Orientation (JoLO) Prediction (19)
Judgment of Line Orientation (JoLO)
Judgment of Line Orientation (JoLO) Evaluation (19)
Boston Naming (BNT) Prediction (20)
Boston Naming Test
Boston Naming (BNT) Evaluation (20)
WTAR Prediction (21)
WTAR
WTAR Evaluation (21)
WCST
WCST Evaluation (2)
Logical Memory II (LMII) Prediction (22)
Logical Memory II
Logical Memory II (LMII) Evaluation (22)
Dot Counting (DC) Prediction (23)
Dot Counting
Dot Counting (DC) Evaluation (23)
General Evaluation (24)
Concern (POST) (25)
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APPENDIX E

Prediction
Evaluation 1 (B): In general, how
concerned is your family about your
current thinking skills or cognitive
ability?
Evaluation 2 (G): In general, how
concerned are you about your current
thinking skills or cognitive ability?

Evaluation
Evaluation 1 (B): Now that we’ve completed
all these different tasks, how concerned is
your family about your current thinking
skills or cognitive ability?
Evaluation 2 (G): In general, how concerned
are you about your current thinking skills or
cognitive ability?

If I were to give you a test that
assessed your ability to solve
problems in new ways without really
knowing where to start, how well do
you think you’d do?

Earlier you said you’d do this well if I tested
your ability to solve problems in new ways.
Now that we’ve done the task, how well do
you think you actually did?

Overall, how do you think your
general cognitive ability compares
with your same age and educated
peers?

Now that we’ve done a short set of tasks that
look at your overall cognitive ability, how
well do you think you actually did in
comparison to your same age and educated
peers?

Trails A

If I were to give you a sheet with 25
randomly distributed, numbered
circles and ask you to connect them in
order as fast as you could, how well
do you think you’d do?

Earlier you said you’d do this well if I asked
you to connect 25 randomly distributed,
numbered circles. Now that we’ve done the
task, how well do you think you actually
did?

Trails B

If I were to give you a sheet with 25
randomly distributed circles, half of
them numbered and half of them
lettered, and asked you to connect
them alternating between numbers and
letters in order as fast as you could,
how well do you think you’d do?

Earlier you said you’d do this well if I asked
you to connect 25 randomly distributed
circles alternating between numbers and
letters in order. Now that we’ve done the
task, how well do you think you actually
did?

FAS

If I were to give you a letter of the
alphabet and you were given one
minute to come up with as many
words as you could that start with that
letter, how well do you think you’d
do?

Earlier you said you would do this well if
given one minute to say as many words as
you could that started with a given letter.
Now that we’ve actually done the task, how
well do you think you did?

Animals

PREDICITON AND EVALUATIONS RATING SCRIPT

If I were to give you a category (like
things you could find in a kitchen) and
ask you to name as many items that
fall within that category as you could
in one minute, how well do you think

Earlier you said you would do this well if
given a category and asked to name as many
items as you could in one minute. Now that
we’ve actually done the task, how well do
you think you actually did?
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If I were to read you a list of words to
memorize and asked you to repeat as
many words as you could, how well
do you think you’d do?

Earlier you said you’d do this well (point to
estimate) if asked to memorize a list of
words I read to you. Now that we’ve done
the task, how well do you think you actually
did?

BD

If I were to give you a set of blocks
and ask you to arrange the blocks so
that they look like a given picture I
show you, how well do you think
you’d do?

Earlier you said you’d do this well if asked
to recreate
a picture out of blocks. Now that we’ve done
the task, how well do you think you actually
did?

CVLT
DR

you’d do?

Earlier I read you a list of words and
asked you to repeat back as many
words as you could. If I were to ask
you to repeat back as many of those
words as you can now, how well do
you think you’d do?

Earlier you said you’d do this well (point to
estimate) if asked to repeat as many words as
you could remember from a list I read to you
some time ago. Now that we’ve done the
task, how well do you think you actually
did?

Earlier I read a list of words to you
several times and asked you to repeat
back as many of them as you could
remember. How well do you think
you’d be able to recognize those
words from a list including words that
were and were not from that original
list?
If I were to give you a key that
showed a list of shapes that
corresponded to numbers, how
quickly do you think you could
substitute the appropriate numbers for
a row of shapes?

Earlier you said you’d do this well (point to
estimate) if asked to recognize the words
from the list that I read to you earlier from a
list including words that were and were not
from that original list. Now that we’ve
actually done the task, how well do you think
you actually did?

In general, how often do you think
you’ve experienced depression over
the past two weeks in comparison to
other people your same age?
Earlier I read a list of words to you
several times and asked you to repeat
back as many of them as you could
remember. If I were to give you words
two at a time, one of which was on the
list and one of which was not, how
accurately do you think you’d be able
to pick out the word from the list?

You just completed a questionnaire that
assesses your level of depression. How do
you think your answers compare to other
people your same age?
Earlier you said you’d do this well (point to
estimate) if asked to pick out the correct
word if given two choices. Now that we’ve
actually done the task, how well do you think
you actually did?
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You said you’d do this well if asked to
substitute the appropriate numbers for a row
of shapes if given a key. Now that we’ve
done the task, how well do you think you
actually did?
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If I were to read you a story to
memorize and asked you to repeat it
back to me, how well do you think
you’d do?

Earlier you said you’d do this well (point to
estimate) if asked to memorize a story I read
to you. Now that we’ve done the task, how
well do you think you actually did?

If I were to read you a string of
numbers and asked you to repeat them
back to me in the same order, how
well do you think you’d do?

Earlier you said you’d do this well if asked
to repeat a string of numbers in the same
order that I read them to you in. Now that
we’ve done the task, how well do you think
you actually did?

If I were to read you a string of
numbers and asked you to repeat them
back to me in reverse order, how well
do you think you’d do?

Earlier you said you’d do this well if asked
to repeat a string of numbers in reverse
order. Now that we’ve done the task, how
well do you think you actually did?

How well do you think you could pick
out the line in the group above (point
to sample) that matches the line
shown below (point to sample)?

Earlier you said you’d do this well if asked
to pick out the lines in the group that
corresponded to the lines shown below. Now
that we’ve actually completed the task, how
well do you think you did?

If I were to assess your word finding
ability by showing you a series of
pictures of objects and asking you to
name them, how well do you think
you’d do?
If I were to give you a list of
uncommon words to pronounce out
loud, how well do you think you’d
do?

Earlier you said that you’d do this well if
asked to name items when shown a picture
of them. Now that we’ve done the task, how
well do you think you actually did?

I read you two stories earlier, do you
remember? If I were to ask you to tell
me as much about those stories as you
can remember now, how well do you
think you’d do?

Earlier you said you’d do this well (point to
estimate) if asked to repeat back as much of
those stories as you could. Now that we’ve
done the task, how well do you think you
actually did?
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Earlier you said you’d do this well if I asked
you to pronounce a list of uncommon words
out loud. Now that we’ve done the task, how
well do you think you actually did?

GENERAL

In general, how well do you think you did on
the tasks you engaged in today?
If you were to have engaged in these same
tasks before you (or your family) began
noticing changes in your cognitive ability,
how well do you think you would have
done?
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APPENDIX G
SAMPLE RATING SCALES

Not Concerned

Very Concerned
189

Extremely Well

Extremely Poorly
190

